var title_f43_33_44560="CW Doppler computer MV area";
var content_f43_33_44560=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64364&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64364&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mitral valve area from continuous wave Doppler",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 385px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A computer system, incorporated into current echocardiographic equipment, can automatically measure the P 1/2 time on the continuous wave Doppler tracing and compute the mitral valve area (MVA). In this case the P 1/2 time is 255 msec and the MVA is 220/255 or 0.86 cm",
"    <sup>",
"     2",
"    </sup>",
"    .",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44560=[""].join("\n");
var outline_f43_33_44560=null;
var title_f43_33_44561="U-S pentalogy of Cantrell";
var content_f43_33_44561=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60660&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60660&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ultrasound picture of a 10-week fetus with pentalogy of Cantrell",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 279px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ana Monteagudo, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44561=[""].join("\n");
var outline_f43_33_44561=null;
var title_f43_33_44562="Narrow band imaging Endosc I";
var content_f43_33_44562=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F50844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F50844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Narrow band imaging of Barrett's esophagus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 229px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An area with nondysplastic Barrett's mucosa at the squamo-columnar junction imaged with high resolution endoscopy (left) and with narrow band imaging (right).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.Barrett.nl. Copyright &copy; Amsterdam Esophageal Research Foundation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44562=[""].join("\n");
var outline_f43_33_44562=null;
var title_f43_33_44563="Stepwise asthma Rx 12 and up";
var content_f43_33_44563=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F56729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F56729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 634px\">",
"   <div class=\"ttl\">",
"    Stepwise approach for managing asthma in youths greater than or equal to 12 years of age and adults",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 614px; height: 559px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The stepwise approach is meant to assist, not replace, the clinical decision-making required to meet individual patient needs. If alternative treatment is used and response is inadequate, discontinue it and use the preferred treatment before stepping up. Zileuton is a less desirable alternative due to limited studies as adjunctive therapy and the need to monitor liver function. Theophylline requires monitoring of serum concentration levels. In step 6, before oral systemic corticosteroids are introduced, a trial of high-dose ICS + LABA + either LTRA, theophylline, or zileuton may be considered, although this approach has not been studied in clinical trials. Step 1, 2, and 3 preferred therapies are based on Evidence A; step 3 alternative therapy is based on Evidence A for LTRA, Evidence B for theophylline, and Evidence D for zileuton. Step 4 preferred therapy is based on Evidence B, and alternative therapy is based on Evidence B for LTRA and theophylline and Evidence D for zileuton. Step 5 preferred therapy is based on Evidence B. Step 6 preferred therapy is based on (EPR-2 1997) and Evidence B for omalizumab. Immunotherapy for steps 2-4 is based on Evidence B for house-dust mites, animal danders, and pollens; evidence is weak or lacking for molds and cockroaches. Evidence is strongest for immunotherapy with single allergens. The role of allergy in asthma is greater in children than in adults. Clinicians who administer immunotherapy or omalizumab should be prepared and equipped to identify and treat anaphylaxis that may occur.",
"    <br/>",
"    <strong>",
"     Alphabetical order is used when more than one treatment option is listed within either preferred or alternative therapy.",
"    </strong>",
"    <div class=\"footnotes\">",
"     EIB: exercise-induced bronchospasm; ICS: inhaled corticosteroid; LABA: long-acting inhaled beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonist; LTRA: leukotriene receptor antagonist; SABA: inhaled short-acting beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonist.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: National Heart, Blood, and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma. NIH Publication no. 08-4051, 2007.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44563=[""].join("\n");
var outline_f43_33_44563=null;
var title_f43_33_44564="Thoracic spinous process fracture";
var content_f43_33_44564=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F86897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F86897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Thoracic spinous process fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 655px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The radiograph of the thoracolumbar spine in lateral projection (A, and magnified in B) reveals an equivocal abnormality of the spinous process of T12. A CT scan using sagittal reformatting (C) and transverse projection (D) are more convincing for fractures through the spinous process of T11 (white arrowhead) and T12 (small white arrow). A fracture of a left sided 11th rib is of incidental note.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Gregory Waryasz, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44564=[""].join("\n");
var outline_f43_33_44564=null;
var title_f43_33_44565="Mirizzi syndrome";
var content_f43_33_44565=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mirizzi syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44565/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44565/contributors\">",
"     Renuka Umashanker, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44565/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44565/contributors\">",
"     Douglas Smink, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44565/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44565/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44565/contributors\">",
"     Stanley W Ashley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44565/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44565/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44565/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/33/44565/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Mirizzi syndrome refers to common hepatic duct obstruction caused by an extrinsic compression from an impacted stone in the cystic duct or Hartmann's pouch of the gallbladder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. It has been estimated to occur in 0.7 to 1.8 percent of all cholecystectomies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. It is often not recognized preoperatively, which can lead to significant morbidity and biliary injury, particularly with laparoscopic surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gallbladder consists of the fundus, body, infundibulum, and neck. The infundibulum is an area of tapering between the gallbladder body and neck and Hartmann's pouch is a bulging of the inferior surface of the infundibulum that lies close to the neck of the gallbladder. The gallbladder is connected at its neck to the cystic duct which empties into the common bile duct.",
"   </p>",
"   <p>",
"    Large gallstones can become impacted in the cystic duct or in Hartmann's pouch. These stones can produce common hepatic duct obstruction (the Mirizzi syndrome) by two mechanisms: mechanical obstruction of the hepatic duct because of the proximity of the cystic duct and the common hepatic duct, and secondary inflammation with frequent episodes of cholangitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/9-11\">",
"     9-11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two classifications that are usually used to clarify the variants of Mirizzi syndrome and to aid in choosing the appropriate therapeutic procedure:",
"   </p>",
"   <p>",
"    The original classification by McSherry described two types of Mirizzi syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/12\">",
"     12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type I &ndash; Compression of the common hepatic duct or common bile duct by a stone impacted in the cystic duct or Hartmann's pouch (",
"      <a class=\"graphic graphic_figure graphicRef65705 \" href=\"mobipreview.htm?1/62/2018\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef54888 \" href=\"mobipreview.htm?21/49/22289\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Type II &ndash; Erosion of the calculus from the cystic duct into the common hepatic duct or common bile duct, producing a cholecystocholedochal fistula (",
"      <a class=\"graphic graphic_figure graphicRef54508 \" href=\"mobipreview.htm?18/17/18704\">",
"       figure 3",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A more useful classification system also takes into account the presence and extent of a cholecystobiliary (cholecystohepatic or cholecystocholedochal) fistula, also known as a biliobiliary fistula, due to erosion of the anterior or lateral wall of the common bile duct by impacted stones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type I &ndash; External compression of the common hepatic duct due to a stone impacted at the neck of the gallbladder or at the cystic duct.",
"     </li>",
"     <li>",
"      Type II &ndash; The fistula involves less than one-third of the circumference of the common bile duct.",
"     </li>",
"     <li>",
"      Type III &ndash; Involvement of between one-third and two-thirds of the circumference of the common bile duct.",
"     </li>",
"     <li>",
"      Type IV &ndash; Destruction of the entire wall of the common bile duct.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Mirizzi syndrome is part of the differential diagnosis of obstructive jaundice. Most patients present with the clinical triad of jaundice, fever, and right upper quadrant pain. The major laboratory findings are elevations in the serum concentrations of alkaline phosphatase and bilirubin in over 90 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among patients with gallstones, these clinical and laboratory findings are most often due to cholangitis secondary to a stone in the common bile duct (choledocholithiasis). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24790?source=see_link\">",
"     \"Acute cholangitis\"",
"    </a>",
"    .) The diagnostic approach usually begins with ultrasonography followed by cholangiography via direct cholangiography, endoscopic retrograde cholangiopancreatography, or magnetic resonance cholangiography (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55576 \" href=\"mobipreview.htm?29/56/30607\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography and CT scanning are commonly used in patients with obstructive jaundice. Ultrasonography in this setting generally reveals gallstones and a contracted gallbladder. Features suggestive of Mirizzi syndrome include (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef86878 \" href=\"mobipreview.htm?2/37/2642\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/16\">",
"     16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dilatation of the biliary system above the level of the gallbladder neck.",
"     </li>",
"     <li>",
"      The presence of a stone impacted in the gallbladder neck.",
"     </li>",
"     <li>",
"      An abrupt change to a normal width of the common duct below the level of the stone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These features can also be seen with endoscopic ultrasonography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CT scanning does not significantly add to sonographic findings with respect to the stone and biliary obstruction but can be helpful in ascertaining if malignancy is present by revealing enlarged porta hepatis lymph nodes or hepatic metastases lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cholangiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative cholangiography is helpful to confirm the diagnosis and to determine whether a fistula is present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/16\">",
"     16",
"    </a>",
"    ]. Typically, endoscopic retrograde cholangiopancreatography (ERCP) is used, but percutaneous transhepatic cholangiography (PTC) can also be an option. Magnetic resonance cholangiopancreatography (MRCP) has also been shown to be a useful imaging modality for diagnosis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75454 \" href=\"mobipreview.htm?4/12/4290\">",
"     image 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55576 \" href=\"mobipreview.htm?29/56/30607\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/19\">",
"     19",
"    </a>",
"    ], but lacks the option of therapeutic intervention of ERCP or PTC.",
"   </p>",
"   <p>",
"    Endoscopic retrograde cholangiopancreatography (ERCP) may reveal (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76550 \" href=\"mobipreview.htm?17/27/17854\">",
"     image 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Obstruction of the common hepatic duct",
"     </li>",
"     <li>",
"      An impacted stone in the neck of the gallbladder or cystic duct",
"     </li>",
"     <li>",
"      Stone size",
"     </li>",
"     <li>",
"      Biliobiliary fistulas by the demonstration of the passage of contrast material from the proximal dilated biliary channels into the gallbladder [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/4\">",
"       4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Duodenal, pancreatic, or ampullary pathology",
"     </li>",
"     <li>",
"      Features of malignancy (see",
"      <a class=\"local\" href=\"#H10\">",
"       'Association with gallbladder cancer'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    ERCP is superior to percutaneous transhepatic cholangiography (PTC) in the setting of Mirizzi's syndrome for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The cystic duct may run parallel to the common hepatic duct and join it far below the usual meeting point. This anomaly cannot be well visualized by PTC but easily seen by ERCP.",
"     </li>",
"     <li>",
"      Significant obstruction of the common hepatic duct, the distal common bile duct may not be adequately visualized by PTC.",
"     </li>",
"     <li>",
"      Preoperative ERCP and sphincterotomy, if necessary for removal of intraductal gallstones, frequently avoid the need for intraoperative bile duct exploration.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Biliary decompression by internal stenting can be performed in patients with cholangitis or elevated serum bilirubin concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/4\">",
"     4",
"    </a>",
"    ]. For those requiring surgery, ERCP can help the surgeon identify the common bile duct at surgery and may reduce the risk of operative injury to the bile duct.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is the mainstay of therapy for Mirizzi syndrome, permitting removal of the causal factors: the inflamed gallbladder and the impacted stone. If the diagnosis of Mirizzi syndrome is made preoperatively, an operative strategy that minimizes the risk of injury to the biliary tract can be carried out. ERCP, direct cholangiography, or magnetic resonance cholangiography should be performed in patients with clinical jaundice (serum bilirubin &gt;3.0",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    and signs and symptoms suggestive of biliary obstruction. Intraoperative cholangiography is frequently employed to clarify the biliary anatomy at the time of surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A standardized surgical approach has been recommended based on the classification of the variants of Mirizzi syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type I &ndash; Partial or total cholecystectomy, either laparoscopic or open. Common bile duct exploration is typically not required (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Laparoscopic surgery'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Type II &ndash; Cholecystectomy plus closure of the fistula, either by suture repair with absorbable material, T tube placement, or choledochoplasty with the remnant gallbladder.",
"     </li>",
"     <li>",
"      Type III &ndash; Choledochoplasty or bilioenteric anastomosis (choledochoduodenostomy, cholecystoduodenostomy, or choledochojejunostomy), is required, depending on the size of the fistula. Suture of the fistula is not indicated.",
"     </li>",
"     <li>",
"      Type IV &ndash; Bilioenteric anastomosis, typically choledochojejunostomy, is preferred because the entire wall of the common bile duct has been destroyed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The approach may vary with the type of fistula present; both the operative mortality and postoperative morbidity increase according to the severity of the lesion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Laparoscopic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mirizzi syndrome presents a difficult challenge for laparoscopic surgery because the dense adhesions and edematous inflammatory tissue cause distortion of the normal anatomy and increase the risk for biliary injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/8\">",
"     8",
"    </a>",
"    ]. Thus, the use of laparoscopic surgery as the primary treatment of Mirizzi syndrome is controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/20,23,24\">",
"     20,23,24",
"    </a>",
"    ], although it has been reported for patients with type I and type II anatomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/20,25,26\">",
"     20,25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A systematic review of 10 case series reported that laparoscopic cholecystectomy was successful for 73 of 124 patients (59 percent) with Mirizzi syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/27\">",
"     27",
"    </a>",
"    ]. In a retrospective series of 35 patients who had surgery for Mirizzi syndrome, laparoscopic surgery was attempted in 15 patients and the conversion rate to open surgery was 67 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/26\">",
"     26",
"    </a>",
"    ]. Although laparoscopic surgery may be possible in some patients with type I anatomy, open cholecystectomy remains the standard of care for Mirizzi syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/20,22\">",
"     20,22",
"    </a>",
"    ]. If a laparoscopic approach appears feasible, a prudent policy is to begin the dissection laparoscopically and convert to an open procedure if the anatomy is unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/22/18792?source=see_link\">",
"     \"Complications of laparoscopic cholecystectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Endoscopic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic treatment can be effective as a temporizing measure before surgery and can be definitive treatment for unsuitable surgical candidates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/15,28,29\">",
"     15,28,29",
"    </a>",
"    ]. Endoscopic removal of common bile duct stones also avoids the need for common bile duct exploration at the time of surgery.",
"   </p>",
"   <p>",
"    However, endoscopic approaches can be technically challenging, are not always successful, and have been associated with complications. Long-term success appears to be most likely in patients with type II disease who do not have residual gallbladder stones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/30\">",
"     30",
"    </a>",
"    ]. The following illustrates experience in the largest reports.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One report described the experience with 14 patients with Mirizzi syndrome treated with electrohydraulic lithotripsy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/15\">",
"       15",
"      </a>",
"      ]. Twelve patients had a single stone and complete clearance was achieved with one treatment session; two had multiple stones and required an additional treatment session. Asymptomatic leakage of contrast medium from the cystic duct into the peritoneal cavity was observed in one patient after removal of a large impacted cystic duct stone. This patient recovered with conservative therapy and suffered no adverse events.",
"     </li>",
"     <li>",
"      In another series of 25 patients with cholangiographic evidence of Mirizzi syndrome, 12 were referred for surgery after preliminary endoscopic therapy and 13 were treated solely with endoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/29\">",
"       29",
"      </a>",
"      ]. The endoscopic approach included sphincterotomy, mechanical lithotripsy, dissolution therapy with methyl tert-butyl ether, extracorporeal shockwave lithotripsy, and common bile duct stents. Complete clearance of stones from the biliary tree was achieved in only 3 of 13 patients while nine patients were treated with long-term stenting. Five patients died, including two who died of biliary causes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Association with gallbladder cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Mirizzi syndrome has been associated with a high frequency of gallbladder cancer.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one series of 1759 cholecystectomies, 18 cases of Mirizzi syndrome were identified; five (28 percent) had coincidental gallbladder carcinoma (versus only 2 percent in the patients without Mirizzi syndrome) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/6\">",
"       6",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The patients with and without gallbladder carcinoma were comparable in age, gender, type of lesions, and the duration of jaundice. The patients with gallbladder carcinoma had a longer history of preexistent gallbladder disease (10.4 versus 6.8 years in those without carcinoma). The serum concentration of the tumor-associated antigen CA 19-9 was elevated in 12 of the 18 patients with Mirizzi syndrome but was significantly higher in those with malignancy (peaking at 1000",
"      <span class=\"nowrap\">",
"       unit/mL).",
"      </span>",
"      The authors suggested that it is prudent to obtain an intraoperative frozen section of the gallbladder in patients with Mirizzi syndrome.",
"     </li>",
"     <li>",
"      In another report, Mirizzi syndrome was present in 133 patients out of a total of 4800 (3 percent) who underwent cholecystectomy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/31\">",
"       31",
"      </a>",
"      ]. Of the 133 patients, seven (5 percent) had gallbladder cancer compared with only 1 percent in those with gallstone disease without Mirizzi syndrome. Of the seven patients, the gallbladder cancer was detected preoperatively in one, intraoperatively in one, and on pathologic examination of the gallbladder in the remaining five.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although gallbladder carcinoma may be common in patients with Mirizzi syndrome, the latter disorder is unusual among patients with gallbladder carcinoma. In one series of 324 cases of gallbladder carcinoma, for example, 18 had common bile duct stones but only three had Mirizzi syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44565/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Mirizzi syndrome refers to common hepatic duct obstruction caused by an extrinsic compression from an impacted stone in the cystic duct.",
"     </li>",
"     <li>",
"      The Mirizzi syndrome is part of the differential diagnosis of obstructive jaundice. Most patients present with the clinical triad of jaundice, fever, and right upper quadrant pain. The major laboratory findings are elevations in the serum concentrations of alkaline phosphatase and bilirubin in over 90 percent of patients. The diagnostic approach usually begins with ultrasonography followed by cholangiography via endoscopic retrograde cholangiopancreatography, direct percutaneous cholangiography, or magnetic resonance cholangiography (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef55576 \" href=\"mobipreview.htm?29/56/30607\">",
"       image 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgery is the mainstay of therapy for Mirizzi syndrome, permitting removal of the causal factors: the inflamed gallbladder and the impacted stone. Although laparoscopic surgery may be possible in some patients with Type I anatomy, open cholecystectomy remains the standard of care for Mirizzi syndrome with compression of the common duct. For patients with a fistula, or erosion into the common duct, the choice of repair depends on the extent of the damage to the common duct. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endoscopic treatment with or without electrohydraulic lithotripsy (EHL) can be effective as a temporizing measure before surgery and can be definitive treatment for poor surgical candidates. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Endoscopic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The Mirizzi syndrome has been associated with a high frequency of gallbladder cancer. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Association with gallbladder cancer'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/1\">",
"      Witte CL. Choledochal obstruction by cystic duct stone. Mirizzi's syndrome. Am Surg 1984; 50:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/2\">",
"      Alberti-Flor JJ, Iskandarani M, Jeffers L, Schiff ER. Mirizzi syndrome. Am J Gastroenterol 1985; 80:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/3\">",
"      Mirizzi PL. Syndrome del conducto hepatico. J Int de Chir 1948; 8:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/4\">",
"      Mishra MC, Vashishtha S, Tandon R. Biliobiliary fistula: preoperative diagnosis and management implications. Surgery 1990; 108:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/5\">",
"      Corlette MB, Bismuth H. Biliobiliary fistula. A trap in the surgery of cholelithiasis. Arch Surg 1975; 110:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/6\">",
"      Redaelli CA, B&uuml;chler MW, Schilling MK, et al. High coincidence of Mirizzi syndrome and gallbladder carcinoma. Surgery 1997; 121:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/7\">",
"      Beltran MA, Csendes A, Cruces KS. The relationship of Mirizzi syndrome and cholecystoenteric fistula: validation of a modified classification. World J Surg 2008; 32:2237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/8\">",
"      Yip AW, Chow WC, Chan J, Lam KH. Mirizzi syndrome with cholecystocholedochal fistula: preoperative diagnosis and management. Surgery 1992; 111:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/9\">",
"      Starling JR, Matallana RH. Benign mechanical obstruction of the common hepatic duct (Mirizzi syndrome). Surgery 1980; 88:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/10\">",
"      Montefusco P, Spier N, Geiss AC. Another facet of Mirizzi's syndrome. Arch Surg 1983; 118:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/11\">",
"      Koehler RE, Melson GL, Lee JK, Long J. Common hepatic duct obstruction by cystic duct stone: Mirizzi syndrome. AJR Am J Roentgenol 1979; 132:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/12\">",
"      McSherry CK, Ferstenberg H, Virshup M. The Mirizzi syndrome: Suggested classification and surgical treatment. Surg Gastroenterol 1982; 1:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/13\">",
"      Csendes A, D&iacute;az JC, Burdiles P, et al. Mirizzi syndrome and cholecystobiliary fistula: a unifying classification. Br J Surg 1989; 76:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/14\">",
"      Ibrarullah M, Saxena R, Sikora SS, et al. Mirizzi's syndrome: identification and management strategy. Aust N Z J Surg 1993; 63:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/15\">",
"      Binmoeller KF, Thonke F, Soehendra N. Endoscopic treatment of Mirizzi's syndrome. Gastrointest Endosc 1993; 39:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/16\">",
"      Becker CD, Hassler H, Terrier F. Preoperative diagnosis of the Mirizzi syndrome: limitations of sonography and computed tomography. AJR Am J Roentgenol 1984; 143:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/17\">",
"      Lakhtakia S, Gupta R, Tandan M, et al. Mirizzi's syndrome: EUS appearance. Gastrointest Endosc 2006; 63:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/18\">",
"      Berland LL, Lawson TL, Stanley RJ. CT appearance of Mirizzi syndrome. J Comput Assist Tomogr 1984; 8:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/19\">",
"      Yun EJ, Choi CS, Yoon DY, et al. Combination of magnetic resonance cholangiopancreatography and computed tomography for preoperative diagnosis of the Mirizzi syndrome. J Comput Assist Tomogr 2009; 33:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/20\">",
"      Kwon AH, Inui H. Preoperative diagnosis and efficacy of laparoscopic procedures in the treatment of Mirizzi syndrome. J Am Coll Surg 2007; 204:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/21\">",
"      Baer HU, Matthews JB, Schweizer WP, et al. Management of the Mirizzi syndrome and the surgical implications of cholecystcholedochal fistula. Br J Surg 1990; 77:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/22\">",
"      Desai DC, Smink RD Jr. Mirizzi syndrome type II: is laparoscopic cholecystectomy justified? JSLS 1997; 1:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/23\">",
"      Targarona EM, Andrade E, Balagu&eacute; C, et al. Mirizzi's syndrome. Diagnostic and therapeutic controversies in the laparoscopic era. Surg Endosc 1997; 11:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/24\">",
"      Sare M, G&uuml;rer S, Taskin V, et al. Mirizzi syndrome: choice of surgical procedure in the laparoscopic era. Surg Laparosc Endosc 1998; 8:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/25\">",
"      Yeh CN, Jan YY, Chen MF. Laparoscopic treatment for Mirizzi syndrome. Surg Endosc 2003; 17:1573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/26\">",
"      Erben Y, Benavente-Chenhalls LA, Donohue JM, et al. Diagnosis and treatment of Mirizzi syndrome: 23-year Mayo Clinic experience. J Am Coll Surg 2011; 213:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/27\">",
"      Antoniou SA, Antoniou GA, Makridis C. Laparoscopic treatment of Mirizzi syndrome: a systematic review. Surg Endosc 2010; 24:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/28\">",
"      Binnie NR, Nixon SJ, Palmer KR. Mirizzi syndrome managed by endoscopic stenting and laparoscopic cholecystectomy. Br J Surg 1992; 79:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/29\">",
"      England RE, Martin DF. Endoscopic management of Mirizzi's syndrome. Gut 1997; 40:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/30\">",
"      Tsuyuguchi T, Saisho H, Ishihara T, et al. Long-term follow-up after treatment of Mirizzi syndrome by peroral cholangioscopy. Gastrointest Endosc 2000; 52:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/31\">",
"      Prasad TL, Kumar A, Sikora SS, et al. Mirizzi syndrome and gallbladder cancer. J Hepatobiliary Pancreat Surg 2006; 13:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44565/abstract/32\">",
"      Haribhakti SP, Awasthi S, Pradeep R, et al. Carcinoma gallbladder: atypical presentations and unusual associations. Trop Gastroenterol 1997; 18:32.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 656 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.150.3.100-CF9877BBA9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44565=[""].join("\n");
var outline_f43_33_44565=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cholangiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Laparoscopic surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Endoscopic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Association with gallbladder cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/656\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/656|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?29/56/30607\" title=\"diagnostic image 1\">",
"      Mirizzi syndrome MRCP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?2/37/2642\" title=\"diagnostic image 2\">",
"      Ultrasound acute cholecystitis and Mirizzi syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?4/12/4290\" title=\"diagnostic image 3\">",
"      Imaging of Mirizzi syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?17/27/17854\" title=\"diagnostic image 4\">",
"      Mirizzi syndrome ERCP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/656|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/62/2018\" title=\"figure 1\">",
"      Obstructed common hepatic duct from impacted cystic duct stone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/49/22289\" title=\"figure 2\">",
"      Mirizzi syndrome with compression of the common duct",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/17/18704\" title=\"figure 3\">",
"      Mirizzi syndrome with erosion into the common hepatic duct",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24790?source=related_link\">",
"      Acute cholangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/22/18792?source=related_link\">",
"      Complications of laparoscopic cholecystectomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_33_44566="6-mercaptopurine (6-MP) metabolite monitoring and TPMT testing in the treatment of inflammatory bowel disease with 6-MP or azathioprine";
var content_f43_33_44566=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   6-mercaptopurine (6-MP) metabolite monitoring and TPMT testing in the treatment of inflammatory bowel disease with 6-MP or azathioprine",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44566/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44566/contributors\">",
"     Richard P MacDermott, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44566/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44566/contributors\">",
"     Paul Rutgeerts, MD, PhD, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44566/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44566/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/33/44566/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The therapeutic efficacy, bone marrow toxicity, and liver toxicity of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    (AZA) and 6-mercaptopurine (6-MP) may be related to their metabolites: 6-thioguanine (6-TG) and 6-methylmercaptopurine (6-MMP). AZA is a prodrug that is metabolized to 6-MP, which is then further metabolized along an anabolic pathway to several metabolites including 6-TG and 6-MMP. Two enzymes are responsible for catalyzing these reactions: thiopurine methyltransferase (TPMT) and hypoxanthine phosphoribosyl transferase (",
"    <a class=\"graphic graphic_figure graphicRef72170 \" href=\"mobipreview.htm?5/34/5664\">",
"     figure 1",
"    </a>",
"    ). 6-TG levels between 230 and 400 may correlate with response and remission of IBD. Bone marrow suppression may correlate with elevated levels of 6-TG greater than 400, while elevated levels of 6-MMP levels greater than 5700 may correlate with liver toxicity, manifested as increased liver enzymes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TPMT ENZYME DETERMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;TPMT enzyme activity is a major factor determining AZA and 6-MP metabolism, and therefore 6-TG and 6-MMP levels. Approximately 89 percent of the population has wild type TPMT, which is associated with normal or \"high\" TPMT enzyme activity while 11 percent are heterozygous and have corresponding low TPMT enzyme activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Most importantly, 0.3 percent (1 in 300) of the population is homozygous for mutations of TPMT and thus have negligible activity, which causes 6-MP to be preferentially metabolized to produce high levels of 6-TG, which then leads to bone marrow suppression. Intermediate and normal metabolizers can have up to a three-fold difference in initial target doses of AZA and 6-MP to achieve therapeutic 6-TG concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     TPMT genotyping",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic polymorphism of TPMT causes some individuals to be particularly vulnerable to side effects and makes empiric dose-adjustments of AZA and 6-MP riskier. Measurement of TPMT genotypes",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    TPMT enzyme activity before instituting AZA or 6-MP may help prevent toxicity by identifying individuals with low or absent TPMT enzyme activity, which may lead to increased risk of myelosuppression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/1,2,4-6\">",
"     1,2,4-6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/32/22026?source=see_link\">",
"     \"Overview of pharmacogenomics\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Dosing strategies involving such testing may be cost-effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Multiple studies have described the use of TPMT genotyping or measurement of activity in predicting toxicity. As a general rule, these have demonstrated that prediction of toxicity is possible in some patients but is not consistently reliable. An illustrative report included 67 patients receiving AZA for rheumatic disease, six of whom were heterozygous for mutant TPMT alleles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/4\">",
"     4",
"    </a>",
"    ]. Five of these patients had to discontinue therapy within one month because of leukopenia, while the sixth did not adhere to therapy. In comparison, the median duration of therapy was 39 weeks in those with wild type alleles.",
"   </p>",
"   <p>",
"    However, the majority of patients who develop myelosuppression while taking AZA do not have detectable TPMT gene mutations. This was illustrated in a study that included 41 patients who developed myelosuppression during treatment with AZA and in whom only 27 percent had mutant alleles of the TPMT gene associated with enzyme deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/8\">",
"     8",
"    </a>",
"    ]. Thus, even though TPMT testing is performed, a CBC (and also liver function tests) must still be obtained on a monthly basis.",
"   </p>",
"   <p>",
"    There continues to be variation among experts in how TPMT genotyping results should be used.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some authorities recommend that all patients undergo baseline TPMT genotype testing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/9,10\">",
"       9,10",
"      </a>",
"      ]. Those with homozygous mutant alleles should not receive",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      or 6-MP. IBD patients with wild type or normal heterozygote mutant alleles can be treated with azathioprine or 6-MP by beginning with a low dose and increasing incrementally to a target weight-based dose every two to four weeks.",
"     </li>",
"     <li>",
"      Some clinicians suggest using a more aggressive approach to dosing of 6-MP or AZA in patients with normal alleles by beginning with the target weight-based dose at the outset (compared to the traditional approach of beginning with a low dose of 50 mg of AZA or 6-MP followed by gradually increasing doses). However, a clear benefit of a more aggressive approach is unproven. Rapid achievement of therapeutic levels with intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      loading did not shorten time to remission compared with standard oral dosing in a randomized controlled trial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/11\">",
"       11",
"      </a>",
"      ]. Thus, a more aggressive oral dosing scheme may not translate into a clinical benefit.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     TPMT phenotyping",
"    </span>",
"    &nbsp;&mdash;&nbsp;TPMT genotypes correlate with TPMT enzyme activity and TPMT enzyme activity (phenotype) can also be measured directly. Thus, detection of low or absent TPMT enzyme activity before introducing AZA or 6-MP therapy can also help avert potentially life-threatening toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/12\">",
"     12",
"    </a>",
"    ]. Conversely, those with higher than average TPMT activity may remain refractory to conventional doses of AZA or 6-MP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One group of experts has proposed the following strategy for using TPMT enzyme activity (",
"    <a class=\"graphic graphic_figure graphicRef81792 \" href=\"mobipreview.htm?13/5/13407\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/5\">",
"     5",
"    </a>",
"    ]. Those with absent TPMT enzyme activity should not receive AZA or 6-MP. Those with low (&lt;5",
"    <span class=\"nowrap\">",
"     U/mL)",
"    </span>",
"    enzyme activity can be treated with low dose 6-MP or AZA at doses of 0.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of 6-MP per day or 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    AZA per day combined with careful monitoring of CBC, liver function tests, and 6-TG plus 6-MMP levels. IBD patients with TPMT enzyme activity between 5 to 12",
"    <span class=\"nowrap\">",
"     U/mL",
"    </span>",
"    may be more likely to respond to a more moderate dosing strategy (such as 1.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of 6-MP per day or 1.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    AZA per day). In those with above average (&gt;12",
"    <span class=\"nowrap\">",
"     U/mL)",
"    </span>",
"    enzyme activity, high doses of 6-MP or AZA such as 1.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of 6-MP per day or 2.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    AZA per day may be needed to achieve a favorable clinical response. Even higher doses (such as 2.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    AZA per day) may be needed for those with very high (&gt;20",
"    <span class=\"nowrap\">",
"     U/mL)",
"    </span>",
"    TPMT enzyme activity.",
"   </p>",
"   <p>",
"    However, assessment of TPMT activity may require repeated measurements while patients are taking AZA or 6-MP, since 6-MP and AZA can induce an increase in TPMT activity. Similarly, other medications can affect",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    and 6-MP metabolism. Thus, it is important to consider drug interactions. 5-ASA drugs, for example, can reversibly inhibit TPMT activity and thus lead to corresponding increases in 6-TG with resultant leukopenia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/13-16\">",
"     13-16",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/40/25223?source=see_link\">",
"     Allopurinol",
"    </a>",
"    inhibits the enzyme xanthine oxidase and should be avoided since concomitant use can potentially lead to life-threatening bone marrow suppression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     MONITORING METABOLITES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies of AZA and 6-MP have demonstrated that therapeutic efficacy correlates with concentrations of 6-TG between 230 and 400, that bone marrow suppression correlates with concentrations of 6-TG greater than 400 and that liver toxicity correlates with concentrations of 6-MMP greater than 5000 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/17-25\">",
"     17-25",
"    </a>",
"    ]. No correlation was found between therapeutic efficacy and 6-MMP levels. A meta-analysis of 12 studies found a significant association between 6-TG levels and the likelihood of clinical remission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/17\">",
"     17",
"    </a>",
"    ]. Most studies were small. Whether measurement in individual patients can improve their individual long-term outcomes has not been established.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Following 6-TG levels for optimal dosing of AZA or 6-MP",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, 6-TG levels correlate with therapeutic efficacy and toxicity. However, there are important limitations in their use in individual patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Despite a correlation with clinical response rates, there is wide range of response (and toxicity) across a range of erythrocyte 6-TG levels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/19\">",
"       19",
"      </a>",
"      ]. For example, in a study that included 92 children with IBD, a clinical response to AZA or 6-MP correlated with 6-TG levels between 230 and 400, while the development of leukopenia correlated with 6-TG levels greater than 400 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Furthermore, the predictive value of metabolite levels in individual patients is low. In one study, for example, the correlation coefficient between Crohn's disease activity and erythrocyte 6-TG levels was only -0.457 (a perfect correlation being 1.00) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/19\">",
"       19",
"      </a>",
"      ]. In another report of 74 adults, there was no correlation between the commercially recommended therapeutic range for 6-TG and response in disease activity, although mean metabolite levels were higher among those in clinical remission [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another limitation to using metabolites levels to guide drug dosing is that there may be substantial variation in levels between measurements in individual patients. A study of 131 adults with IBD found that while there was an overall correlation between 6-TG levels and therapeutic efficacy, there was as much as a fivefold intra-patient variation between measurements [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An Australian study retrospectively examined the utility of measuring metabolite concentrations and 6-TG levels in patients with inflammatory bowel disease (IBD) who had continuing symptoms despite stable thiopurine treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/26\">",
"       26",
"      </a>",
"      ]. The authors found that dose-optimization or toxicity-avoidance strategies based upon metabolite testing was associated with improved clinical outcomes. Using the results of metabolite testing to direct treatment was associated with improved clinical outcomes in 40 of 46 patients (87 percent). On the other hand, improved clinical outcomes were observed in only 3 of 17 patients (18 percent) patients whose treatment decisions were discordant with those recommended by metabolite testing (p = 0.0001).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Following 6-TG and 6-MMP levels to predict toxicity AZA or 6-MP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone marrow and liver toxicity due to AZA or 6-MP correlate with elevated 6-TG and 6-MMP levels respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. In one study, for example, 6-MMP levels greater than 5000 correlated with hepatotoxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/18\">",
"     18",
"    </a>",
"    ]. In another study, 6-TG levels of &gt;400 picomoles per 8 X 10",
"    <sup>",
"     8",
"    </sup>",
"    erythrocytes in patients with normal TPMT activity predicted refractoriness to AZA and an increased risk of myelotoxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/63/10232?source=see_link\">",
"     \"Pharmacology and side effects of azathioprine when used in rheumatic diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, 6-MMP levels are not a highly accurate predictor of toxicity in individual patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/28\">",
"     28",
"    </a>",
"    ]. Furthermore, adverse reactions (such as pancreatitis) can occur unrelated to elevated levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/19\">",
"     19",
"    </a>",
"    ]. Thus, measurement of 6-TG and 6-MMP levels cannot replace regular monitoring for toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Demonstration of AZA or 6-MP non-compliance or resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low or absent 6-TG levels in non-responding patients may indicate noncompliance, use of a sub-therapeutic dose of",
"    <span class=\"nowrap\">",
"     AZA/6-MP,",
"    </span>",
"    or preferential metabolism to 6-MMP instead of 6-TG (ie, 6-MP resistance) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/23,29\">",
"     23,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An approach to 6-MP resistance in both adults and children is the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/40/25223?source=see_link\">",
"     allopurinol",
"    </a>",
"    to cause shunting of 6-MMP metabolites with a resultant shift in metabolism towards 6-TG [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44566/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. Long-term studies will be needed to assess the clinical efficacy and safety of this approach. Because of the potential for increased bone marrow toxicity, the use of allopurinol in 6-MP resistant patients remains experimental.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following represent our approach based upon the available evidence. Further prospective controlled trials may help to better elucidate optimal use of these assays. In no case should 6-MP metabolite testing replace continued monitoring of CBC and liver function tests as well as clinical status. Patients should have weekly complete blood count (CBC) drawn for the first month followed by monthly CBCs and liver function tests, independent of what 6-MP metabolite assays are obtained. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/31/7673?source=see_link\">",
"     \"Immunomodulator therapy in Crohn's disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest obtaining both TPMT genotype and TPMT enzyme activity (phenotype) testing in all patients in whom AZA or 6-MP is being considered (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Genotype testing is suggested by the manufacturer and the US Food and Drug Administration. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'TPMT genotyping'",
"      </a>",
"      above.) It may be particularly important in African American patients who tend to have lower baseline white blood cell counts. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/47/18170?source=see_link\">",
"       \"Overview of neutropenia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients who previously developed leukopenia or elevated liver biochemical tests while taking 6-MP or AZA, we suggest obtaining not only TPMT genotype testing and TPMT enzyme activity, but also 6-MP metabolite testing during treatment (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      It is important to re-emphasize that patients with normal TPMT status can still exhibit bone marrow",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      liver toxicity. A normal TPMT screening test does not preclude bone marrow",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      liver toxicity. Furthermore, patients with high TPMT activity may be predisposed to forming potentially hepatotoxic levels of 6-MMP, possibly increasing the risk for hepatotoxicity with an aggressive dosing regimen. Monitoring of the CBC and liver function tests weekly for the first month and then monthly must be continued as long as the patient is being given AZA or 6-MP.",
"     </li>",
"     <li>",
"      Concentrations of 6-TG between 230 and 400 correlate with an increased likelihood of obtaining a therapeutic response and remission while 6-MMP levels greater than 5000 correlate with the increased possibility of liver toxicity. However, their value in guiding dosage changes to optimize treatment in individual patients remains unsettled. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Following 6-TG levels for optimal dosing of AZA or 6-MP'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In non-responding patients who have been prescribed what is believed to be a therapeutic dose of AZA or 6-MP we suggest obtaining 6-TG and 6-MMP levels (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Low levels may support clinical suspicion of non-compliance, although there are alternative explanations. Such patients may be on too low a dose of AZA or 6-MP or may have preferential metabolism of AZA or 6-MP toward 6-MMP instead of toward 6-TG. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Demonstration of AZA or 6-MP non-compliance or resistance'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/1\">",
"      Lennard L, Gibson BE, Nicole T, Lilleyman JS. Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia. Arch Dis Child 1993; 69:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/2\">",
"      Lennard L, Van Loon JA, Weinshilboum RM. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther 1989; 46:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/3\">",
"      Gardiner SJ, Gearry RB, Begg EJ, et al. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold. Clin Gastroenterol Hepatol 2008; 6:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/4\">",
"      Black AJ, McLeod HL, Capell HA, et al. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med 1998; 129:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/5\">",
"      Cuffari C, Dassopoulos T, Turnbough L, et al. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. Clin Gastroenterol Hepatol 2004; 2:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/6\">",
"      Dubinsky MC, Reyes E, Ofman J, et al. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Am J Gastroenterol 2005; 100:2239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/7\">",
"      Winter J, Walker A, Shapiro D, et al. Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/8\">",
"      Colombel JF, Ferrari N, Debuysere H, et al. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 2000; 118:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/9\">",
"      Lichtenstein GR. Use of laboratory testing to guide 6-mercaptopurine/azathioprine therapy. Gastroenterology 2004; 127:1558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/10\">",
"      Relling MV, Gardner EE, Sandborn WJ, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther 2011; 89:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/11\">",
"      Sandborn WJ, Tremaine WJ, Wolf DC, et al. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology 1999; 117:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/12\">",
"      Gisbert JP, Ni&ntilde;o P, Rodrigo L, et al. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients. Am J Gastroenterol 2006; 101:2769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/13\">",
"      Szumlanski CL, Weinshilboum RM. Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine. Br J Clin Pharmacol 1995; 39:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/14\">",
"      Dewit O, Vanheuverzwyn R, Desager JP, Horsmans Y. Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn's disease. Aliment Pharmacol Ther 2002; 16:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/15\">",
"      Gilissen LP, Bierau J, Derijks LJ, et al. The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients. Aliment Pharmacol Ther 2005; 22:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/16\">",
"      de Boer NK, Wong DR, Jharap B, et al. Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism. Am J Gastroenterol 2007; 102:2747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/17\">",
"      Osterman MT, Kundu R, Lichtenstein GR, Lewis JD. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology 2006; 130:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/18\">",
"      Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/19\">",
"      Cuffari C, Th&eacute;or&ecirc;t Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut 1996; 39:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/20\">",
"      Gupta P, Gokhale R, Kirschner BS. 6-mercaptopurine metabolite levels in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001; 33:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/21\">",
"      Mardini HE, Arnold GL. Utility of measuring 6-methylmercaptopurine and 6-thioguanine nucleotide levels in managing inflammatory bowel disease patients treated with 6-mercaptopurine in a clinical practice setting. J Clin Gastroenterol 2003; 36:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/22\">",
"      Wright S, Sanders DS, Lobo AJ, Lennard L. Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease. Gut 2004; 53:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/23\">",
"      Goldenberg BA, Rawsthorne P, Bernstein CN. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease. Am J Gastroenterol 2004; 99:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/24\">",
"      Belaiche J, Desager JP, Horsmans Y, Louis E. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease. Scand J Gastroenterol 2001; 36:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/25\">",
"      Roblin X, Serre-Debeauvais F, Phelip JM, et al. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine. Aliment Pharmacol Ther 2005; 21:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/26\">",
"      Haines ML, Ajlouni Y, Irving PM, et al. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Inflamm Bowel Dis 2011; 17:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/27\">",
"      Roblin X, Peyrin-Biroulet L, Biroulet LP, et al. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity. Am J Gastroenterol 2008; 103:3115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/28\">",
"      Shaye OA, Yadegari M, Abreu MT, et al. Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients. Am J Gastroenterol 2007; 102:2488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/29\">",
"      Dubinsky MC, Yang H, Hassard PV, et al. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology 2002; 122:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/30\">",
"      Sparrow MP, Hande SA, Friedman S, et al. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther 2005; 22:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/31\">",
"      Sparrow MP, Hande SA, Friedman S, et al. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Clin Gastroenterol Hepatol 2007; 5:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44566/abstract/32\">",
"      Rahhal RM, Bishop WP. Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2008; 14:1678.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4058 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-9070587B58-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44566=[""].join("\n");
var outline_f43_33_44566=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TPMT ENZYME DETERMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TPMT genotyping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      TPMT phenotyping",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      MONITORING METABOLITES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Following 6-TG levels for optimal dosing of AZA or 6-MP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Following 6-TG and 6-MMP levels to predict toxicity AZA or 6-MP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Demonstration of AZA or 6-MP non-compliance or resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/4058\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4058|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?5/34/5664\" title=\"figure 1\">",
"      6-MP metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?13/5/13407\" title=\"figure 2\">",
"      TPMT testing II",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/31/7673?source=related_link\">",
"      Immunomodulator therapy in Crohn's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/47/18170?source=related_link\">",
"      Overview of neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/32/22026?source=related_link\">",
"      Overview of pharmacogenomics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/63/10232?source=related_link\">",
"      Pharmacology and side effects of azathioprine when used in rheumatic diseases",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_33_44567="Glycemic control for acute myocardial infarction in patients with and without diabetes mellitus";
var content_f43_33_44567=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Glycemic control for acute myocardial infarction in patients with and without diabetes mellitus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44567/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44567/contributors\">",
"     Richard W Nesto, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44567/contributors\">",
"     Silvio E Inzucchi, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44567/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44567/contributors\">",
"     Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44567/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44567/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44567/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/33/44567/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with diabetes mellitus are at increased risk for myocardial infarction (MI) and diabetes is considered a coronary risk equivalent by the National Cholesterol Education Program [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/1\">",
"     1",
"    </a>",
"    ], since type 2 diabetic patients without a prior MI have the same risk of developing an MI as nondiabetic patients who have already had an MI (",
"    <a class=\"graphic graphic_figure graphicRef80251 \" href=\"mobipreview.htm?34/1/34845\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/37/27226?source=see_link\">",
"     \"Prevalence of and risk factors for coronary heart disease in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Maintenance of strict glycemic control improves long-term microvascular outcomes in patients with both type 1 and type 2 diabetes. Intensive glycemic control aiming for near-normal levels has been shown to have a substantial beneficial effect (58 percent reduction in major CVD events) on macrovascular outcomes in type 1 diabetes, when applied early in the disease course and after one to two decades of therapy. In the setting of type 2 diabetes, with several co-prevalent risk factors for CVD, any beneficial effects of intensive glycemic control on macrovascular disease are likely to be less than those from similarly stringent control of blood pressure and lipid levels. In the acute setting, the evidence of benefit from strict glycemic control with insulin therapy in patients with acute MI is limited. The evidence in other groups of patient in inconsistent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/23/28023?source=see_link\">",
"     \"Glycemic control and intensive insulin therapy in critical illness\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/34/11817?source=see_link\">",
"     \"Glycemic control and vascular complications in type 1 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7578?source=see_link\">",
"     \"Glycemic control and vascular complications in type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Poor glycemic control in diabetic patients and stress hyperglycemia in nondiabetic patients is associated with worse outcomes after acute MI but it is not fully understood as to whether strict glycemic control during AMI hospitalizations improves outcomes. These issues will be reviewed here.",
"   </p>",
"   <p>",
"    The possible value of glycemic control in diabetic patients undergoing coronary artery bypass graft surgery is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/15/30970?source=see_link&amp;anchor=H23#H23\">",
"     \"Coronary artery revascularization in patients with diabetes mellitus and multivessel coronary artery disease\", section on 'Perioperative glycemic control'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SERUM VERSUS BLOOD GLUCOSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Practitioners should be aware that glucose measured in whole blood is generally 12 percent lower than values obtained from serum (or plasma). In the studies cited below, an attempt has been made to specify which was reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HYPERGLYCEMIA AND OUTCOME AFTER ACUTE MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association between hyperglycemia and outcome after acute MI has been evaluated in two settings: the short-term predictive value of the admission serum glucose in patients with and without diabetes and the long-term increase in risk in patients with diabetes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Predictive value of admission glucose",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a positive association between the serum glucose at the time of MI and mortality in patients with and without diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/3-8\">",
"     3-8",
"    </a>",
"    ]. The prognostic significance of what has been presumed to represent stress hyperglycemia was addressed in an analysis of 15 trials that reported in-hospital mortality after an MI in relation to admission serum glucose concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/3\">",
"     3",
"    </a>",
"    ]. The analysis comes to the following conclusions of these trials in which the admission glucose were random and may have represented fasting or postprandial states:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients without diabetes, those with glucose concentrations between 110 and 143",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (6.1 to 8",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      had a 3.9-fold higher risk of death compared to patients with lower glucose concentrations. Glucose values between 144 and 180",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (8 to 10",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      were associated with a three-fold higher risk of heart failure or cardiogenic shock.",
"     </li>",
"     <li>",
"      Diabetic patients with glucose concentrations &ge;180 to 196",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (10 to 11",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      also had an increased risk of death compared with normoglycemic diabetic patients (relative risk 1.7), but this relative risk was lower than in non-diabetics.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to the admission value, a graded relationship has been found between the fasting glucose obtained within 24 hours of admission and 30-day mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The possible mechanisms by which stress hyperglycemia is associated with worse outcomes were evaluated in a review of 460 consecutive patients with STEMI who were treated with primary percutaneous coronary intervention (PCI); 322 (70 percent) had a serum glucose &ge;140",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (7.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    on admission, but only 14 percent had a history of diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/11\">",
"     11",
"    </a>",
"    ]. The patients with hyperglycemia were significantly less likely to have TIMI grade 3 (normal) flow before PCI compared to those with normoglycemia (12 versus 28 percent, adjusted odds ratio 2.6 for the absence of reperfusion). The impairment in coronary flow might reflect a prothrombotic state or endothelial dysfunction associated with hyperglycemia, more severe disease leading to a greater stress response, or hyperglycemia might be a marker for some other determinant of outcome.",
"   </p>",
"   <p>",
"    Despite the observation of worse outcomes in patients with higher glucose concentrations on admission and within 24 hours, the available studies do not rule out the possibility that high blood glucose in this setting is a marker for a sicker patient, as opposed to being causative for worse outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     J- or U-shaped curve",
"    </span>",
"    &nbsp;&mdash;&nbsp;A review of 4224 patients in trials of fibrinolysis or primary PCI in patients with STEMI found a U-shaped relationship between the serum glucose (mostly admission values) and the 30-day rate of death or recurrent MI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/12\">",
"     12",
"    </a>",
"    ]. The following findings were noted in patients with hypoglycemia, defined as blood glucose values of &lt;81",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (4.5",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    euglycemia, defined as blood glucose values of 81 to 99",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (4.5 to 5.5",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    and severe hyperglycemia, defined as blood glucose values &gt;199",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (11.0",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The",
"      30-day mortality rate in the three groups was 4.6, 1.0, and 4.7 percent, respectively",
"     </li>",
"     <li>",
"      The 30-day rate of recurrent MI or death in the three groups was 10.5, 4.2, and 7.2 percent, respectively",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After adjustment for baseline differences, the relative risk for mortality was significantly increased, compared to the euglycemic group, in patients with hypoglycemia (odds ratio 3.37) or severe hyperglycemia (odds ratio 3.09). The risk was also significantly increased in patients with blood glucose values between 150 and 199",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (8.3 and 11.0",
"    <span class=\"nowrap\">",
"     mmol/L,",
"    </span>",
"    odds ratio 2.93). The U-shaped relationship was seen in both diabetic and nondiabetic patients.",
"   </p>",
"   <p>",
"    Similar findings (higher mortality with both hyperglycemia on admission and hypoglycemia during hospitalization) were noted at two years in a review of 713 consecutive patients with diabetes and non-ST elevation acute coronary syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/13\">",
"     13",
"    </a>",
"    ]. Both persistent hypoglycemia and hyperglycemia were found to be better predictors of mortality than admission glucose in a separate study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is not yet clear from these data whether treatment-induced hypoglycemia is driving increased risk. One analysis of hyperglycemia in patients with acute MI found that spontaneous hypoglycemia was associated with increased hospital mortality, but not hypoglycemia associated with insulin therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conceivably, other medical factors, such as malnutrition, hepatic or renal disease or sepsis may be playing a role in these observational data.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Worse outcomes in diabetic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term outcome after an acute MI is worse in diabetic patients than nondiabetic patients with both a non-ST elevation MI (NSTEMI) and an ST elevation MI (STEMI). The adverse effect is manifested by increases in mortality and nonfatal cardiovascular end points (such as reinfarction or heart failure)&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/2,16\">",
"     2,16",
"    </a>",
"    ]. Diabetic patients tend be older and to have a greater prevalence of comorbidities compared to patients without diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/16\">",
"     16",
"    </a>",
"    ]. However, the increase in risk persists after adjustment for these differences. The data supporting these conclusions is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/20/41289?source=see_link&amp;anchor=H17#H17\">",
"     \"Treatment of acute myocardial infarction in diabetes mellitus\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     UNDIAGNOSED DIABETES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency with which patients with an acute MI have undiagnosed diabetes was addressed in a prospective study in which glucose metabolism (via fasting blood glucose and oral glucose tolerance test) was evaluated in 181 consecutive patients with an acute MI and no prior history of diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/17\">",
"     17",
"    </a>",
"    ]. The criteria for diagnosing diabetes were a fasting plasma glucose &ge;126",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (6.1",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    two-hour postload plasma glucose above 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (11.1",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    The respective values for impaired glucose tolerance were a fasting plasma glucose between 110 and 125",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (6.1 to 6.9",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and a two hour postload plasma glucose between 140 and 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (7.8 to 11.1",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p>",
"    The",
"    following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Impaired glucose tolerance was present in 35 percent at hospital discharge and 40 percent three months later. The respective values for previously undiagnosed diabetes were 31 and 25 percent at these time periods. However, the incidence of previously undiagnosed diabetes was much lower (10 and 13 percent) when only the fasting blood glucose was used, as suggested by the American Diabetes Association. Whether the same patients had abnormal glucose metabolism at discharge and three months is not clear. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/54/38758?source=see_link\">",
"       \"Diagnosis of diabetes mellitus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Independent predictors for abnormal glucose tolerance at three months were the hemoglobin A1C concentration on admission and the fasting blood glucose on day four. The former observation, which indicates that the metabolic abnormality preceded the infarction, and the persistence of abnormal glucose tolerance at three months suggest that the hyperglycemia during hospitalization cannot be simply explained as stress hyperglycemia in some patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of elevated levels of Hb A1c found in most of these patients makes stress hyperglycemia a less likely diagnosis. At the least, these findings strongly suggest that the fasting plasma glucose concentration and hemoglobin A1c should be measured during hospitalization in nondiabetic patients with an acute MI and that elevated values be repeated after discharge to identify those at increased risk",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     VALUE OF GLYCEMIC CONTROL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence from which recommendations for glycemic control in patients with acute myocardial infarction (MI) comes from studies in three populations: critically ill patients (a minority of whom have an acute MI) in intensive care units; patients admitted with acute MI; patients admitted to general medical wards.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Critically ill patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Randomized trials have assessed the efficacy of strict glycemic control (target blood glucose 80 to 110",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [4.4 to 6.1",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    compared to standard care (180-200",
"    <span class=\"nowrap\">",
"     mg/dl;",
"    </span>",
"    10.0-11.1",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    in patients admitted to an intensive care unit (ICU). The studies evaluating the efficacy of strict glycemic control in patients admitted to ICUs and recommendations for glycemic control in such patients are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/23/28023?source=see_link\">",
"     \"Glycemic control and intensive insulin therapy in critical illness\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although initial single-center studies suggested a strong benefit, mainly in post-surgical patients, these data have not been replicated by others. The largest of the randomized trials in ICU patients, the NICE-SUGAR trial, found an increase in the rate of death at 90 days with intensive glucose control (81-108",
"    <span class=\"nowrap\">",
"     mg/dl;",
"    </span>",
"    4.5-6.0",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    as compared to those whose blood glucose was maintained between 144-180",
"    <span class=\"nowrap\">",
"     mg/dl",
"    </span>",
"    (8.0 to 10.0",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/15\">",
"     15",
"    </a>",
"    ]. In addition, the data from these studies may or may not apply to patients with myocardial infarction. The optimal blood glucose target in hyperglycemic critically ill patients is uncertain, but we believe the compromise of 140 to 180",
"    <span class=\"nowrap\">",
"     mg/dl",
"    </span>",
"    (7.8 to 10.0",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    seems reasonable.",
"   </p>",
"   <p>",
"    Patients with acute MI who might be labeled critically ill include those with hemodynamic or electrical instability, acute heart failure, or co-existent serious acute illnesses such as acute exacerbation of obstructive lung disease requiring respiratory support or acute blood loss requiring transfusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Studies of patients with acute MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of trials have attempted to address the value of intensive insulin therapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    glycemic control specifically in patients with an acute MI. None was as large and well designed as the aforementioned ICU trials and each has important flaws. Furthermore, none of the trials achieved the level of glucose control that would have been considered intensive in the ICU trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     DIGAMI trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the DIGAMI trial, 620 diabetic patients with an acute MI were randomly assigned to an insulin-glucose infusion for 24 hours followed by subcutaneous insulin four times daily for &ge;3 months or standard treatment with insulin therapy only if clinically indicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/18\">",
"     18",
"    </a>",
"    ]. The target blood glucose level for patients assigned to the insulin-glucose infusion was 126 to 196",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (7 to 10.9",
"    <span class=\"nowrap\">",
"     mmol/liter).",
"    </span>",
"   </p>",
"   <p>",
"    With",
"    respect to glycemic control, the following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At randomization, the mean blood glucose was about 280",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (15.6",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      The blood glucose was significantly lower with intensive insulin at 24 hours (173 versus 211",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [9.6 versus 11.7",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      and hospital discharge (148 versus 162",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [8.2 versus 9.0",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"     </li>",
"     <li>",
"      At randomization, the HbA1c was 8.1 percent. The reduction in HbA1c was significantly greater with intensive insulin therapy at three months (1.1 versus 0.4 percent) and one year (0.9 versus 0.4 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Mortality was significantly lower in the group assigned to more aggressive insulin therapy at one year (19 versus 26 percent) and at 3.4 years (33 versus 44 percent)&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/4,18\">",
"     4,18",
"    </a>",
"    ]. The greatest reduction in mortality was seen in low-risk patients who had not been receiving insulin prior to the infarction.",
"   </p>",
"   <p>",
"    Since DIGAMI also included an outpatient insulin therapy component, the isolated effect of glycemic control in-hospital could therefore not be easily assessed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     DIGAMI-2 trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;The value of insulin therapy was further addressed in the DIGAMI-2 trial, in which patients with type 2 diabetes and acute MI were randomly assigned to one of three glucose management strategies: group 1, inpatient insulin",
"    <span class=\"nowrap\">",
"     infusion/outpatient",
"    </span>",
"    intensive subcutaneous insulin therapy; group 2, inpatient insulin",
"    <span class=\"nowrap\">",
"     infusion/outpatient",
"    </span>",
"    standard treatment; or group 3,",
"    <span class=\"nowrap\">",
"     inpatient/outpatient",
"    </span>",
"    routine glucose management according to local practice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although it was anticipated that mortality rates would be lowest in group 1, they were similar in all three groups. However, there were a number of problems with this study that interfere with interpretation of the results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Glycemic control, which was expected to be the best in group 1, was also similar in the three groups.",
"     </li>",
"     <li>",
"      The overall event rate was lower than expected in all groups (perhaps due to implementation of other secondary prevention strategies), which may have attenuated any statistical differences between groups.",
"     </li>",
"     <li>",
"      The trial was stopped earlier than planned due to a failure to recruit an adequate number of patients; since less than 50 percent of the required patients were recruited, the power to detect a difference among the treatment groups was substantially reduced.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     HI-5 trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possible benefit of more intensive glucose control in patients with an acute MI with either a history of diabetes or an admission blood glucose &ge;140",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (7.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    was evaluated in the Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/20\">",
"     20",
"    </a>",
"    ]. In this trial, 240 such patients were randomly assigned to conventional therapy or to an",
"    <span class=\"nowrap\">",
"     insulin/dextrose",
"    </span>",
"    infusion to maintain the blood glucose between 72 and 180",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (4 and 10",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    for at least 24 hours. After 24 hours, the patients were managed with standard care by their own physicians with a recommend HbA1c of less than 7 percent.",
"   </p>",
"   <p>",
"    There was no difference in the primary end point of mortality in-hospital or at three or six months. However, HI-5 was seriously flawed by the small number of patients, lack of blinding, maintenance of glycemic control for only 24 hours, and failure to attain a significant difference in mean 24-hour blood glucose between the intensive therapy and control groups (149 versus 162",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [8.3 versus 9.0",
"    <span class=\"nowrap\">",
"     mmol/L]).",
"    </span>",
"   </p>",
"   <p>",
"    Subset analysis found that patients who had a mean blood glucose &le;144",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (8.0",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    during the first 24 hours had large reductions in mortality in-hospital (0 versus 7 percent) and at three and six months (2 versus 11 percent). The possible mortality benefit in this subgroup analysis is consistent with the above surgical ICU trial but needs to be confirmed in patients with an acute MI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Observational evidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional evidence supporting a benefit from glycemic control comes from an observational study of 7820 hyperglycemic patients (admission blood glucose &ge;140",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    7.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    hospitalized with acute myocardial infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/21\">",
"     21",
"    </a>",
"    ]. After multivariable adjustment, lower mean postadmission glucose levels were associated with better all-cause in-hospital mortality. There was no difference in mortality rates between insulin-treated and non-insulin treated patients irrespective of mean postadmission glucose level.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     General medical patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients hospitalized with acute MI are not critically ill. Indeed, with early reperfusion using either percutaneous coronary intervention or fibrinolytic therapy, most are classified as critically ill and many are discharged within 48 to 72 hours. Therefore, it may not be appropriate to apply evidence from studies of critically ill patients, or even older studies of MI.",
"   </p>",
"   <p>",
"    However, there is limited evidence, from studies of general medical patients regarding the optimal management of hyperglycemia, which can be applied to patients with acute MI. That evidence suggests that reasonable glycemic goals are to avoid hypoglycemia (fasting blood glucose concentrations no lower than 90",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [5.0",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    and to keep all glucose levels below 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (11.1",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    in an attempt to avoid dehydration, caloric loss, glycosuria, and to reduce the risk of infection and, although rare, ketoacidosis. This issue is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/39/26233?source=see_link\">",
"     \"Management of diabetes mellitus in hospitalized patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal strategy for the management of hyperglycemia in patients with and without diabetes admitted with acute myocardial infarction (MI) is unknown. Studies of critically ill patients may not be relevant, studies in patients with acute MI are flawed, and evidence from studies of patients admitted to general medical wards is limited.",
"   </p>",
"   <p>",
"    We believe that there is general consensus around the following points:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Glucose control should be initiated when serum glucose values are above 180- 200",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (10-11",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"     </li>",
"     <li>",
"      Hypoglycemia, defined as a fasting blood glucose concentration below 70",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [(3.9",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      should be avoided. To ensure safety, a reasonable lower goal might be to maintain all blood glucose levels &gt;90-100",
"      <span class=\"nowrap\">",
"       mg/dl",
"      </span>",
"      <span class=\"nowrap\">",
"       (5-5.6mmol/L).",
"      </span>",
"     </li>",
"     <li>",
"      Critically ill patients, such as those in cardiogenic shock, represent as small subset of all those with an acute MI. A recent trend is to recommend that blood glucose be maintained between 140-180",
"      <span class=\"nowrap\">",
"       mg/dl",
"      </span>",
"      (7.8-10",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      with intravenous insulin in these individuals in the ICU [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/3,22-24\">",
"       3,22-24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     METHOD OF TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The discussions of how to achieve glycemic control in critically ill patients and in patients with diabetes admitted to general medical wards are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/23/28023?source=see_link&amp;anchor=H15#H15\">",
"     \"Glycemic control and intensive insulin therapy in critical illness\", section on 'General approach'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/39/26233?source=see_link&amp;anchor=H9#H9\">",
"     \"Management of diabetes mellitus in hospitalized patients\", section on 'Prevention and treatment of hyperglycemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS OF OTHERS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Acute glucose targets",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the lack of high level evidence, the glucose targets during an acute MI are not clearly defined. Thus, the 2009",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    focused update on ST elevation MI gave a weak recommendation for the use of an insulin based regimen to achieve and maintain blood glucose less than 180",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (10",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    During this time hypoglycemia should be avoided [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/25\">",
"     25",
"    </a>",
"    ]. This recommendation was made for patients with and without a diagnosis of diabetes. We agree with this recommendation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Chronic glycemic control",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines recommended that the goal of antihyperglycemic therapy after the acute phase of the MI should be to achieve a hemoglobin A1C of less than 7 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44567/abstract/23\">",
"     23",
"    </a>",
"    ], which is consistent with the general treatment goal for patients with type 2 diabetes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/35/43577?source=see_link\">",
"     \"Initial management of blood glucose in type 2 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7578?source=see_link&amp;anchor=H9#H9\">",
"     \"Glycemic control and vascular complications in type 2 diabetes mellitus\", section on 'Macrovascular disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The correction and prevention of hyperglycemia have become standard care for hospitalized patients, including those with acute myocardial infarction (MI). However, whether control of hyperglycemia is sufficient to reduce morbidity and mortality is not proven at this time. The evidence upon which recommendations for glycemic control can be made in such patients is weak for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The randomized trials in patients with MI are significantly flawed.",
"     </li>",
"     <li>",
"      The best data supporting glycemic control come from the trials of critically ill patients in intensive care units, but these trials included few patients with myocardial infarction. In addition the conclusions of some studies differ from others.",
"     </li>",
"     <li>",
"      Most patients admitted with acute MI are not critically ill.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While there is general agreement that glucose value above 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (11",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    should be treated, there is insufficient evidence to establish an acceptable, minimal blood glucose (treatment target). Although lowering of high blood glucose levels may decrease the risk of poor clinical outcomes, overtreatment leading to hypoglycemia is associated with poor outcomes and hypoglycemia should be strictly avoided. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Value of glycemic control'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H5\">",
"     'J- or U-shaped curve'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For both stable and unstable patients with acute myocardial infarction with hyperglycemia, including patients with and without diabetes, we suggest an insulin based regimen to achieve and maintain blood glucose less than 180",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (10",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    (",
"    <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"     Grade 2B",
"    </a>",
"    ). There is insufficient evidence to establish a minimal acceptable blood glucose.",
"   </p>",
"   <p>",
"    The discussions of how to achieve glycemic control in critically ill patients and in patients with diabetes admitted to general medical wards are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/23/28023?source=see_link&amp;anchor=H15#H15\">",
"     \"Glycemic control and intensive insulin therapy in critical illness\", section on 'General approach'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/39/26233?source=see_link&amp;anchor=H9#H9\">",
"     \"Management of diabetes mellitus in hospitalized patients\", section on 'Prevention and treatment of hyperglycemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    More data are needed to inform a decision as to whether a more stringent target is justified or even safe, based on the trends seen in clinical trials of other critically ill patients.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/1\">",
"      National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/2\">",
"      Haffner SM, Lehto S, R&ouml;nnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/3\">",
"      Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/4\">",
"      Malmberg K, Norhammar A, Wedel H, Ryd&eacute;n L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99:2626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/5\">",
"      Wahab NN, Cowden EA, Pearce NJ, et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40:1748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/6\">",
"      Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005; 111:3078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/7\">",
"      Mehta SR, Yusuf S, D&iacute;az R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/8\">",
"      Goyal A, Mehta SR, D&iacute;az R, et al. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation 2009; 120:2429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/9\">",
"      Suleiman M, Hammerman H, Boulos M, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005; 111:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/10\">",
"      Cao JJ, Hudson M, Jankowski M, et al. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol 2005; 96:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/11\">",
"      Timmer JR, Ottervanger JP, de Boer MJ, et al. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005; 45:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/12\">",
"      Pinto DS, Skolnick AH, Kirtane AJ, et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005; 46:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/13\">",
"      Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005; 26:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/14\">",
"      Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008; 117:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/15\">",
"      Kosiborod M, Inzucchi SE, Goyal A, et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 2009; 301:1556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/16\">",
"      Franklin K, Goldberg RJ, Spencer F, et al. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 2004; 164:1457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/17\">",
"      Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359:2140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/18\">",
"      Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997; 314:1512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/19\">",
"      Malmberg K, Ryd&eacute;n L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/20\">",
"      Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006; 29:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/21\">",
"      Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucose normalization and outcomes in patients with acute myocardial infarction. Arch Intern Med 2009; 169:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/22\">",
"      Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041.",
"     </a>",
"    </li>",
"    <li>",
"     Anderson J, Adams C, Antman E, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, American College or Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2007; 50:e1 www.acc.org/qualityandscience/clinical/statements.htm (Accessed on September 18, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44567/abstract/24\">",
"      Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449.",
"     </a>",
"    </li>",
"    <li>",
"     Kushner, FG, Hand, M, Smith, SC Jr, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120:2271. Available at: file://circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.109.192663.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 58 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.172.26-C801F8800B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44567=[""].join("\n");
var outline_f43_33_44567=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SERUM VERSUS BLOOD GLUCOSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HYPERGLYCEMIA AND OUTCOME AFTER ACUTE MI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Predictive value of admission glucose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      J- or U-shaped curve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Worse outcomes in diabetic patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      UNDIAGNOSED DIABETES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      VALUE OF GLYCEMIC CONTROL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Critically ill patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Studies of patients with acute MI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - DIGAMI trial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - DIGAMI-2 trial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - HI-5 trial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Observational evidence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      General medical patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      METHOD OF TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      RECOMMENDATIONS OF OTHERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Acute glucose targets",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Chronic glycemic control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/58\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/58|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/1/34845\" title=\"figure 1\">",
"      Diabetes increases coronary mortality",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/15/30970?source=related_link\">",
"      Coronary artery revascularization in patients with diabetes mellitus and multivessel coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/54/38758?source=related_link\">",
"      Diagnosis of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/23/28023?source=related_link\">",
"      Glycemic control and intensive insulin therapy in critical illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/34/11817?source=related_link\">",
"      Glycemic control and vascular complications in type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7578?source=related_link\">",
"      Glycemic control and vascular complications in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/35/43577?source=related_link\">",
"      Initial management of blood glucose in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/39/26233?source=related_link\">",
"      Management of diabetes mellitus in hospitalized patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/37/27226?source=related_link\">",
"      Prevalence of and risk factors for coronary heart disease in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/20/41289?source=related_link\">",
"      Treatment of acute myocardial infarction in diabetes mellitus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_33_44568="Management of low-grade glioma";
var content_f43_33_44568=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of low-grade glioma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44568/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44568/contributors\">",
"     Lawrence D Recht, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44568/contributors\">",
"     Martin van den Bent, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44568/contributors\">",
"     Helen A Shih, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44568/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44568/contributors\">",
"     Patrick Y Wen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44568/contributors\">",
"     Jay S Loeffler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44568/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44568/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/33/44568/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gliomas comprise a group of primary central nervous system (CNS) neoplasms with characteristics of neuroglial cells (eg, astrocytes, oligodendrocytes) that express varying degrees of aggressiveness. The slower growing lesions are commonly referred to as low-grade gliomas (LGGs), while the more rapidly progressive tumors are referred to as high-grade gliomas (HGGs). LGGs are less common, comprising approximately one-fifth of CNS glial tumors. Approximately 1800 new cases of LGG are diagnosed each year in the United States.",
"   </p>",
"   <p>",
"    LGGs can be divided into several distinct entities based upon their histopathologic appearance. These differences correlate with important differences in biologic behavior and thus have important implications for patient management. LGGs can develop anywhere in the CNS, although studies usually are directed to a particular location (eg, cerebral hemispheres, optic pathways, brainstem).",
"   </p>",
"   <p>",
"    The goals of treatment for patients with LGGs include prolonging overall and progression-free survival and minimizing morbidity. This requires preventing tumor enlargement and transformation into high-grade gliomas (HGGs) and minimizing treatment-related complications.",
"   </p>",
"   <p>",
"    The management of diffuse astrocytomas and pilocytic astrocytomas will be reviewed here. The classification, diagnosis, and natural history of low-grade glioma is discussed separately, as is the management of oligodendroglial tumors. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/1/2071?source=see_link\">",
"     \"Diagnosis and classification of low-grade gliomas\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/24/11655?source=see_link\">",
"     \"Treatment of oligodendroglial tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIFFUSE ASTROCYTOMAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse astrocytomas have a protracted natural history, which often terminates with transformation into HGG.",
"   </p>",
"   <p>",
"    Surgery, radiation therapy (RT), and chemotherapy all have a role in the management of these tumors, but their indolent natural history has resulted in a number of areas of uncertainty. Areas of controversy in the management of these patients include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An aggressive treatment approach including immediate surgical intervention versus a delayed intervention in patients with limited disease and symptoms",
"     </li>",
"     <li>",
"      The role and timing of RT",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      chemotherapy (ie, as an adjuvant immediately after surgery versus delayed until there is evidence of recurrent or progressive disease)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most of the clinical studies that have attempted to address these questions have included different mixtures of patients with oligodendroglial histology (either oligoastrocytomas or oligodendrogliomas), further complicating their interpretation. In addition, recent advances in the understanding of molecular markers, such as the",
"    <span class=\"nowrap\">",
"     1p/19q",
"    </span>",
"    codeletion, now also need to be taken into consideration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235553302\">",
"    <span class=\"h2\">",
"     Initial management",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h3\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with presumed LGGs, surgery provides tissue for histopathologic diagnosis and molecular characterization. In addition, surgical intervention can be therapeutic.",
"   </p>",
"   <p>",
"    For patients in whom a gross total resection is feasible, surgery may constitute the only treatment initially required. In a prospective series of 111 patients who were felt to have a gross tumor resection based upon surgical assessment, the overall survival rates at two and five years were 99 and 93 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/1\">",
"     1",
"    </a>",
"    ]. However, only 48 percent of patients remained progression free at five years. Factors associated with a poorer prognosis included large tumor size (&ge;4 cm), astrocytoma or oligoastrocytoma histology rather than oligodendroglioma, and residual disease &ge;1 cm by MRI. The role of adjuvant RT",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chemotherapy in these patients is uncertain, but is usually postponed until documented progression.",
"   </p>",
"   <p>",
"    Gross total resection is often not possible without a significant risk of serious neurological sequelae because of the diffuse infiltrative nature of these tumors. In this situation, a combined modality approach that includes RT",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chemotherapy may be indicated. In favorable prognosis patients (eg, young, presenting with seizures only), observation is an option after early resection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235552481\">",
"    <span class=\"h4\">",
"     Timing of resecton",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediate surgery is generally required for patients presenting with a large mass or extensive neurologic symptoms, both to establish the diagnosis and debulk the tumor. For patients with a small tumor and minimal symptoms, the role of immediate surgical intervention versus delayed resection is controversial.",
"   </p>",
"   <p>",
"    Many neurosurgeons favor a maximal safe resection at the time of diagnosis for all patients with a presumed LGG, based upon reviews of the literature that have found a trend toward improved survival with this approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. However, there is a bias in these observations since the surgical results are compared to those in patients in whom it was not possible to do a maximal resection.",
"   </p>",
"   <p>",
"    In contrast, a more conservative approach is advocated by others for carefully selected patients with small, minimally symptomatic LGGs (seizures only) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. In this approach, aggressive surgery and RT are delayed until there is radiographic evidence of tumor growth, intractable seizures, progressive neurologic impairment, or radiological evidence of transformation to a high-grade glioma. However, a percentage of patients may no longer be candidates for surgery at the time of progression.",
"   </p>",
"   <p>",
"    There are no randomized trials in such patients that have compared surgery with a conservative approach that delays surgery until there is evidence of progression or clinical deterioration. Data regarding these approaches are derived from observational studies, including a retrospective cohort study that sought to compare early versus delayed surgery at two adjacent regional referral centers in Norway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/6\">",
"     6",
"    </a>",
"    ]. In this population-based study of 153 patients with presumed LGG, one center favored early maximal safe resection (performed in 86 percent) and the other favored diagnostic biopsy and watchful waiting (performed in 71 percent, with 50 percent ultimately undergoing resection). While survival was superior at the center that favored early maximal safe resection (74 versus 60 percent alive at 5 years), this benefit likely reflects the higher rate of resection in this population (89 versus 50 percent) rather than the timing of resection. Of note, about 40 percent of patients in both cohorts had presenting symptoms of headache",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    neurological deficits in addition to seizures, and the median age of both groups was 45 years. These are characteristics that many would consider high risk and inappropriate for a watchful waiting approach.",
"   </p>",
"   <p>",
"    Until further studies are performed, we suggest surgical resection rather than initial observation for patients with transient symptoms and a small tumor not creating a mass effect on adjacent structures. However, careful observation is an alternative in these patients. Subsequent surgical resection is indicated if there is evidence of accelerated tumor growth or transformation to a high-grade glioma, intractable seizures, or progressive neurologic impairment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235552558\">",
"    <span class=\"h4\">",
"     Extent of resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized trials evaluating the extent of surgery, but retrospective evidence supports a more extensive resection rather than simple debulking in patients undergoing resection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/7-9\">",
"     7-9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the most detailed study, magnetic resonance imaging (MRI) was used to assess the preoperative and postoperative tumor volume in a retrospective study of 216 patients with hemispheric LGGs operated on at a single institution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/8\">",
"     8",
"    </a>",
"    ]. Tumor volumes were used to calculate the extent of resection and correlated with patient outcomes. Multivariate analysis found that the completeness of the initial resection was the most important factor in predicting improved overall survival, while lower preoperative tumor volume correlated with increases in both progression-free survival and malignant progression-free survival.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Adjuvant radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;RT is widely used after surgery to treat residual disease in patients with diffuse astrocytomas. Technical advances in both diagnostic radiology and radiation oncology have significantly improved the planning and delivery of RT.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MRI &mdash; The widespread use of MRI allows more accurate definition of tumors that can be difficult to detect by computed tomography (CT). Important advances include detection of the fluid-attenuated inversion recovery (FLAIR) abnormality and use of a 1 to 2.5 cm margin to allow for treatment of microscopic disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      IMRT &mdash; Intensity-modulated radiation therapy (IMRT) is increasingly used to deliver the desired dose to a target while minimizing radiation to surrounding normal radiosensitive tissues. IMRT is a form of CT-based planning that utilizes software to generate a variable dose within each radiation beam and thereby create an optimal composite plan. IMRT is particularly valuable for tumors juxtaposed to radiation sensitive critical structures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Controversies in the use of RT for LGGs have involved the optimal timing and dose of radiation. Three randomized cooperative group trials have assessed the impact of these factors on outcome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h4\">",
"     Timing of RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The European Organization for Research and Treatment of Cancer (EORTC) 22845 trial randomly assigned 311 patients to receive either immediate RT (54 Gy in six weeks) or no therapy until progression following initial biopsy or subtotal resection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/11\">",
"     11",
"    </a>",
"    ]. At a median follow-up of almost eight years, immediate postoperative RT significantly prolonged the progression-free survival (median 5.4 versus 3.7 years, without postoperative RT), but did not affect overall survival (7.4 versus 7.2 years). The majority of patients in the no therapy group (65 percent) received RT at progression.",
"   </p>",
"   <p>",
"    The absence of a survival benefit suggests that RT slows the progression of LGGs but does not prevent transformation into high-grade gliomas. Although quality of life was not assessed in detail, better seizure control was observed among patients receiving postoperative RT. The lack of survival benefit with immediate adjuvant RT has been used as a justification to postpone radiation until disease progression, thereby postponing or avoiding potential radiation-associated toxicity.",
"   </p>",
"   <p>",
"    Prognostic factors are often used to choose patients who may benefit from immediate RT. Patients with a greater likelihood of rapid disease progression receive RT immediately after recovery from surgery. High-risk features include pure astrocytic histology, persistence of significant disease-related neurological symptoms including seizures, recurrent disease, progression of disease, age &ge;40, size of tumor &gt;6 cm, tumor crossing the midline, or a high proliferative index (MIB-1 &gt;3 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/12-14\">",
"     12-14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h4\">",
"     Dose and schedule of RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most radiation oncologists have extrapolated the balance between efficacy and toxicity for the treatment of LGGs to 54 Gy with a range of 45 to 60 Gy.",
"   </p>",
"   <p>",
"    Two multicenter randomized trials both failed to show a survival benefit from escalation of the dose of RT in patients with LGGs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/13,15\">",
"     13,15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In EORTC trial 22844, 379 patients with cerebral LGGs were randomly assigned to 59.4 Gy in 33 treatments or 45 Gy in 25 treatments following surgery or biopsy; they were then followed for a median of 74 months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/15\">",
"       15",
"      </a>",
"      ]. At a minimum follow-up of 50 months, there were no significant outcome differences (59 versus 58 percent alive, and 50 versus 47 percent progression-free, in the high and low dose groups respectively).",
"     </li>",
"     <li>",
"      A North American multicenter trial randomly assigned 203 patients with supratentorial LGGs to treatment with 64.8 Gy or 50.4 Gy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/13\">",
"       13",
"      </a>",
"      ]. There was no improvement in the survival rate with the higher dose of RT (85 versus 94 percent at two years and 64 versus 72 percent at five years, compared to the lower dose of RT). In addition, a higher rate of severe radiation necrosis was seen with the higher dose of RT (5.0 versus 2.5 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other RT approaches that have been evaluated for incompletely resected lesions include hyperfractionated RT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/16\">",
"     16",
"    </a>",
"    ] and fractionated stereotactic radiotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/17\">",
"     17",
"    </a>",
"    ]. However, no advantage has been demonstrated for either of these strategies compared to conventional RT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h4\">",
"     Side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although RT is relatively well tolerated, important late toxicities can occur:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Progressive neurocognitive impairment is a potential consequence both of the disease and its treatment. However, it is not always clear whether any observed impairment is an effect of the RT or whether the tumor itself and antiepileptic drug treatment are contributory. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/22/37226?source=see_link&amp;anchor=H15#H15\">",
"       \"Complications of cranial irradiation\", section on 'Late reactions'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Several longitudinal studies showed that the majority of patients with diffuse astrocytomas eventually transform into a higher grade of malignancy. It is not clear whether RT contributes to this transformation or whether this is a part of the natural history of LGGs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/18-20\">",
"       18-20",
"      </a>",
"      ]. The almost identical survival of patients in EORTC 22845, regardless of whether or not postoperative radiation was given immediately, suggests that RT-induced transformation to a high-grade glioma is not a frequent event shortening survival [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/42/8874?source=see_link\">",
"       \"Risk factors for brain tumors\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Adjuvant chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of routine postoperative chemotherapy remains uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most extensive data come from the RTOG 9802 trial, in which 251 patients with incompletely resected LGG were randomly assigned to postoperative RT with or without six cycles of adjuvant chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/22\">",
"     22",
"    </a>",
"    ]. RT on both trial arms consisted of 54 Gy in 30 fractions. Chemotherapy consisted of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/45/24279?source=see_link\">",
"     procarbazine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/27/37302?source=see_link\">",
"     lomustine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/29/1498?source=see_link\">",
"     vincristine",
"    </a>",
"    (PCV). The patient population included those with diffuse astrocytoma, oligodendroglioma, and mixed",
"    <span class=\"nowrap\">",
"     astrocytoma/oligodendroglioma",
"    </span>",
"    in 26, 42, and 32 percent of cases, respectively.",
"   </p>",
"   <p>",
"    The primary endpoint of the trial was overall survival. Although there was a trend toward longer survival, the difference was not statistically significant (five-year overall survival 72 versus 63 percent, HR 0.72, 95% CI 0.47-1.10).",
"   </p>",
"   <p>",
"    At the first published report of this trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/22\">",
"     22",
"    </a>",
"    ], the analysis was still immature with 65 percent of patients alive and without an analysis based on histology or molecular status",
"    <span class=\"nowrap\">",
"     (1p/19q).",
"    </span>",
"    Further follow-up is required to determine whether the small trend toward improved outcome after the addition of PCV becomes statistically and clinically meaningful. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/24/11655?source=see_link\">",
"     \"Treatment of oligodendroglial tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235552771\">",
"    <span class=\"h2\">",
"     Recurrent disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with diffuse low-grade glioma will eventually recur. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Prognosis and natural history'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Distinguishing recurrent disease from radiation necrosis can be difficult using imaging procedures including MRI, and biopsy may be required. In the event of recurrence, combinations of salvage surgery, radiation, and chemotherapy are considered. Furthermore, recurrent disease may be due to either low-grade glioma or may represent a transformation into high-grade glioma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/30/36328?source=see_link\">",
"     \"Management of recurrent malignant gliomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235552846\">",
"    <span class=\"h3\">",
"     Radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following a complete course of radiation therapy (45 to 60 Gy), retreatment with conventional external beam RT is usually not feasible due to an increased risk of neurotoxicity and radiation-induced necrosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/22/37226?source=see_link\">",
"     \"Complications of cranial irradiation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Stereotactic radiotherapy (SRT) may permit reirradiation limited to the area of recurrence without undue risk of complications by minimizing the dose of radiation to normal structures. The possible role of SRT was illustrated by a series of 172 patients with recurrent gliomas, including 71 with grade 2 tumors and 101 with grade 3 or 4 lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/23\">",
"     23",
"    </a>",
"    ]. All had previously received a definitive course of RT, with a median dose of 60 Gy. At recurrence, all patients received an additional 36 Gy in 18 fractions, using SRT to improve conformal delivery. Treatment was well tolerated, and median survival following reirradiation among patients with LGGs was 22 months. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/5/32855?source=see_link\">",
"     \"Stereotactic cranial radiosurgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235552853\">",
"    <span class=\"h3\">",
"     Chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two studies, which included patients with both astrocytomas and oligodendroglial tumors, reported that the objective response rates to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/47/11000?source=see_link\">",
"     temozolomide",
"    </a>",
"    for patients with astrocytomas were similar to those with oligodendroglial tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Overall, 25 of 45 patients with astrocytomas in these two reports had a partial or complete response to temozolomide chemotherapy. In these two retrospective studies, progression-free survival was 73 and 39 percent at one year, suggesting at least several months of durable response in about one-half of patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Seizures and increased intracranial pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seizures associated with supratentorial LGGs can be a source of major morbidity and are more difficult to manage than idiopathic epilepsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/26\">",
"     26",
"    </a>",
"    ]. In patients with refractory seizures due to LGGs, consideration should be given to surgical resection of the tumor. Over one-half of patients with a preoperative duration of seizures of less than one year will have nearly complete or total resolution of seizures after tumor resection. Most clinicians advocate seizure-type surgery with intraoperative recording to localize the seizure focus in these instances, although it is difficult to definitively demonstrate that this approach is superior to a standard tumor resection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/16/18697?source=see_link\">",
"     \"Seizures in patients with primary and metastatic brain tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/39/41593?source=see_link\">",
"     \"Surgical therapy of epilepsy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of symptoms due to increased intracranial pressure is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/39/33402?source=see_link\">",
"     \"Evaluation and management of elevated intracranial pressure in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Cognitive rehabilitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficits in cognitive functioning can be due to treatment or the tumor itself. These can be manifested as symptoms or objective findings that involve the patient's attention, memory, and executive functioning.",
"   </p>",
"   <p>",
"    Cognitive rehabilitation has been studied in an effort to ameliorate these deficits following resection of LGG. In a multicenter trial, 140 adults with LGGs or anaplastic gliomas were randomly assigned to an active intervention or a control group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/29\">",
"     29",
"    </a>",
"    ]. The active intervention included six individual weekly two-hour sessions, which included both cognitive retraining and skill training for compensatory mechanisms. Patients were evaluated at baseline, at the completion of the cognitive rehabilitation (six weeks) and at six months. Overall, 127 of 140 patients completed the six-month evaluation.",
"   </p>",
"   <p>",
"    Patients reported subjective improvement in symptoms at the immediate postintervention assessment, which did not persist at the six-month evaluation. However, formal neuropsychologic testing revealed improvement in attention and verbal memory at the six-month follow-up, which was not present at the immediate completion of treatment. Whether such benefits persist beyond six months is unknown.",
"   </p>",
"   <p>",
"    The general applicability of these results remains uncertain. Patients were limited to those who reported cognitive symptoms and who had objective deficits on neuropsychologic testing. Patients with more severe deficits who were not able to fully participate in the rehabilitation program were excluded.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H701994788\">",
"    <span class=\"h2\">",
"     Surveillance after treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no formal clinical trials that define the optimal frequency for follow-up after treatment.",
"   </p>",
"   <p>",
"    Guidelines from the National Comprehensive Cancer Network (NCCN) recommend that a repeat MRI should be obtained every three to six months for five years, and then at least annually thereafter for patients with a low-grade glioma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/45/4821?source=see_link&amp;anchor=H701992677#H701992677\">",
"     \"Assessment of disease status and surveillance after treatment in patients with brain tumors\", section on 'Surveillance after treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     OLIGODENDROGLIAL TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In observational studies, oligodendrogliomas and mixed tumors with an oligodendroglial component (ie, oligoastrocytomas) are particularly responsive to chemotherapy. The role of chemotherapy in oligodendroglial tumors is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/24/11655?source=see_link\">",
"     \"Treatment of oligodendroglial tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576579976\">",
"    <span class=\"h1\">",
"     RESPONSE CRITERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard response criteria based upon tumor measurements are difficult, since LGGs are typically nonenhancing and ill defined. The most reliable end point is survival but this is difficult to assess in patients with LGGs due to their prolonged natural history. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/45/4821?source=see_link&amp;anchor=H1576579620#H1576579620\">",
"     \"Assessment of disease status and surveillance after treatment in patients with brain tumors\", section on 'Low-grade gliomas'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PROGNOSIS AND NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the natural history of diffuse astrocytomas varies greatly, most patients eventually deteriorate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/5,31,32\">",
"     5,31,32",
"    </a>",
"    ]. For many patients there will be a period of relative radiographic and clinical stability that averages five to seven years. However, tumor growth eventually accelerates, and the clinical course then is indistinguishable from that of an HGG (ie, anaplastic astrocytoma, glioblastoma).",
"   </p>",
"   <p>",
"    Results from the Surveillance, Epidemiology and End Results (SEER) database illustrate the prognosis and natural history of low-grade astrocytic and oligodendroglial tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/33\">",
"     33",
"    </a>",
"    ]. In this analysis, prognosis was related to age at diagnosis (",
"    <a class=\"graphic graphic_figure graphicRef73050 \" href=\"mobipreview.htm?40/17/41245\">",
"     figure 1",
"    </a>",
"    ). For tumors diagnosed between 1990 and 2001, the ten-year survival rates were 86, 53, and 20 percent for patients &lt;20 years, 20 to 64 years, and &gt;64 years of age respectively. The survival rates for adults improved since 1990, which probably reflects both earlier diagnoses of minimally symptomatic patients using better imaging modalities, as well as improvements in therapy.",
"   </p>",
"   <p>",
"    Multiple studies have looked at factors present at diagnosis that help to predict prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/12,34-38\">",
"     12,34-38",
"    </a>",
"    ]. In a multivariate analysis of 401 patients with LGG from three centers, factors associated with longer survival included age less than 40 years, epilepsy as the presenting symptom, and an absence of contrast enhancement on CT scan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/34\">",
"     34",
"    </a>",
"    ]. On the other hand, CT contrast enhancement of the original tumor predicted a high likelihood of rapid progression and a shorter clinical course [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/12,34\">",
"     12,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to these clinical and imaging parameters, immunochemical assessment of the proliferative index (PI) has prognostic significance in patients with LGGs. Patients with an LGG and a relatively high PI, as determined using the MIB-1 monoclonal antibody to detect the Ki-67 nuclear antigen, have a poorer prognosis compared to those with a low PI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Molecular markers appear to provide additional information about prognosis in patients with LGGs. In particular, patients with promoter methylation of the methylguanine-DNA methyltransferase (MGMT) gene and those with mutations of the isocitrate dehydrogenase genes (IDH1 and IDH2) have a better prognosis than those lacking these molecular markers. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/53/14169?source=see_link&amp;anchor=H20#H20\">",
"     \"Pathogenesis and biology of malignant gliomas\", section on 'Prognostic impact of molecular alterations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast to adults, the natural history of LGGs in children appears to be more prolonged. In one series of 65 children with grade 2 astrocytomas (mean age at diagnosis 13 years), the cumulative incidence of malignant transformation was 7 percent at 15 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are only limited data on the impact of pregnancy on the natural history and prognosis of LGGs. In the largest series, eight pregnancies were identified in 443 women over a 15 year period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/41\">",
"     41",
"    </a>",
"    ]. Five of these eight were diagnosed prior to the pregnancy. In six cases, there was a suggestion that the clinical course worsened during the pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/9/20634?source=see_link&amp;anchor=H17#H17\">",
"     \"Neurologic disorders complicating pregnancy\", section on 'Brain tumors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PILOCYTIC ASTROCYTOMAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pilocytic astrocytomas, formerly referred to as juvenile pilocytic astrocytomas, are distinguished from diffuse astrocytomas and oligodendroglial tumors because of their earlier age of onset, lack of invasiveness, and favorable prognosis in many patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/42\">",
"     42",
"    </a>",
"    ]. Such tumors are usually curable if completely resected; thus the goal of surgery should be complete removal. However, multicentric spread can occur, especially with hypothalamic tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/1/2071?source=see_link&amp;anchor=H7#H7\">",
"     \"Diagnosis and classification of low-grade gliomas\", section on 'Pilocytic astrocytomas'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Malignant transformation of pilocytic astrocytomas to HGGs occurs in less than 5 percent of cases, but it may happen more frequently in patients who have been previously irradiated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/20,44\">",
"     20,44",
"    </a>",
"    ]. RT has not been demonstrated to have a favorable impact on survival or prevention of tumor progression in pilocytic astrocytomas; as a result, RT should be avoided in the initial management of these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/45-50\">",
"     45-50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical resection is the standard initial approach in patients with pilocytic astrocytomas. Even if resection is incomplete, RT and chemotherapy are usually withheld until there is evidence of tumor growth. RT at the time of diagnosis may be required for patients in whom surgery is not feasible. RT is also indicated in those patients with pilocytic astrocytomas who have progressive disease following surgical resection. When RT is recommended, an involved field fractionated course to 54 Gy is most commonly used.",
"   </p>",
"   <p>",
"    Pilocytic astrocytomas have a much better prognosis than low-grade astrocytic and oligodendroglial tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/42,51-55\">",
"     42,51-55",
"    </a>",
"    ]. With complete surgical resection, JPAs are potentially curable; thus, the goal of surgery should be complete removal. Even with incomplete tumor resection JPAs are often associated with prolonged survival. As an example, in a series of 361 pediatric patients with LGGs treated at a single institution over a 22 year period, 63 percent of patients had pilocytic astrocytoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/55\">",
"     55",
"    </a>",
"    ]. The 10 and 20-year overall survival rates for the entire series were 87 and 82 percent, respectively. However, a substantial number of long-term survivors did experience adverse outcomes including for example intellectual impairment, endocrine abnormalities, hearing loss, and blindness.",
"   </p>",
"   <p>",
"    In another series of 51 patients all of whom had pilocytic astrocytoma, 82 percent of patients were alive after ten years and 89 percent of survivors were fully active [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/42\">",
"     42",
"    </a>",
"    ]. Ten-year survival was higher in those who underwent gross total or radical subtotal tumor resection (100 versus 74 percent, in patients with a lesser resection or biopsy alone). Transformation to a more anaplastic tumor occurs in approximately 10 percent of patients and can be associated with rapid disease progression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44568/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/30/36328?source=see_link\">",
"     \"Management of recurrent malignant gliomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/34/6690?source=see_link\">",
"       \"Patient information: Astrocytoma (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/42/36515?source=see_link\">",
"       \"Patient information: Primary low-grade glioma in adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low-grade gliomas (LGGs) are uncommon primary tumors of the central nervous system that often have an indolent course. Surgery, radiation therapy (RT), and chemotherapy all are useful in selected situations, although there are multiple areas of uncertainty concerning the optimal treatment of these patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immediate surgery is generally required for patients presenting with a large mass or extensive neurologic symptoms, both to establish the diagnosis and debulk the tumor. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients with transient symptoms and a small tumor not creating a mass effect on adjacent structures, we suggest surgical resection (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). However, careful observation is an alternative in these patients. Subsequent surgical resection is indicated if there is evidence of accelerated tumor growth or transformation to a high-grade glioma, intractable seizures, or progressive neurologic impairment. (See",
"      <a class=\"local\" href=\"#H235552481\">",
"       'Timing of resecton'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients undergoing surgical resection, we recommend the maximal resection consistent with avoiding significant neurologic sequelae rather than simple debulking (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). If resection is not technically feasible, biopsy followed by RT",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      chemotherapy is indicated. &nbsp;(See",
"      <a class=\"local\" href=\"#H235552558\">",
"       'Extent of resection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Postoperative management for patients with diffuse astrocytoma:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We recommend that RT be administered postoperatively if there are persistent neurologic symptoms due to the tumor (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Postoperative RT can also be considered in cases with a poor prognosis due to the tumor, including those with substantial residual disease, high MIB-1 index (&gt;3 percent), or age &gt;40 years. If symptoms are limited and there are no other poor prognostic features, we suggest that RT be deferred (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Timing of RT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who receive adjuvant RT, we recommend limiting the RT dose to approximately 54 Gy in six weeks to minimize the risk of late neurologic complications (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Dose and schedule of RT'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/22/37226?source=see_link\">",
"       \"Complications of cranial irradiation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with a diffuse astrocytoma, we do not routinely administer adjuvant chemotherapy. However, for patients with a large residual tumor or other significant negative prognostic factors, adjuvant chemotherapy (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/47/11000?source=see_link\">",
"       temozolomide",
"      </a>",
"      or PCV) is an alternative. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Adjuvant chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients with diffuse astrocytoma eventually recur. Surgery, radiation, and chemotherapy all can have a role in the management of these patients, and their application needs to be individualized based upon the site and extent of recurrence, along with the history of prior treatment. (See",
"      <a class=\"local\" href=\"#H235552771\">",
"       'Recurrent disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Oligodendrogliomas &mdash; The management of patients with low-grade oligodendroglial tumors is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/24/11655?source=see_link\">",
"       \"Treatment of oligodendroglial tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pilocytic astrocytomas &mdash; Surgical resection is used for the diagnosis and initial treatment of patients with pilocytic astrocytomas. We recommend that RT be reserved for the subsequent management of symptomatic patients who are not resectable or in whom progressive disease develops (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Pilocytic astrocytomas'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/1\">",
"      Shaw EG, Berkey B, Coons SW, et al. Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. J Neurosurg 2008; 109:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/2\">",
"      Pouratian N, Schiff D. Management of low-grade glioma. Curr Neurol Neurosci Rep 2010; 10:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/3\">",
"      Whittle IR. What is the place of conservative management for adult supratentorial low-grade glioma? Adv Tech Stand Neurosurg 2010; 35:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/4\">",
"      Sanai N, Chang S, Berger MS. Low-grade gliomas in adults. J Neurosurg 2011; 115:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/5\">",
"      Recht LD, Lew R, Smith TW. Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 1992; 31:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/6\">",
"      Jakola AS, Myrmel KS, Kloster R, et al. Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA 2012; 308:1881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/7\">",
"      Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 2001; 95:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/8\">",
"      Smith JS, Chang EF, Lamborn KR, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 2008; 26:1338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/9\">",
"      McGirt MJ, Chaichana KL, Attenello FJ, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 2008; 63:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/10\">",
"      Pirzkall A, Nelson SJ, McKnight TR, et al. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 2002; 53:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/11\">",
"      van den Bent MJ, Afra D, de Witte O, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 2005; 366:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/12\">",
"      Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002; 20:2076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/13\">",
"      Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002; 20:2267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/14\">",
"      Shafqat S, Hedley-Whyte ET, Henson JW. Age-dependent rate of anaplastic transformation in low-grade astrocytoma. Neurology 1999; 52:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/15\">",
"      Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996; 36:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/16\">",
"      Jeremic B, Shibamoto Y, Grujicic D, et al. Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma. A phase II study. Radiother Oncol 1998; 49:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/17\">",
"      Plathow C, Schulz-Ertner D, Thilman C, et al. Fractionated stereotactic radiotherapy in low-grade astrocytomas: long-term outcome and prognostic factors. Int J Radiat Oncol Biol Phys 2003; 57:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/18\">",
"      M&uuml;ller W, Afra D, Schr&ouml;der R. Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas. Acta Neurochir (Wien) 1977; 37:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/19\">",
"      M&uuml;ller W, Afra D, Schr&ouml;der R. Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with oligodendrogliomas. Acta Neurochir (Wien) 1977; 39:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/20\">",
"      Dirks PB, Jay V, Becker LE, et al. Development of anaplastic changes in low-grade astrocytomas of childhood. Neurosurgery 1994; 34:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/21\">",
"      Eyre HJ, Crowley JJ, Townsend JJ, et al. A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J Neurosurg 1993; 78:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/22\">",
"      Shaw EG, Wang M, Coons SW, et al. Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. J Clin Oncol 2012; 30:3065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/23\">",
"      Combs SE, Thilmann C, Edler L, et al. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol 2005; 23:8863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/24\">",
"      Pace A, Vidiri A, Gali&egrave; E, et al. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol 2003; 14:1722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/25\">",
"      Quinn JA, Reardon DA, Friedman AH, et al. Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol 2003; 21:646.",
"     </a>",
"    </li>",
"    <li>",
"     Glantz M, Recht LD. Epilepsy in the cancer patient. In: Handbook of Clinical Oncology, Neuro-Oncology - Part III, Vecht CJ (Ed), Elsevier, Amsterdam 1997. p.9.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/27\">",
"      Pilcher WH, Silbergeld DL, Berger MS, Ojemann GA. Intraoperative electrocorticography during tumor resection: impact on seizure outcome in patients with gangliogliomas. J Neurosurg 1993; 78:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/28\">",
"      Zentner J, Hufnagel A, Wolf HK, et al. Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery 1997; 41:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/29\">",
"      Gehring K, Sitskoorn MM, Gundy CM, et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol 2009; 27:3712.",
"     </a>",
"    </li>",
"    <li>",
"     NCCN guidelines file://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/31\">",
"      Olson JD, Riedel E, DeAngelis LM. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 2000; 54:1442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/32\">",
"      Bauman G, Fisher B, Watling C, et al. Adult supratentorial low-grade glioma: long-term experience at a single institution. Int J Radiat Oncol Biol Phys 2009; 75:1401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/33\">",
"      Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer 2006; 106:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/34\">",
"      Bauman G, Lote K, Larson D, et al. Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 1999; 45:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/35\">",
"      Medbery CA 3rd, Straus KL, Steinberg SM, et al. Low-grade astrocytomas: treatment results and prognostic variables. Int J Radiat Oncol Biol Phys 1988; 15:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/36\">",
"      Smith DF, Hutton JL, Sandemann D, et al. The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management. J Neurol Neurosurg Psychiatry 1991; 54:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/37\">",
"      Hutton JL, Smith DF, Sandemann D, et al. Development of prognostic index for primary supratentorial intracerebral tumours. J Neurol Neurosurg Psychiatry 1992; 55:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/38\">",
"      Law M, Oh S, Babb JS, et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. Radiology 2006; 238:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/39\">",
"      Torp SH, Alsaker M. Ki-67 immunoreactivity, basic fibroblastic growth factor (bFGF) expression, and microvessel density as supplementary prognostic tools in low-grade astrocytomas. An immunohistochemical study with special reference to the reliability of different Ki-67 antibodies. Pathol Res Pract 2002; 198:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/40\">",
"      Broniscer A, Baker SJ, West AN, et al. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol 2007; 25:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/41\">",
"      Pallud J, Duffau H, Razak RA, et al. Influence of pregnancy in the behavior of diffuse gliomas: clinical cases of a French glioma study group. J Neurol 2009; 256:2014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/42\">",
"      Forsyth PA, Shaw EG, Scheithauer BW, et al. Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients. Cancer 1993; 72:1335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/43\">",
"      Mishima K, Nakamura M, Nakamura H, et al. Leptomeningeal dissemination of cerebellar pilocytic astrocytoma. Case report. J Neurosurg 1992; 77:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/44\">",
"      Alpers CE, Davis RL, Wilson CB. Persistence and late malignant transformation of childhood cerebellar astrocytoma. Case report. J Neurosurg 1982; 57:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/45\">",
"      Palma L, Guidetti B. Cystic pilocytic astrocytomas of the cerebral hemispheres. Surgical experience with 51 cases and long-term results. J Neurosurg 1985; 62:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/46\">",
"      Leibel SA, Sheline GE, Wara WM, et al. The role of radiation therapy in the treatment of astrocytomas. Cancer 1975; 35:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/47\">",
"      Vertosick FT Jr, Selker RG, Arena VC. Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography. Neurosurgery 1991; 28:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/48\">",
"      Shaw EG, Daumas-Duport C, Scheithauer BW, et al. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 1989; 70:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/49\">",
"      Garcia DM, Fulling KH, Marks JE. The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum. Cancer 1985; 55:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/50\">",
"      Westergaard L, Gjerris F, Klinken L. Prognostic factors in oligodendrogliomas. Acta Neurochir (Wien) 1997; 139:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/51\">",
"      Burkhard C, Di Patre PL, Sch&uuml;ler D, et al. A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. J Neurosurg 2003; 98:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/52\">",
"      Brown PD, Buckner JC, O'Fallon JR, et al. Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial. Int J Radiat Oncol Biol Phys 2004; 58:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/53\">",
"      Fernandez C, Figarella-Branger D, Girard N, et al. Pilocytic astrocytomas in children: prognostic factors--a retrospective study of 80 cases. Neurosurgery 2003; 53:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/54\">",
"      Morreale VM, Ebersold MJ, Quast LM, Parisi JE. Cerebellar astrocytoma: experience with 54 cases surgically treated at the Mayo Clinic, Rochester, Minnesota, from 1978 to 1990. J Neurosurg 1997; 87:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/55\">",
"      Armstrong GT, Conklin HM, Huang S, et al. Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro Oncol 2011; 13:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/56\">",
"      Krieger MD, Gonzalez-Gomez I, Levy ML, McComb JG. Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas. Pediatr Neurosurg 1997; 27:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44568/abstract/57\">",
"      Ellis JA, Waziri A, Balmaceda C, et al. Rapid recurrence and malignant transformation of pilocytic astrocytoma in adult patients. J Neurooncol 2009; 95:377.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5198 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-197.136.42.3-447D2A5374-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44568=[""].join("\n");
var outline_f43_33_44568=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIFFUSE ASTROCYTOMAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H235553302\">",
"      Initial management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      - Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H235552481\">",
"      Timing of resecton",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H235552558\">",
"      Extent of resection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Adjuvant radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Timing of RT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Dose and schedule of RT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Side effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Adjuvant chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H235552771\">",
"      Recurrent disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H235552846\">",
"      - Radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H235552853\">",
"      - Chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Seizures and increased intracranial pressure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Cognitive rehabilitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H701994788\">",
"      Surveillance after treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      OLIGODENDROGLIAL TUMORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1576579976\">",
"      RESPONSE CRITERIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PROGNOSIS AND NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PILOCYTIC ASTROCYTOMAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/5198\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/5198|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/17/41245\" title=\"figure 1\">",
"      Survival LGG age",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/45/4821?source=related_link\">",
"      Assessment of disease status and surveillance after treatment in patients with brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/22/37226?source=related_link\">",
"      Complications of cranial irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/1/2071?source=related_link\">",
"      Diagnosis and classification of low-grade gliomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/39/33402?source=related_link\">",
"      Evaluation and management of elevated intracranial pressure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/30/36328?source=related_link\">",
"      Management of recurrent malignant gliomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/9/20634?source=related_link\">",
"      Neurologic disorders complicating pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/53/14169?source=related_link\">",
"      Pathogenesis and biology of malignant gliomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/34/6690?source=related_link\">",
"      Patient information: Astrocytoma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/42/36515?source=related_link\">",
"      Patient information: Primary low-grade glioma in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/42/8874?source=related_link\">",
"      Risk factors for brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/16/18697?source=related_link\">",
"      Seizures in patients with primary and metastatic brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/5/32855?source=related_link\">",
"      Stereotactic cranial radiosurgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/39/41593?source=related_link\">",
"      Surgical therapy of epilepsy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/24/11655?source=related_link\">",
"      Treatment of oligodendroglial tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_33_44569="Overview of the non-acute management of unstable angina and non-ST elevation myocardial infarction";
var content_f43_33_44569=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the non-acute management of unstable angina and non-ST elevation myocardial infarction",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44569/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44569/contributors\">",
"     Jeffrey A Breall, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44569/contributors\">",
"     Julian M Aroesty, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44569/contributors\">",
"     Michael Simons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44569/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44569/contributors\">",
"     Christopher P Cannon, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44569/contributors\">",
"     James Hoekstra, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44569/contributors\">",
"     Donald Cutlip, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/33/44569/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/33/44569/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/33/44569/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 14, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the diagnosis of unstable angina (UA) or an acute non-ST elevation myocardial infarction (NSTEMI) is made, the early management of the patient involves the simultaneous achievement of several goals including relief of ischemic pain, assessment of the hemodynamic state and correction of abnormalities that are present, determining the optimal timing of cardiac catheterization and potential percutaneous coronary intervention (PCI), and initiation of antithrombotic therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/43/15034?source=see_link\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/20/37193?source=see_link\">",
"     \"Overview of the acute management of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These early diagnostic and therapeutic interventions are followed by the initiation of short- and long-term interventions aimed at improving in-hospital and long-term outcomes. This topic will summarize the management of patients with unstable angina or acute NSTEMI in the hours and days following reperfusion. The reader will be directed to a more detailed discussion of these issues in other topics.",
"   </p>",
"   <p>",
"    The management of the patient with a ST elevation (STEMI) or with a complication of an acute MI (eg, cardiogenic shock, mitral regurgitation, ventricular septal defect) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/41/44697?source=see_link\">",
"     \"Overview of the acute management of ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/37/35418?source=see_link\">",
"     \"Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39225?source=see_link\">",
"     \"Mechanical complications of acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     FURTHER MEDICAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following initial therapy as discussed above, further medical therapy includes oral beta blockers (if not already given), statins, and possibly nitrates, aldosterone antagonists, ACE inhibitors. There is only a limited role for calcium channel blockers and oral anticoagulation, and no role for hormone replacement therapy in postmenopausal women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Oral beta blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who did not receive a beta blocker during the first 24 hours because of early contraindications should be reevaluated for beta blocker candidacy. An oral cardioselective beta blocker, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39417?source=see_link\">",
"     metoprolol",
"    </a>",
"    (25 to 50 mg twice daily with the short-acting preparation or daily with the long-acting XL preparation) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/46/30440?source=see_link\">",
"     atenolol",
"    </a>",
"    (50 to 100 mg daily), may be used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients are continued on an oral beta blocker indefinitely. The efficacy of beta blocker therapy is related in part to the degree of heart rate slowing. These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/53/11098?source=see_link\">",
"     \"Beta blockers in the management of acute coronary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Nitrates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nitrates can be useful during the first 24 to 48 hours in patients with recurrent ischemia, hypertension, or heart failure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/63/24566?source=see_link\">",
"     \"Nitrates in the management of acute coronary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Phosphodiesterase-5 inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The phosphodiesterase-5 inhibitors (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/40/21127?source=see_link\">",
"     vardenafil",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/4/19528?source=see_link\">",
"     tadalafil",
"    </a>",
"    ) are contraindicated in patients taking nitrates because of the potential for exaggerated vasodilation and hypotension and an increased risk of MI or death. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/15/8442?source=see_link\">",
"     \"Sexual activity in patients with heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Statin therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Statin therapy should be instituted prior to hospital discharge, with some data supporting initiation at the time of diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/20/37193?source=see_link&amp;anchor=H12643985#H12643985\">",
"     \"Overview of the acute management of unstable angina and non-ST elevation myocardial infarction\", section on 'Statin therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Calcium channel blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcium channel blockers are used as adjunctive therapy in patients with ongoing or recurrent symptoms of ischemia despite optimal therapy with beta blockers (with or without nitrates), in patients who are unable to tolerate adequate doses of one or both of these agents, or in patients with rapid atrial fibrillation when beta blockers are contraindicated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/33/40469?source=see_link\">",
"     \"Calcium channel blockers in the management of acute coronary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines for the treatment of a non-ST elevation ACS recommended",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/16/12554?source=see_link\">",
"     diltiazem",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    as initial therapy for patients with ongoing ischemia when beta blockers are contraindicated, only if there is no heart failure or left ventricular dysfunction&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/1\">",
"     1",
"    </a>",
"    ]. The guidelines also suggested oral long acting calcium channel blockers (diltiazem or verapamil) for ongoing ischemia despite beta blockers and nitrates, or in patients with rapid atrial fibrillation when beta blockers are contraindicated.",
"   </p>",
"   <p>",
"    There are conflicting data from controlled trials as to whether calcium channel blockers do or do not reduce mortality in patients with NSTEMI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. With respect to unstable angina, a meta-analysis of calcium channel blocker trials found no difference in the incidence of subsequent MI (19.6 versus 19.0 percent for placebo) or death (2.4 versus 1.6 percent for placebo) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/33/40469?source=see_link\">",
"     \"Calcium channel blockers in the management of acute coronary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The second generation dihydropyridine calcium channel blockers",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/18/296?source=see_link\">",
"     amlodipine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/45/2775?source=see_link\">",
"     felodipine",
"    </a>",
"    appear to be safe in other forms of cardiovascular disease. Extrapolation from the results of these trials does not necessarily confirm that amlodipine or felodipine are safe in patients with an acute MI. Nonetheless, these agents, especially amlodipine, are often used in patients with an acute MI when hypertension is not adequately controlled by other therapy of proven benefit (beta blockers and ACE inhibitors). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/33/40469?source=see_link\">",
"     \"Calcium channel blockers in the management of acute coronary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Immediate release",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/5/12377?source=see_link\">",
"     nifedipine",
"    </a>",
"    is contraindicated because of the reflex sympathetic activation, tachycardia, and hypotension associated with its use. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/12/32966?source=see_link&amp;anchor=H10#H10\">",
"     \"Major side effects and safety of calcium channel blockers\", section on 'Increased mortality after acute MI'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These agents should be continued after discharge in those patients who require them for anti-ischemic or antihypertensive therapy as well as for rate control of atrial tachyarrhythmias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Blood transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia can reduce the delivery of oxygen to the myocardium and, in a review of clinical trials of patients with a non-ST elevation ACS, the risk of cardiovascular mortality, nonfatal MI, or recurrent ischemia at 30 days was significantly increased in patients with a hemoglobin concentration below 11",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25754?source=see_link&amp;anchor=H28#H28\">",
"     \"Risk factors for adverse outcomes after unstable angina or non-ST elevation myocardial infarction\", section on 'Anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is unlikely that transfusion is beneficial for patients with an ACS who have a hemoglobin above 10",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    but the benefits probably exceed the risks for patients with a hematocrit below 21 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/7\">",
"     7",
"    </a>",
"    ]. There are no published high quality data that can be used to formulate recommendations for the threshold for red blood cell transfusion in patients with an ACS. A 2013 systematic review of 10 studies (including one small randomized trial) of over 200,000 patients with either NSTEMI or STEMI found an increased rate of all-cause mortality associated with a strategy of blood transfusion compared to no transfusion (18.2 versus 10.2 percent; risk ratio 2.91, 95% CI 2.46-3.44) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/8\">",
"     8",
"    </a>",
"    ]. This association continued after multivariate analysis. However, the practical application of this study is limited as the authors did not perform an analysis stratified by baseline hemoglobin level.",
"   </p>",
"   <p>",
"    Individual patient characteristics such as the rate of blood loss and severity of myocardial ischemia need to be taken into account when considering blood transfusion. We suggest transfusing to maintain the hemoglobin &ge;9",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    particularly when the anemia is acute, and there is evidence of ongoing ischemia or the patient is scheduled to undergo an invasive cardiac procedure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/55/28538?source=see_link&amp;anchor=H5079586#H5079586\">",
"     \"Approach to acute upper gastrointestinal bleeding in adults\", section on 'Blood transfusions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2011 American College of Cardiology",
"    <span class=\"nowrap\">",
"     Foundation/American",
"    </span>",
"    Heart Association focused update of the prior guideline on unstable",
"    <span class=\"nowrap\">",
"     angina/non",
"    </span>",
"    ST-elevation MI did not make any recommendations concerning the potential benefit or risk of blood transfusion in the setting of an ACS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/52/5961?source=see_link\">",
"     \"Indications for red cell transfusion in the adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Antiarrhythmic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of atrial and ventricular arrhythmias is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/20/37193?source=see_link&amp;anchor=H18#H18\">",
"     \"Overview of the acute management of unstable angina and non-ST elevation myocardial infarction\", section on 'Arrhythmia management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Venous thromboembolism prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prophylaxis for venous thromboembolism should be considered in patients who are immobilized. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/21/36186?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in medical patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, many patients with NSTEMI are now ambulatory within 24 hours, particularly if they have received revascularization therapy and have had uncomplicated courses. The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines recommended that until the patient is ambulatory, the physician should use either unfractionated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    (UFH) or low molecular weight heparin (LMWH) to reduce the risk of deep venous thrombosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/1\">",
"     1",
"    </a>",
"    ]. The 2008 American College of Chest Physicians guideline on the prevention of venous thromboembolism does not include uncomplicated myocardial infarction with a short duration of bed rest among the medical conditions for which prophylaxis is recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/10\">",
"     10",
"    </a>",
"    ], however prophylaxis should be considered in patients with other additional risk factors for DVT.",
"   </p>",
"   <p>",
"    In patients with uncomplicated NSTEMI who will be at bed rest for less than 24 hours, venous thromboembolism prophylaxis is not necessary (unless indicated for some other reason). For NSTEMI patients in whom bed rest is anticipated for more than 24 hours and for whom anticoagulation is no longer required as part of the management of their acute coronary syndrome, we suggest low-dose UFH (5000 units, two or three times daily depending on patient risk level), LMWH (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    40",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    2.5",
"    <span class=\"nowrap\">",
"     mg/day,",
"    </span>",
"    all given subcutaneously, until the patient is ambulatory.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Glycemic control",
"    </span>",
"    &nbsp;&mdash;&nbsp;The correction of hyperglycemia has become standard care for hospitalized patients, including those with acute myocardial infarction (MI). However, whether control of hyperglycemia is sufficient to reduce morbidity and mortality is not proven at this time. The evidence upon which recommendations for glycemic control can be made and the specific recommendations are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/33/44567?source=see_link\">",
"     \"Glycemic control for acute myocardial infarction in patients with and without diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/35/43577?source=see_link&amp;anchor=H3#H3\">",
"     \"Initial management of blood glucose in type 2 diabetes mellitus\", section on 'Degree of glycemic control'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Gastrointestinal prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with ACS who develop gastrointestinal bleeding (GI) after PCI have significantly worse outcomes. The discussion of the long-term primary prevention of gastrointestinal bleeding is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/9/20632?source=see_link&amp;anchor=H5971608#H5971608\">",
"     \"Periprocedural and long-term gastrointestinal bleeding in patients undergoing percutaneous coronary intervention\", section on 'Outcomes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     RECURRENT CHEST PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest pain after NSTEMI may occur and it is important to determine whether this is representative of recurrent",
"    <span class=\"nowrap\">",
"     ischemia/infarction",
"    </span>",
"    or simply resolving discomfort after the initial event. This can sometimes be difficult but often the clinical quality of the pain along with ST segment shifts seen on the electrocardiogram and a typical rise and fall in cardiac biomarkers can be very useful distinguishing features. Coronary angiography is sometimes necessary to evaluate recurrent chest pain. Chest pain after coronary intervention is also common and can be sorted out in a similar fashion. In particular, the lack of ST segment shifts on the ECG following coronary intervention is often a useful discriminating feature",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Recurrent ischemia and reinfarction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with an NSTEMI who have undergone apparently successful percutaneous coronary intervention, recurrent ischemia or reinfarction represents either ischemia in a coronary distribution not revascularized or possible stent thrombosis. Recurrent ischemia is often manifest by the recurrence of symptoms and new or changing ECG abnormalities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial medical management of recurrent ischemia should include escalation of therapy with beta blockers and nitrates to decrease myocardial oxygen demand and reduce ischemia. Intravenous anticoagulation should be initiated if it is not already being administered. For patients with hemodynamic instability, poor left ventricular function, or a large area of myocardium at risk, insertion of an intraaortic balloon pump should also be considered.",
"   </p>",
"   <p>",
"    PCI is the treatment of choice for patients with recurrent ischemia, unless the patient's coronary anatomy or clinical status preclude coronary intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Infarction pericarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute pericarditis, generally defined as a pericardial friction rub with or without chest discomfort, may rarely complicate the course of an acute NSTEMI. Chest pain is typically pleuritic. Pain in one or both trapezius ridges is especially consistent with the diagnosis. The evaluation and management of this complication are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/31/24055?source=see_link&amp;anchor=H2#H2\">",
"     \"Pericardial complications of myocardial infarction\", section on 'Peri-infarction pericarditis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A somewhat separate issue, chest pain or silent ischemia on stress testing before or soon after discharge, is discussed below. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Stress testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PREPARING FOR DISCHARGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal duration of hospitalization for patients with non-ST elevation ACS who have been revascularized with PCI has not been defined. The employment of early angiography and revascularization has led to shorter hospitalizations for patients and the use of stenting and potent antiplatelet therapy in the periprocedural period has led to a reduction in recurrent ischemic events. On the other hand, potent antiplatelet and antithrombotic therapies are associated with an increased risk of major bleeding which may complicate and lengthen hospitalization. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/1/29722?source=see_link&amp;anchor=H30#H30\">",
"     \"Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction\", section on 'Timing of discharge'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior to discharge, the patient should undergo risk stratification. Other components of predischarge planning include counseling about changes in lifestyle and appropriate medical therapy to reduce the risk for further ischemic episodes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Ambulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first major step in the transition from acute care to hospital discharge in patients with non-ST elevation ACS is ambulation. The proper timing of ambulation is patient and institution dependent and requires balancing the risk of bleeding after coronary intervention with the deleterious effects of deconditioning that can be induced by prolonged bed rest. We suggest the following approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among patients who have undergone percutaneous revascularization, progressive ambulation can be started after the time required to achieve adequate hemostasis (often three to six hours) in patients who are hemodynamically stable and not having ongoing ischemic symptoms.",
"     </li>",
"     <li>",
"      Among patients who have not undergone revascularization, progressive ambulation can be started when the patient is hemodynamically stable without attendant complications for three to six hours after the peak of the cardiac marker rise.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Chronic anticoagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines on",
"    <span class=\"nowrap\">",
"     UA/NSTEMI",
"    </span>",
"    and 2004 ACCP guidelines on antithrombotic therapy recommend the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    post-ACS in patients at high risk for embolization, such as atrial fibrillation, and in selected other settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/1,11\">",
"     1,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/60/20425?source=see_link\">",
"     \"Chronic anticoagulation after acute coronary syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of chronic anticoagulation with dual antiplatelet therapy is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/31/13818?source=see_link\">",
"     \"Triple antithrombotic therapy in patients with cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Long-term risk stratification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a non-ST elevation ACS should undergo further risk assessment prior to discharge. The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines on",
"    <span class=\"nowrap\">",
"     UA/NSTEMI",
"    </span>",
"    identified clinical events that place the patient at high risk, including recurrent ischemic chest pain, sustained ventricular tachycardia, hemodynamic instability, and heart failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/1\">",
"     1",
"    </a>",
"    ]. Such patients, like those deemed to be at high early risk, should undergo coronary angiography and revascularization, if appropriate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/43/2746?source=see_link\">",
"     \"Risk stratification after unstable angina or non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Stress testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Predischarge stress testing to detect residual ischemia is generally",
"    <strong>",
"     not",
"    </strong>",
"    performed in patients who have undergone PCI or CABG and have been",
"    <strong>",
"     fully",
"    </strong>",
"    revascularized (eg, single vessel disease and successful PCI). Such patients often undergo exercise testing a few weeks or more after discharge as part of a cardiac rehabilitation program or for activity counseling.",
"   </p>",
"   <p>",
"    In contrast, patients who have undergone partial revascularization or no revascularization are candidates for predischarge low level stress testing, usually with exercise. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/43/2746?source=see_link&amp;anchor=H16#H16\">",
"     \"Risk stratification after unstable angina or non-ST elevation myocardial infarction\", section on 'Stress testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with symptomatic ischemia on postinfarct stress testing, we suggest the following approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Coronary angiography followed by revascularization if appropriate is performed in patients with noninvasive evidence suggesting a moderate to large amount of myocardium at risk. Examples include ischemia during stage I or II of the Bruce protocol, a hypotensive blood pressure response or symptoms of pulmonary congestion, more than 2 mm of ST segment depression, or imaging studies suggesting involvement of either a large portion of the anterior wall or showing multiple areas of ischemia.",
"     </li>",
"     <li>",
"      Patients with only mild ischemia can be continued on medical therapy alone, but patient preference may be important.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The management of silent ischemia detected on stress testing is similar and discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/35/4665?source=see_link&amp;anchor=H16#H16\">",
"     \"Silent myocardial ischemia: Prognosis and therapy\", section on 'Post-MI ischemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Evaluation of LV function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of resting left ventricular function is an important part of risk stratification in patients with a non-ST elevation ACS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/1\">",
"     1",
"    </a>",
"    ]. Patients with left ventricular systolic dysfunction have increased mortality at long-term follow-up and more than a 50 percent probability of having multivessel coronary disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the absence of a specific indication (eg, heart failure or suspected mechanical complication), the LVEF is usually measured before discharge.",
"   </p>",
"   <p>",
"    Multiple imaging techniques for assessing left ventricular function are available and each has equivalent prognostic value in the post-MI patient. In general, echocardiography should be used for routine assessment of LVEF after a non-ST elevation ACS. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/6/11369?source=see_link\">",
"     \"Role of echocardiography in acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/55/18297?source=see_link\">",
"     \"Ischemic mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Pharmacologic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases, the inpatient antiischemic medical regimen used during hospitalization (other than intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    ) should be continued after discharge and the",
"    <span class=\"nowrap\">",
"     antiplatelet/anticoagulant",
"    </span>",
"    medications should be changed to an outpatient regimen. The goals for continued medical therapy after discharge relate to potential prognostic benefits, treatment of major risk factors such as hypertension, smoking, hyperlipidemia, and diabetes mellitus, and control of ischemic symptoms if they recur.",
"   </p>",
"   <p>",
"    Appropriate use of antiplatelet agents, beta blockers, lipid-lowering drugs, and, in selected patients, ACE inhibitors may reduce six-month mortality by as much as 90 percent compared with patients who receive no appropriate therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/60/40906?source=see_link\">",
"     \"Secondary prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Antiplatelet therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of an absolute contraindication,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    is recommended indefinitely in all patients who have had an acute coronary syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37066?source=see_link&amp;anchor=H39#H39\">",
"     \"Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thienopyridine therapy is indicated in all patients after NSTEMI, for at least one month and up to a year, irrespective of whether revascularization or stenting occurs. The specific recommendations for the duration of therapy after MI or stent placement are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/20/39242?source=see_link\">",
"     \"Antiplatelet agents in acute non-ST elevation acute coronary syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/24/10634?source=see_link&amp;anchor=H18#H18\">",
"     \"Antiplatelet therapy after coronary artery stenting\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Nitrates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term nitrate therapy is useful for the treatment of recurrent ischemia or (on occasion) heart failure as long as it does not preclude adequate therapy with agents proven to reduce mortality, such as beta blockers or ACE inhibitors. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/29/2521?source=see_link&amp;anchor=H6#H6\">",
"     \"Nitrates in the management of stable angina pectoris\", section on 'Nitrate tolerance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All ACS patients should be given a prescription for sublingual or spray",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    and instructed in its use prior to discharge [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427691404\">",
"    <span class=\"h2\">",
"     Vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend influenza and pneumococcal vaccination as part of a comprehensive secondary prevention program in adults with coronary and other atherosclerotic vascular diseases. If indicated, we suggest vaccination for these during hospitalization for an acute coronary syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21705?source=see_link\">",
"     \"Pneumococcal vaccination in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/8/37002?source=see_link\">",
"     \"Seasonal influenza vaccination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Ventricular arrhythmias",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of implantable cardioverter defibrillators after MI is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/62/15338?source=see_link\">",
"     \"Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of late arrhythmias is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30890?source=see_link&amp;anchor=H38#H38\">",
"     \"Clinical features and treatment of ventricular arrhythmias during acute myocardial infarction\", section on 'Late arrhythmias'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Return to activities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be counseled about return to prior activities before discharge. The majority of patients who remain asymptomatic can probably return to prior nonphysical activities, including work, safely within two weeks, although few data are available.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Daily physical activity, such as walking, should be encouraged; the intensity of physical activity can be increased according to the cardiac rehabilitation plan. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31417?source=see_link\">",
"       \"Components of cardiac rehabilitation and exercise prescription\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      When sexual activity can be safely resumed is dependent upon a number of factors including whether or not the patient has been revascularized and, if not, if there is ischemia on stress testing (",
"      <a class=\"graphic graphic_table graphicRef71511 \" href=\"mobipreview.htm?43/3/44092\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An important caveat is that phosphodiesterase-5 inhibitors -",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/40/21127?source=see_link\">",
"     vardenafil",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/4/19528?source=see_link\">",
"     tadalafil",
"    </a>",
"    - cannot be taken within 24 to 48 hours of a nitrate. These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/15/8442?source=see_link\">",
"     \"Sexual activity in patients with heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Driving can begin a week after discharge if the patient is judged to be in compliance with individual state laws.",
"     </li>",
"     <li>",
"      Since commercial aircraft are pressurized to 7500 to 8000 feet, air travel should be undertaken only by stable patients (without a fear of flying) within the first two weeks and then only as long as they travel with companions, carry sublingual",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/24/11656?source=see_link\">",
"       nitroglycerin",
"      </a>",
"      , and request airport transportation to avoid rushing. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/42/16042?source=see_link&amp;anchor=H17#H17\">",
"       \"High altitude, air travel, and heart disease\", section on 'Air travel'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients with a more complicated course, return to usual activities should be delayed by two to three weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     DISCHARGE MEDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appropriate medical therapy can reduce the risk of subsequent ischemic events and mortality in patients who have had an acute MI. In addition to the interventions discussed in this section, beta blockers, statins, nitrates, and calcium channel blockers may be useful long term and are discussed above. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Further medical therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     ACE inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiotensin converting enzyme (ACE) inhibitors are beneficial after acute STEMI, particularly in patients with an anterior infarct or reduced left ventricular function. There is less information concerning efficacy in NSTEMI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/15,16\">",
"     15,16",
"    </a>",
"    ] and even less in unstable angina [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/30/26088?source=see_link\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Clinical trials\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines on unstable angina or NSTEMI recommend ACE inhibitors in patients with diabetes, heart failure, a left ventricular ejection fraction &lt;40 percent, and hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/1\">",
"     1",
"    </a>",
"    ]. The guidelines also suggest that there may be benefit in all patients after an MI. We recommend that ACE inhibitors be started in-hospital but not necessarily in the first 24 hours as recommended by the guidelines. An ACE inhibitor is continued for at least six weeks in patients with anterior NSTEMI.",
"   </p>",
"   <p>",
"    Caution is required to avoid causing hypotension in the first few hours after the infarction. Concern about concurrent",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    therapy attenuating the effect of an ACE inhibitor appears largely unwarranted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/55/13175?source=see_link&amp;anchor=H9#H9\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Recommendations for use\", section on 'Aspirin and angiotensin inhibition'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Angiotensin II receptor blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;An angiotensin II receptor blocker (ARB) is an alternative for patients unable to tolerate an ACE inhibitor (usually due to cough). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/30/26088?source=see_link&amp;anchor=H17#H17\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Clinical trials\", section on 'Comparison to ACE inhibitor'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An ARB in addition to an ACE inhibitor in the immediate post-MI setting has not been shown to lead to clear benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/30/26088?source=see_link&amp;anchor=H18#H18\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Clinical trials\", section on 'Combination with ACE inhibitor'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Aldosterone antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines recommend the administration of a mineralocorticoid receptor antagonist to all NSTEMI patients who are receiving a therapeutic dose of an ACE inhibitor, have an LVEF &le;40 percent, have either symptomatic HF or diabetes mellitus, and are free of significant renal dysfunction or hyperkalemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Therapy should be begun before discharge, since a mortality benefit is seen within 30 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/20\">",
"     20",
"    </a>",
"    ]. The use of aldosterone antagonists is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/54/28521?source=see_link&amp;anchor=H4#H4\">",
"     \"Use of aldosterone antagonists in heart failure\", section on 'Eplerenone in EPHESUS trial'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     RISK FACTOR MODIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factor modification using",
"    <span class=\"nowrap\">",
"     behavioral/lifestyle",
"    </span>",
"    changes such as dietary modification, increase in activity level, and smoking cessation are associated with better outcomes after acute coronary syndromes. Patient education should be given at the time of discharge and referral to a cardiac rehabilitation program should be made. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/60/40906?source=see_link&amp;anchor=H22#H22\">",
"     \"Secondary prevention of cardiovascular disease\", section on 'Therapeutic lifestyle changes'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H40\">",
"     'Cardiac rehabilitation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertension should be treated in patients who have had a non-ST elevation acute coronary syndrome. The optimal goal blood pressure and choice of antihypertensive drugs in such patients are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/2/29737?source=see_link&amp;anchor=H15#H15\">",
"     \"Blood pressure management in patients with atherosclerotic cardiovascular disease\", section on 'Goal blood pressure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36314?source=see_link\">",
"     \"Choice of therapy in primary (essential) hypertension: Recommendations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Glycemic control",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term management of diabetes in patients with cardiovascular disease is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/50/21290?source=see_link&amp;anchor=H8#H8\">",
"     \"Thiazolidinediones in the treatment of diabetes mellitus\", section on 'Cardiovascular Effects'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7578?source=see_link\">",
"     \"Glycemic control and vascular complications in type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Smoking cessation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking cessation reduces the risk of recurrent coronary events. The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines recommended education about smoking cessation during hospitalization and referral to a smoking cessation program or outpatient cardiac rehabilitation program where nicotine replacement therapy and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    are available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/1\">",
"     1",
"    </a>",
"    ]. The guidelines recommended against the initiation of nicotine replacement during hospitalization, in part due to concerns about its effect on blood pressure and heart rate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/28/1482?source=see_link\">",
"     \"Cardiovascular risk of smoking and benefits of smoking cessation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/13/17626?source=see_link&amp;anchor=H13311131#H13311131\">",
"     \"Pharmacotherapy for smoking cessation in adults\", section on 'Nicotine replacement therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, the issue of whether nicotine replacement can be started during hospitalization has not been well studied and there is some evidence of lack of harm with transdermal nicotine replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/33/44569/abstract/21\">",
"     21",
"    </a>",
"    ]. We suggest that cautious initiation of nicotine replacement can be considered during hospitalization for those patients with ACS in whom the benefits appear to outweigh the risks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Good dietary habits and use of a prudent diet can reduce the risk of coronary heart disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/57/31641?source=see_link\">",
"     \"Healthy diet in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increase in activity level in patients with established cardiovascular disease is associated with better outcomes. This topic is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/28/14793?source=see_link&amp;anchor=H19#H19\">",
"     \"Exercise and fitness in the prevention of cardiovascular disease\", section on 'Secondary prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Stress management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychosocial stress factors are associated with a poor long-term prognosis, and reducing emotional stress may improve outcomes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/55/16250?source=see_link\">",
"     \"Psychosocial and other social factors in acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Cardiac rehabilitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multifactorial cardiac rehabilitation can produce significant long-term reductions in both total and cardiovascular mortality. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/41/13977?source=see_link\">",
"     \"Efficacy of cardiac rehabilitation in patients with coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients presenting with an NSTEMI have a lower in-hospital mortality than those with an STEMI, but a similar or perhaps worse long-term outcome. This topic is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/50/41769?source=see_link\">",
"     \"Prognosis after myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/53/10068?source=see_link\">",
"       \"Patient information: Heart attack (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/6/37987?source=see_link\">",
"       \"Patient information: Heart attack recovery (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/21/6483?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/16/40195?source=see_link\">",
"       \"Patient information: Heart attack (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/52/12100?source=see_link\">",
"       \"Patient information: Heart attack recovery (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/61/32726?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI), early diagnostic and therapeutic interventions, such as antiplatelet therapy and early reperfusion in selected patients, are associated with improved early outcomes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/43/15034?source=see_link\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/20/37193?source=see_link\">",
"     \"Overview of the acute management of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    After the patient has been stabilized and these early interventions carried out, other short- and long-term interventions aimed at improving both in-hospital and long-term outcomes need to be considered. This topic briefly discusses the management of patients with unstable angina or acute NSTEMI in the hours and days following reperfusion and refers the reader to more detailed discussions of these issues in other topics.",
"   </p>",
"   <p>",
"    The following interventions are beneficial in the majority of patients with NSTEMI or unstable angina who have undergone early interventions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beta blockers (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Oral beta blockers'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Statins (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Statin therapy'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Aggressive management of recurrent myocardial ischemia or infarction (see",
"      <a class=\"local\" href=\"#H13\">",
"       'Recurrent chest pain'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      ACE inhibitors in patients with diabetes, heart failure, a left ventricular ejection fraction &lt;40 percent, and hypertension (see",
"      <a class=\"local\" href=\"#H30\">",
"       'ACE inhibitors'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H31\">",
"       'Angiotensin II receptor blockers'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Long-term risk stratification with assessment of left ventricular function and either diagnostic coronary arteriography or pre-discharge stress testing. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Long-term risk stratification'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The major modifiable risk factors for coronary artery disease (smoking, hypertension, diabetes, and dyslipidemia) need to be evaluated and corrected as necessary. A long-term plan for their control needs to be discussed with the patient; referral to an outpatient cardiac rehabilitation program is useful for this purpose. (See",
"    <a class=\"local\" href=\"#H33\">",
"     'Risk factor modification'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Anderson J, Adams C, Antman E, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, American College or Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2007; 50:e1 www.acc.org/qualityandscience/clinical/statements.htm (Accessed on September 18, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/2\">",
"      Gibson RS, Hansen JF, Messerli F, et al. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies. Am J Cardiol 2000; 86:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/3\">",
"      The effect of diltiazem on mortality and reinfarction after myocardial infarction. The Multicenter Diltiazem Postinfarction Trial Research Group. N Engl J Med 1988; 319:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/4\">",
"      Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. N Engl J Med 1986; 315:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/5\">",
"      Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ 1989; 299:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/6\">",
"      Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111:2042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/7\">",
"      H&eacute;bert PC, Fergusson DA. Do transfusions get to the heart of the matter? JAMA 2004; 292:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/8\">",
"      Chatterjee S, Wetterslev J, Sharma A, et al. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. JAMA Intern Med 2013; 173:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/9\">",
"      Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123:2022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/10\">",
"      Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:381S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/11\">",
"      Harrington RA, Becker RC, Cannon CP, et al. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:670S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/12\">",
"      Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004; 110:e340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/13\">",
"      Liebson PR, Klein LW. The non-Q wave myocardial infarction revisited: 10 years later. Prog Cardiovasc Dis 1997; 39:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/14\">",
"      Mukherjee D, Fang J, Chetcuti S, et al. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 2004; 109:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/15\">",
"      Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med 1995; 332:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/16\">",
"      S&oslash;gaard P, N&oslash;gaard A, G&oslash;tzsche CO, et al. Therapeutic effects of captopril on ischemia and dysfunction of the left ventricle after Q-wave and non-Q-wave myocardial infarction. Am Heart J 1994; 127:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/17\">",
"      Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006; 166:1842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/18\">",
"      Latini R, Tognoni G, Maggioni AP, et al. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. J Am Coll Cardiol 2000; 35:1801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/19\">",
"      Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003; 349:1893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/20\">",
"      Pitt B, White H, Nicolau J, et al. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol 2005; 46:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/33/44569/abstract/21\">",
"      Meine TJ, Patel MR, Washam JB, et al. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol 2005; 95:976.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 48 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-C3286EAA3D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44569=[""].join("\n");
var outline_f43_33_44569=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H43\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      FURTHER MEDICAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Oral beta blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Nitrates",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Phosphodiesterase-5 inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Statin therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Antiarrhythmic drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Venous thromboembolism prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Glycemic control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Gastrointestinal prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      RECURRENT CHEST PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Recurrent ischemia and reinfarction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Infarction pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PREPARING FOR DISCHARGE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Ambulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Chronic anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Long-term risk stratification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Stress testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Evaluation of LV function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Pharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Antiplatelet therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Nitrates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H427691404\">",
"      Vaccination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Ventricular arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Return to activities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      DISCHARGE MEDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      ACE inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Angiotensin II receptor blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Aldosterone antagonists",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      RISK FACTOR MODIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Glycemic control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Diet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Stress management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Cardiac rehabilitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/48\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/48|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/3/44092\" title=\"table 1\">",
"      Management sexual dysfunction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/30/26088?source=related_link\">",
"      Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Clinical trials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/55/13175?source=related_link\">",
"      Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Recommendations for use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/20/39242?source=related_link\">",
"      Antiplatelet agents in acute non-ST elevation acute coronary syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/24/10634?source=related_link\">",
"      Antiplatelet therapy after coronary artery stenting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/55/28538?source=related_link\">",
"      Approach to acute upper gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37066?source=related_link\">",
"      Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/53/11098?source=related_link\">",
"      Beta blockers in the management of acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/2/29737?source=related_link\">",
"      Blood pressure management in patients with atherosclerotic cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/33/40469?source=related_link\">",
"      Calcium channel blockers in the management of acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/28/1482?source=related_link\">",
"      Cardiovascular risk of smoking and benefits of smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36314?source=related_link\">",
"      Choice of therapy in primary (essential) hypertension: Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/60/20425?source=related_link\">",
"      Chronic anticoagulation after acute coronary syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30890?source=related_link\">",
"      Clinical features and treatment of ventricular arrhythmias during acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31417?source=related_link\">",
"      Components of cardiac rehabilitation and exercise prescription",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/1/29722?source=related_link\">",
"      Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/41/13977?source=related_link\">",
"      Efficacy of cardiac rehabilitation in patients with coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/28/14793?source=related_link\">",
"      Exercise and fitness in the prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7578?source=related_link\">",
"      Glycemic control and vascular complications in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/33/44567?source=related_link\">",
"      Glycemic control for acute myocardial infarction in patients with and without diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/57/31641?source=related_link\">",
"      Healthy diet in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/42/16042?source=related_link\">",
"      High altitude, air travel, and heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/52/5961?source=related_link\">",
"      Indications for red cell transfusion in the adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/43/15034?source=related_link\">",
"      Initial evaluation and management of suspected acute coronary syndrome in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/35/43577?source=related_link\">",
"      Initial management of blood glucose in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/55/18297?source=related_link\">",
"      Ischemic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/12/32966?source=related_link\">",
"      Major side effects and safety of calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39225?source=related_link\">",
"      Mechanical complications of acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/63/24566?source=related_link\">",
"      Nitrates in the management of acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/29/2521?source=related_link\">",
"      Nitrates in the management of stable angina pectoris",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/41/44697?source=related_link\">",
"      Overview of the acute management of ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/20/37193?source=related_link\">",
"      Overview of the acute management of unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/16/40195?source=related_link\">",
"      Patient information: Heart attack (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/53/10068?source=related_link\">",
"      Patient information: Heart attack (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/52/12100?source=related_link\">",
"      Patient information: Heart attack recovery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/6/37987?source=related_link\">",
"      Patient information: Heart attack recovery (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/61/32726?source=related_link\">",
"      Patient information: Reducing the costs of medicines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/31/24055?source=related_link\">",
"      Pericardial complications of myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/9/20632?source=related_link\">",
"      Periprocedural and long-term gastrointestinal bleeding in patients undergoing percutaneous coronary intervention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/13/17626?source=related_link\">",
"      Pharmacotherapy for smoking cessation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21705?source=related_link\">",
"      Pneumococcal vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/21/36186?source=related_link\">",
"      Prevention of venous thromboembolic disease in medical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/50/41769?source=related_link\">",
"      Prognosis after myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/37/35418?source=related_link\">",
"      Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/55/16250?source=related_link\">",
"      Psychosocial and other social factors in acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25754?source=related_link\">",
"      Risk factors for adverse outcomes after unstable angina or non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/43/2746?source=related_link\">",
"      Risk stratification after unstable angina or non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/6/11369?source=related_link\">",
"      Role of echocardiography in acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/62/15338?source=related_link\">",
"      Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/8/37002?source=related_link\">",
"      Seasonal influenza vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/60/40906?source=related_link\">",
"      Secondary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/15/8442?source=related_link\">",
"      Sexual activity in patients with heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/35/4665?source=related_link\">",
"      Silent myocardial ischemia: Prognosis and therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/50/21290?source=related_link\">",
"      Thiazolidinediones in the treatment of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/31/13818?source=related_link\">",
"      Triple antithrombotic therapy in patients with cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/54/28521?source=related_link\">",
"      Use of aldosterone antagonists in heart failure",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_33_44570="Developmental milestones 12 through 24 mos A";
var content_f43_33_44570=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75336%7EPEDS%2F55365%7EPEDS%2F68086%7EPEDS%2F79265%7EPEDS%2F60900%7EPEDS%2F69590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75336%7EPEDS%2F55365%7EPEDS%2F68086%7EPEDS%2F79265%7EPEDS%2F60900%7EPEDS%2F69590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 630px\">",
"   <div class=\"ttl\">",
"    Developmental milestones: 12 through 24 months",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 610px; height: 786px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     &copy; 2007 Chris Johnson, MD, AAP Council on Children with Disabilities. Adapted with permission and contributions from: Frances Page Glascoe, PhD and Nicholas Robertshaw, authors of PEDS:Developmental Milestones; Franklin Trimm, MD, Vice Chair of Pediatrics, USA/APA Education Committee; the Center for Disease Control \"Act Early\" Initiative; the National Institute for Literacy/Reach Out and Read; and the Inventory of Early Development by Albert Brigance published by Curriculum Associates, Inc. Permission is granted to reproduce these pages on the condition that they are only used as guide to average development and not as a substitute for standardized validated screening for developmental-behavioral problems.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 630px\">",
"   <div class=\"ttl\">",
"    Developmental milestones: 12 through 24 months (continued)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 610px; height: 697px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     &copy; 2007 Chris Johnson, MD, AAP Council on Children with Disabilities. Adapted with permission and contributions from: Frances Page Glascoe, PhD and Nicholas Robertshaw, authors of PEDS:Developmental Milestones; Franklin Trimm, MD, Vice Chair of Pediatrics, USA/APA Education Committee; the Center for Disease Control \"Act Early\" Initiative; the National Institute for Literacy/Reach Out and Read; and the Inventory of Early Development by Albert Brigance published by Curriculum Associates, Inc. Permission is granted to reproduce these pages on the condition that they are only used as guide to average development and not as a substitute for standardized validated screening for developmental-behavioral problems.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 630px\">",
"   <div class=\"ttl\">",
"    Developmental milestones: 24 months through 3 years six months",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 610px; height: 652px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     &copy; 2007 Chris Johnson, MD, AAP Council on Children with Disabilities. Adapted with permission and contributions from: Frances Page Glascoe, PhD and Nicholas Robertshaw, authors of PEDS:Developmental Milestones; Franklin Trimm, MD, Vice Chair of Pediatrics, USA/APA Education Committee; the Center for Disease Control \"Act Early\" Initiative; the National Institute for Literacy/Reach Out and Read; and the Inventory of Early Development by Albert Brigance published by Curriculum Associates, Inc. Permission is granted to reproduce these pages on the condition that they are only used as guide to average development and not as a substitute for standardized validated screening for developmental-behavioral problems.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 630px\">",
"   <div class=\"ttl\">",
"    Developmental milestones: 24 months through 3 years 6 months (continued)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 610px; height: 297px; background-image: url(data:image/gif;base64,R0lGODlhYgIpAcQAAP///+rq6gAAAIiIiLu7u0RERCIiIt3d3ZmZmTMzMxEREWZmZu7u7nd3d8zMzKqqqlVVVRAQEH19fU5OTpycnG1tbS8vL9ra2j4+Ph8fH8vLy15eXoyMjKysrAAAAAAAACH5BAAAAAAALAAAAABiAikBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbkMF8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkHsiAgGVlpeYmZqbnJ2en5WUoKOkpaaXoqeqq5+prK+lrrCzq7K0t7O2uLuqury/nAKTwMSmvsXImMfJuMvMsc/IztHA09S81tevwgDZ2rTe37Dh4q3lp+TnwerS7MXp7sHD8b/w9J729/na+/H995n+AUQ1cNu8grkQglNISuAzh+cgDpQIkKI6bhbpZfTHcNTGeh1BfWQ38mLIWAdP/xpT2YvlOpUlmcUsN1NczYcpXYrUCY2nMpY3iQW9NpRa0Xc5NUWIgOuCgAm4KAiQENCnR5cSmP6EGbKDgA4v2TmFaikCVVZHH1rdhDETAQtwKlxY2vQpqAkCCHiSepbgWnyYCMipgFfvL6kVSGVIvPXksgpwIhg2VRgyhQASppLaYKFTPw4ZBCy+4Ekw2UtjLXGIQBotKadxMLR+hRiz5lvLBMdhTIyuwW6Y5logjYGAb1qpb/Gt+tdzYAG8kdUG5XWypbToOEGmSmHDK8uqzDpnpcGuhuKrkgfAcLrWawGdM/dlNR1bJ8HRO7a9lJnDpaUYCICBbQFSQEFoAvgHoP+AleAl4AWpZSaaXlIJEEFekBFwHhwWVPjgco01p4ks+FmSIV4BZqCBbRNaIpgFoVUQIFQbCuDdhRYG4KBsLy5WCWcjAsVJBBlgsiNxFtq14IAZxjEBX3BpUOKRlaw2W5CseGVBBSsGUKN3NQ73FGwTJlfeZdu8F1+CARwIh39ZwUHBlzqKJpoGOEYApQBSQlfngw3d52clUm2AZ3F2+glgZ0fWyJSDeVnAGpG2GYigf57llOF/TG3wlXwBCFencZ1+ZZlpY9WWQZGUVpZXgNYFsB2IfomIpYtyUHDiVxxM5ZUEcw1YiWAD0hWgBpJeIF9tpz5l2n/zXSekJurJKgD/BabJ9yxdnnaQIXh8yZcZAeOCyB5gr0A6YLLywVqJelJNkJwERY7z3m6VRACVpF6dhkGRkHVQWKG1hTvVuOXethMnusFBVWZEXvBslL4lLIGnaPbKm6Sj/huAvgFwnClw/LFZFlOWgfpsZhTQZVlhH4s5AaiF2eUqqS4G6DCt0tp667CDWkvAwNBJGBmuUNFVGF341QZzBBY8W0lWV/bs2JD1NphXzIVti/K1317b5lTBZsCoHFAJhmZY3wW4GlP4HTfWBZ7CIa9dAfho7yhOWaBlAA07rDCODnf9VMFkR/Dv2U4GynDQ+Wr27NJaQeosjvLCBd8FHBcKXeBby0Oy/yV4DrcezilrJirl1up6LaqH+7nq6hi+GkGXAS+rsNU+1wo0b7sSgJhX3j2X9KORsiYf8a2bJnXI7fmuHyeecrdBsxNg//HXrpPL5nJ1P2xyJRVkzfYpFMgrNLtTYXD7u7FLADtUUsXaEt/wBVB9zJYwX4n7XRrV8mw0NqqEzzaY6skmSmQJT0XsWRlgSsXGZ4nQtAYvFBAZgvQCNY8kJYMOmwv3QNWmS22vdX+STYTgkAG9SCg0BMhQmDhnJwnwLBS9Yw6ugJcXoiUmTvkD2vFGRaeQ5ehIUhMMWH42PeqxUC9HomFohmgZGV7oSZrxCmt+hK8MRIuJptBABS6UAf//0GmGNrPT3aAyAWHtDRR9C1UENQBCOCgLR3PS2bXwciFhwUVPWbRQa+oGOXQtcDC9MhTUBHMhPZ2Qi3GBFAeM5h2RZaYzbdKcAKqmjKS4Q2RpyqH0EFK+8zHkH736IiykEkBTqmMuCQxlNGAmk1c8jySeLAdkLBRL94iSd1bBzkrSExtORkOY7aAGLZOxj1teJJe2QuY7RCTNqzSnmtX4JTCvCU1qahOH12SFyGZ0iWVmolqG5AUJk6kSUJqjFDdESDbiWZFuhpMTEtqSMYtRn+z8wmViMyduOAEa0cglExzrVS8Fihq8LewX6wTFcRyXDPBElBTuTCco6DmRUXD/VCP2/MsxtuMl9FCjn8MkBnimqYny0Mikl+AYy4wUOmo59J0Q3Z1QnrFScWrloR7VqTyDqkp9hFQVmvRPhS6kIZ0VDySboFQ5BbTJF7owDjZE0Gl6BB1y0ilPKZQYfPQGRk/0h3lE6lEFJNWw7PWQqiqyloV+SlFMaIlLhDIhW7E61RStyKpjEQyC8jNKhMZBqZqrwC4JiKwkUeVImQmQWUJDFY6FCad3gYNsImshemnGTQlq63KQOFY/JTVkdNXoJ/jioc1SVWxLfavwoNNaJF2xhG9K6V6mUlvOwjYyskUMmVooV7qAtpcj+4gIP1akwngsYNm0afRgpioVBTFv/1u8BLFOeCz22dBP2HOmDkdBvKxk4FdS4xh4dtWBVPbrkQrMhLo+ti+myPRaZJIAXtrrq8TJxll2iRJb+EYXqcb0VXkRV14MJgGvFKtIHHMXUM264IP198G0i+FvJRBeBkXQEsvN6HhIQavtyKc8Dx6VD01kYfkpqb667USJW4xi5qq4wryJ13sLDGMPjm4XQJRMGo0jh6K+MROUwtHQtkazTTpIMkbri9dGxTTa+ulpUbtpWT2xKgx4qlvp5Z7QfAiqiVpTOwEyGhzewpSZTnW2FVAzawDMxpqGaBNBfh4HNIkz+VhuZlOZMsfMPOJP/FlbShIyVFgGrqlgeWJVBf+riF0p40DrUQLy6dvkgvu5SxtuAqCzX6ErLb9LZxo+m14ynOnmpDILWQ6iHtFRTRGs7WUYgOzMBEkLQ13ZZS0zjHkR0k5YGO8yr8PRG+8oHNiBCBYpzAgcM45rQ2jMXiJ9pMlQBy1x37VpDc7+CxWdsUtpECvuhNtGbceUZ+EEInqIEX7fhDvRH0u829YdLEy9+YJsI9aaLpMeMDynkrsW9y3D3dJYwTn8OiVh0p+rJfinDL65fOcl4VZ2MRYTU+CHN2TWpshMBNvMwrzUSGxQxXMxaWnVhskGR8QVIrFN7tRK/DGs4r0zdUSjPwJCG09PCZ7TRFNt1VZCjGREbBz/OEdyb4+qNkCUGSMt5PTCYkLkxk0skWG4dc0QMs6BTrS6L2t0J8bl3sY1IdCx+FjNinVfVSW6fVM76ogDCy6UPfWa7EQAIgdILngnW+Dpp8l9CtzuUqT43rnexyursU4jz+TSfRyUgKf8l9g8FMTLkXOd8wSblyeG5TWRyiPzYvSZ0HwtQP6dyCB3p9+UpuaitnlxdN7qLgG9fVTqejgW0/S02GUEXq+J2cdaJKzXie53sfzan9Kbsf9mAJqPluTnXvrUj28TRYr97vduP9rMfkLueTXyY977PgP/+aNv/u2vRfzA/34O1S9K+Mvy/dPiPvvDP3/r53/9+ld+AQiA/wRITf7HFfuHfwg4gPWHftF0gAJYgD5hf9v0eQ7YgN8HgSFBgb7EgM/XfvN3gdzUDZFQgiZ4giiYgiq4gizYgi74gjAYg4gwCTJYgzZ4gziYgzq4gzzYgz4oCd3gBpMghEFoBtzABUdIBknIBku4Bk1YBhhBhE+YBlP4BVVYBVfYBVkIhVLohEMohFuohGcQhlFAhllghmGAhmCghloQhWDYhUboBWyIhXDoBnOIBW5oh3Uohlo4hnvIhF5YhHr4hnHYh4U4iIiIBnnYBneIhH5oiFxIiIn4iI24BZXYho/oiIfIiH9YiJd4hjNAAAVgiVcwAAPgAp9oBKnoBKvIA/8FQAA40Ip0qAaLWAMHEAenWIYoYABxgAAmIIqkaAIIwIsCsAArcIsHIAMLYIwoYIqoWAILIAdU8IQIEAcJ4ABCQAC8qADYSALRKAAJkIwo8IQDEAfMiASvGIsmcItwMIolMIyQuI4CII55IQPaKADcCAAEoADgyAAAUABw4IvqKIg58AAC4I9vsIunOAAG8IvuCIolIBineAAJsATO2AJLuIwpcJFKQI3cAAEKII4/4IwQAAEokAANkAJN6AACgI0D4ItZCIwpkI4uQJM20IS3SAAHoAC5uAIyiQI2aQNBqQJViIyTAIsxQJImiZIAgJIPEJIGiZAH0JAzUIs3wJD/JKAAsIgABcAAAFmPXzmKppgABVCN+HiTCgkADWCSYamPo9iW2siPKWmWCsAADQAHp0iXJGCWCcAAcSkAKSkDTdgADykC32iMC5AAARmEDqCYBnAADKCYAtCTkYmXzigABvkAkmmKp3iXk6mS0HiOJDiZ7IiZm6mKJ1CNI2AAnEmWbXmNI/AAEFCZnykCDYOUJbCWJ8AABiCQJ7CSAuCb31gA5SgAj9kNBkmMLwkHCjACZnmQkumbAKCXBaCYIXmb/4gAPOmZPUkCOAmWDcCXfvmW1jmVeKmXIvCctCmdibmYuAgAYykHDsCPLTmOKWCU3UAAeqmdAjCK6Jmbs1mP/wNQAIR5lCIwlTRglSygGw3AACEpArz4ACQwAMaYAA8woPrYnCLgoAQwAOEIAAYgoTcwhcRYjCPAoT+Joo/Jkg4qotoImdwYoiXAAJjZlAPwoixZlSagkbEZkjvpAAtgktoZhMQJnxCAABVZAh46Ape5kEkKnzf6mA7ajSaQkdJom8LgjEiaBB45AsTpoSLJoQ1woyE5plvajIUpAg5gAA6gG+5YjU/6myfAkMYJkyVQpJ8pkzJ6p7DYABX5lCSwp/94ihDQkxhaACb5olNapfKokzxZowlwo29JqJIKoSJKAunopwAAqCMQpNOpofqYpR+ajgsQmKCJAviZF3vKof+DKqglsKYOkJPwaQAL4I7BWZxxgJvPSJA1iQD3KJosOgK3+AAN+Y1wAJ+5epFICphoeQKsCQAOaoq5Coy42ne2eovOCWvLaqrYCp8LIJNzOJiFyZUiUJYLMJHCIAwl2pXRmAC4ea5MeorcAK8iYIrPWY9y6o3nyAAQEAdQCq3tqqtC0KUiEKkXWa2yuQAI4KcOwAABOwKN2Y6vagACSwIQYKqMupHNyQ3DiJdFKJPbiqmwSK/z6JyKmZLpaIoR25//uJWwlrEkUJoL0K0UCowpW6nTebIiCwAkK5Lweov86q8XmY4OAJAQIJIlUJQlS6P6ebKlOZkhSwJrCotMC5//BGqrSImgOsqrNLCwm1qfXsqTammSB1qyWsmRk3AAuimYabmT5ZiMWimKRhm3ttqiIkCsCOmd4kijEhqp4Lq1JCCRAECRT3kAPwqvSyoMkWoCFMqkT3qZ9fq4A4C3K5CR5wiPOToAGNu4RUCwIMkAzji3BOCgFWkAoOqtnWqMGOqcbHoCEICNCUC2+bqXswmfG+uPvQkAhfqxcdoNIlkAEqqpnJq0B3CzGnmosEi59lkCsgqtkFqpN0sAvVuy5Rq8f3q6iJsAmJuluQi8mCqd3qkCCpCS5Zi3LQm2esu6VMqUTgmVB3mgVMm2XDsDK9udX+uPXgkHDQmQCnC2uSiZ/6PoroBbAuv6j/hItwbcv9Y6hHRpl3FAkRKbrf34t/L7jvSJmHCAwfgIi8KwsgtgkBt8opsJudA6wp35wMvbqXJgnrwIACyJmcxZsUDgkXAAm0N7wLC4uLoJwlo5ArphAIVprEvomR+awhArmRSru/1ZnM/KDbw5mQA8oXCwniQQxdGrv2+JlJ5JveHLvPg6nTU8ni0LpU/soRFcr1Mcnd4YwyzMvWgMmDWMtF2MAvu4mFHMn8EZxSrsr3U8qh47kLI4p6IZA7yZoJ3IAvSqi/E4BoE8BY08A4msA4/MBArKA0nckYe8ApH8BJPsA52MmpLoBJs8kFT4hVDwkzkgi//VGL8vEI2DPKKZ2AII8Mo0oLAw8MmdSwND6aAugLY/sIWVCb7BuAOzTMmm/AJ9nLc4gMqknAM9HAPzqcypHMs8S8vpac3KKMxESc0pkLteKrBeewI8Wq/268kssLooMM6O3APFvASVrALsi7GG7JY8IIthuITMPM2byALtjAO2/AKV6MuYjMzuOJRDmbECPZMyXLnnXM4rkNBIEMj9zKXH3AJVi84guo1fiY2HCZ+S+QDD+Zcp+Y2yGwNTKJ4i/aksu8cUmsEuzItsOpyrCQeauZhlKbYVzIfx2g2KWZFr6tL8OYrtGZwqLZYfDcaLCdCpabomCpcE+rIQap0N+5X/sHjTZjyZVFyd+CjHsxubJX2Nr6icWv2ghSybVewApjicVy2h4kmut/icJi3OGVyarMuPqjsAtImrqgmi1nqX+ZsXeS3JKWDWI3CNKP3UP22iJH0E74yqAsrKz1oAiNkAhfujGIqh3ICj8/i+NfCEfGujms2qRToCwlDZ3MiUuonPoyi8zYmonU3NlwmLWkmg07kAok2hQlqXPfylYtmVCiChClucDp20S80At9iNKgqLvvysQYqh+/iPQvqkrD2oujvcc3yizQkBtt3aC0zdu6u50Jrd2/2v3HDZXfm8bi0MB80CTWjaaN2dw2jcLdmaO92tFKuNyj2K+3imO1CF/7ys3Q762X6bxLQ9y0BL0fOrAhddmElsyxRKrtnpjMCY2bZqu886wMJa3t96rXLQncIA4WWZxNrIq8DYs+u9q5G409wQ1ls5sx3+s5uNixJeAN36zyi+l+5IsdUqk8u9lZItjenosOBIACau3NZN2idgobWKAGzZ3Tf7j92o5GVpkiQ84zSrsKOIrSe+ze9Y0AiAthCu4xRqqOgKod0txEIuwPp8kiA95Veupy1u4UfeA419kinJlKs5sr5Ioe49493gjxSsj6x8y7v5vOBKo1Qavu6N2ibJ2ba52tc7xvOcBBCd0+RdrtLbmbaNvtmL6Dstip6uvYQujKPIkiwJt//dDd6BCosXu7aYPqGlGulPztAm0AC/PQBi+4rS++qmSJEjYOsXKraX6Y8zLuCT25Cq6b1xXQJ9Dt+lfpD0Xa8pSaMHMJ/d7epMis3LjgLAjut4bejuqMPnOOKgzIZ9jLQNvucafNf03K+vWLfvieES3Jd/i8fSOa8u/dOt6+4+PIpZvdAYudQu7c+iWenbTs5FqOs1bIz2/o09bO9+XpyirtTC+J78i8AuvGYzDY6Q+ZX7m7wx/O//SuvM3pye/oplfLMcCaieTpJLfIrAKJ6VqZjIqoZP2NFg/p6mmNcvTOTGifF/HaIxLNiDbfL1edhYCo6b/se5nOCK2ImC6+v/EZmmFG/wo24Do2zOpE4DlwzKN1DE6xwDEI6JtFjRgTiJalmY9n2Pk7nYd/vV763WR92sWD/na47jXA/wv5zJKjD2EFnKTs/NZR+aMcsN953ljr6h4s3LVd7bsLzIYoDLTSD5xjz4lO/OTnCce5+bam/4qa4AF16wbc7kl/6v+XzwV+/1Os2JSW73M7DKRHD5TS/7CL6jcRwEmq/1gfuZFEnt1r7rPszK3S7s8krsME/1qE/xjC34gN/lQPDMQ0D70W/2g58CeP4DuU/nqXnBPPvzo8uLuNqdLF+fLv+l9Ez3LXCR0i/9uh8EWx4ETwgBl6r9TQ/47K/6JsCbvpnX/38NAgSACILCJCUCFKlyAEspHKQJ4Lm+873QA4PCIbEI+OkcKcOBYFAIGocZ4acQIQrGLQ/J/YLB3tw0lWAMBomC7YwwlApQSCwlQNjGYXHvhBOYAaCoxJTQNZQMJMEZOMgIKOLYnDwuACQ45DzQbentfYL6/IWSlgJ55pAk6CCs4gxoEZwoPOA0rD4osChCDMjCMBnUmuagEh8H6RUoDkA4HTj8pI0OWCYMI+sYZ3OP7kxlGqQlHDAI1CYMvDUpOEwxLNAh6BaIdCfzMOj+iVzdAuR6h+OZvkw4EjQA0IDOGH3DAh5o18DXi4lctt27hwRjxo5HhkBIiAMeIAKPSv9MybEgEo16ANJkwcGkVZRjHD2S0gMnDgEtH6d9nPLAgMebOEF5ShkjjSKl1WIeIHrkwEoAKV0eLZZv30cWJlkeGKBAXB4B9gAYEOGkKw6lI3yy2bQAwS2DRoxmDbUxb15jEDIl4KSj2sIcDm3hoicizVAGEWH8gVwKL9+LO9Ll6ElNJBI5kTJSBsKk2+ghSX8wEDbNHDp1WqJGrqqGBbasqPx0rfcvV2ZhBhjwQKiQoY7DAF9EdKBv1RNBAuwKCQ0KgSXQ3kJNSVT5FBBEgCQ/KHGFQYESRCcNuuP1paLyTw7Y8WmK8hTJ20UlsbNA88doZpGEB1xHqLwxEEalZYP/ID7fzKAFUG0wAJVUNDxyxUsl8IUKBMN0RkB6CJijnXc05OAAI5nogV4lBylS2APymSbETjDuQd2A15US4H07SLcjHz7mFEo1OBEoVRUy2icEUEYoyB2DoFQFJIE0AplDAysUcVNEtYVho3VslTKAVDhYmAV5JYhQngAOqsGGeEhV2Y0nDkDxnIlo/jBJIQLQseI4BTwiT48LfpIWkT0UCMCRLZgAw0nQLAHDOZDU6d9/2jH6wp400FkCdFo9+UmUPhqDWZx73BSNZBaNpAuEPSFypwDVaYSjEVVEoQ9kcNQ25DWwKMqVPgSoAQyXYQx6aow7LCASC87+IExbAggI/1E7xQokSbL4KUsoK0b+sAwAvfyC1gHiNnOEIs3msKSi4fJCETBUOcttt5PdSwxHMtS7SWoI+HvOJb4YWkBCXtYKphFsODFrEtSScQ5RJ0lDxYMp1PtjvkHu4EB5EER1Vp4YvzSWaziwAZRY4mSzbYaIShXeejD5FEyDXXnMZ1iKMADBDDOfbG7OINu78ScHJtmlAGMasQCtyBKRGjb6IADLRE7tVzMWT3OzFyl0AfScDp4NFzEMV7g7VWEaG310EGwYDGpkAwmD3LWfKXqeyzy2zTcP0dQCwSouMfbbY6bamvLBREUDdGOP5cBG0X1/gTQpFn5RkNtAnOuYAngncP8CBO2wNjB/mDXAdcu27qGEdjroeObSLJiAdiTxXXKWZZSjyoN35Mh6ZHwhQrKnJavNoAgJ+vLO+ivmZUJ4e0u/4LrDSPwOjQqMhLvY9O9lP3nzWSLJMRgNZLx7D7LT6OI+r/qEawKqI+P1PUPukVrv41fOv5O8761KATQaKh51p0YYjz1rKNGJHvEZ9CRPgVp4gCug5r/oOO8YhqrMADfWwR198EYX9NsIieCJcjFBOAuxlgOKpQMVEscwtNjBkVxoFab1r4T4CWG3eKgsH76seUDsiw5NyIOYmMtQTkBiyvCGFrUQZQxu6dnPlgSb/RVRGxmsDH/mk0UMbuGK2Zj/iwW5kbYtkFGLR6TSEFi1h2lIZ4gC5MHjXgBDFqYNhmAyToEatyQKbu6L3hiUz8xCjC7iCwiFrMkF90UrMYYiUThIYw5VIh7dhSEN9RmCJGOAJbmxAkYG+KRoBPRGRcSRB9khRAlR4Z7qnSiBaTsginYwiQNK4zPoC6Qg7beFBiAwkYg0H7PIoagK8i80kOyCqEjZCWZpoQFcOeUeKOk8JN6KjVyAYyXN9kU5hkJzWATFMLfjSyMowJkygYMC1JQJP9nhAY+oxxNqEqhxGsaQrCjBGWTnITs88DU/WIAd1Lm6jlUqDelhXKQsuSZa6iBQmsnDCrzjRG/FIBbUKqhS/9ICqzu8qV2oBICsFtBRAkx0Bs4sEhQsUY+F7uBKSajUAnZSyOmtiT0KMyKDVoWpOCjKYCC9QZzACSX6PRMI6RmA60YDCECgJRHzyKkaSlAL9Fh0T4L5kXRWiTmZtMcSzcKjg7SAhGeoCmK89OZOSpcOYMmiFWu0ykDlMU058YBdrxjHDXfxkq0iQY/TElBPDjMXgrSDfBGNpgF28wIkeNRQ0toBN+NGnZMWdobW3OkIDPecesxmmbiZpLMW4CA3VHBY3FRfxKjABHEOywkimOypjArCIMgVZcxgSD9QqoVh7QJYsDAOYqNhyv1JxxyZ+EcODEXGp8ClaorQzFl9Iv8Nk+FzJPqsDxKqQTGSJOAsUBloU2w7p4/trCqw2UlOQaVEpq3MFwVQylzKgsn/TRJ6UaIBZH0rCZKJ9COGumx/e0LflSJKa/VQL9MIsFWSorcqNlrLACw2UtZOCzL2rTCa+EOT9N3HtiEOAngbBtQOaWaVkJiGgb2wYewiFwyoQ6ZzV1ANPE7XrMDhjxfWUsYdCC4TVXDrANY2GFoNZQTkfQky8QqEJrqIKIjTBnAEqwPZFkC5lwDYbzBsWislxhzQuMIwSbTXj6BuAWKmk2+1nAAEz9W4uqFDklVyLJRRR3mWeAaJbPcRLfNUB5sESJfpejb/aiNp5hQkfoFQjSn/o3gVgNZpZh9S6N5srkcQba4InivWEhwvx+NaE4+Jd9G7KLWQCjgYPxkgO2Fc0jBmGGisRaiD7GkSDglgKKh14LMCbNo5idAMh9+skBkompmLlTUhZPAEROMuwD/AlQE+/Wxi8xPOtoxgPaKyNKZd2hb8pIqe80Y7Bfj5By9CdU+thOzyoBvaQC0qo8WHg/CYgADWs0SHUgOJqd6BxVrA6gwsdWp2i3jRRxlVUb7JF4RhuAi5BQhSQSFTxdZbjRkHpcM5y+iEL8U2Hc8KxJNahOx8dY4b53jGQd5wj/dy5Sxv5Phc3jWZb3HkMYe5zjeOiojctwdn/AIZ56QpjLbN/7aYCDDzcO6yzRKj5N3suM1FXiMc9rAHDFfSwdG4AlSkC+kE7Ah8BtP1H2d4D6Okd7uPEPRJGrQUUo94Ec/Zcownsw/H5Xooir4+tdo7X0Z119DXeve261PrcedBOYUwd5PvvOpHMUag5slhJmiGDZ+7p5T+5gpcmUUft2YKC5r1GdGriU1roOhHyuSTa4jdgzCLwxxIeqKP+vMy9plGVgO1VLxrpaaG+GlOS+oVJ0AhIakPKiJcXz9VmtksVRUY67Oq+emLKRHLR35NSvp7uuvQ7vX+OeCVIV8W0CFbKofdg4GFidm8HxaK8NcoNyFDYpHDsF9/iTWGAfWZy94RYf9eO7wDDMnWS8TCNCkBZRFMObSDWk0c8I3Cl6lBhKTWFViWS6EUEzROq2zgYvTf8yEesZSV/hVXAchDBSFSbHFguBzMXDQZ5FEdznlcfHXFGwybFmCFDXbeDtgfSeHORCzDPFxIl1GN1TCDhdEV3AWFxKjE4kke2knCa0xIyOQNf1CM2THgi4lDiUngR0jYnhEFh5nFgGkgj11Ih/mEUGAdMaWdORBLjh2YfblEifEHGSJatGyNF4JfK+VcFmHEWkDM2pGLDurOWkxZEOXHJB3PBK0andBBkTXA64kOAfZZHDoHYOwfC3xODsBeoyVdgvXVVBigTxiZDoQbezQGDY3/Cf4sC9+EYd5s0hWk2fFZ1ywiGieeXXYBwKpdCBrkmJtxmSlhxSvsxyrgIhrWojFOHSD+Yd39nXb82uWdXx0mjz7sHRHxgB9Q22+JDWZMAwREE53tA7z5WRoaG4ColTlkI8dVyNuN2FxdEafcnk+8WolQCe8VXPLgW8qJ3ZJNGFGYI0qZxxla17mRmXzoiAjSUJ3YmKgVW0W9mwj0o4fAASzUTh6+CyAsQEU2oze5HeWI38d1gzyRitbtYka4Ytg12pdJEw8U3stxw8V9CSno1Re4ok3Q4DYMWuKNHc85o9P1ANDdxwbRSbLZypdVAbBwl1UBVET12vTd2Uf6z960/wFSygg8wolQck70EYCeTNXAhZTCRaFMrlxZetGyAdN46VQE3pvdtFBZueEIoWVNnmUQ9KQTDANwLQNtxWNdJswQxORPQiNULo0DsOVqyEB4pUJ0Cdxc0lwQDGbfAGYQNEkfbhIcfpiKqQOAkeVOFsFkEl3FpWVhqoRC6s1L1Isr4lhQQWZV8l1zLd69JEsnccNlyuAO+GKFmdJziA2PYOWXVObNEcFqGV5ghh80MVsKkJRV1Vp+Ocxj6kXPeYNoEia74QRuYmcPyAIh4A7A0UR7fSZX8sDypcE8NZWkhAf3JcTlUUUcwFEgwNR0BiUAUaflxdPx1ROrqcD3xSOPaP+HrMyIZsCTVb2QXfhLQbHAPFQDsnWK2LBMoEUeaJJYuunWX6mLLHbghXYXKvVWaLUhVeadEFFnVwiXIaIVtWgWHsSgwnGnC4JKT5AVAo7eL0yEY6FfsMzLTaJFSgIlbP5ocgqdEkLWzVTXKOBg8XRobnzFKG6laYpkiS5p5uXhgfHhfxrGIj1RjMINnknnvUHAXNTFfp0LFtQMNKBXH9LlMwppu6VbleHNkQrYCvTCEQDHas0Zob3miILibdUnlVEailqXMLYLaZqlJDAOjP7BjhVAa66gAjCHLuCoS9SRZEhOhL7ihJLnDgxkOD6UfnQFGlLjqC3DhXUbI4RoxHH/GDyuHdv1KZZimkJoU231wDSKWj2IqnkAzHO6KBlwj+2hya8RaFSK2gu1CB18yHrQDviMW49+oZAO50F1i1tKoV8NQeM1npO9aq9i2mxQJjH4ZQ/KXLRyDLnq5KmgnFZuZ+Ssi01hiolhZE7thDpAgVgSVWlqyw08laQpaFiSVKUQJytS0I7tJ7A2wg8eBGKOpZIBAgO4kejt67qGwTxl3aYyiBkA4+q1GnsarDsUWMHqCX2aa9P9DRQEp62xDbtmFJNZoC0WR0IKgoX05VQ+qUxggyH5Q5jJLGHYZWZAAZak6CUkxEKIXpiKXrgSGf0BDG/1orqyqR9yqlh8imuS/2hXhsM4lIPApEPQwhBmtSBa0GwOjSy++pqPdoPTBGmfikssrgWu+gQeptgM/JtnJlIqkEyHkKncMlWaSuuVfY7YoOF7XYI8sUEKMtIS8t8RGoypOm3arqkthelFZWsqpKo2DiUSrMQ0YE3gQhFmHeSHlSuFlqfTGtW2uNK6lFvbohQyXiIBSNpvJhrJAmeHONakRc5sHieFYd5B6pE0PYBYxClkENklVGItKWum+lwPNMKDUa19dqUgqAbPaO35odnQQsCawSyYmFmmie4+rYm/+hPFdoF8KqhIrUEEGWfKpmGTBqRX+BtGxtv7gme0kS3u9Fu/OmT49G2s3sK69f9HLPGGm81bvp5B2fAGkz7rzlmmCzhA5gGV62WeCzgKsh1KVwLVg2zsQUKUs2XvD9Av91ps5HjIzsKVLmwDzhIAjraLMRmITpluiQYglCavjKyLM8iHavVf5sULCp1s3UIfkI6tD48NAXBmFp4wyjTpVAQYFWFI+opozUHxn86wZZoptqEJG7qm9CCRdjLkD49oEL/mS8HuKaoVpCGxCp9ZH+WS4ypbKJ1c5Q6BDBhqAgfB5CJn3+FuwN5lVo5LA7TYoeliFntPpYYkusxqtWZEMYogGNPn6I6AQ97jr2GjGr1U+Z6Zt8GBCxseNu1AqzrpF9BJO6qvAF7ZIWurTeb/8f5upNnm1RyrhCuPMiqOmwPHW9gwKtAgpKSkCTOY8hNzgyKfKyPX7CeYZMW6MREs0xbYsZpyqlr0cmY8s4TiMQcJXTQf57lScXG6svr1bDfwBzA3nTBfswJTbkst6OdUsnkw7B3kXiq02k40LvIuHZj2RB5wLC2d1Lw2cnHYwXnUK5MZaPVhCoOecrsM3IzUnnvCVHxCFeiZBHymgdb4Ky+iotNukGW+zqEySxxA1KRUQXi8CJrsSQHMaz3UaUSIMld17xRTrmN8FieAFjL+xoqWcD61xjLL4ETYaDV2buN0bYFZMxhRlkzzZUQjoAm+VjugYDfT6DrIgscSI1/B/wYc9ZZBm+gA6IrrFjVFk3NDQoYeFU+GlnC5UC2uEsUupaU4czV1bnFP2MOCNQUTYC51yG3EGCNOr6tc0AUmUCnV6qEsArUQT1Jcc6bAzaHcujVTA4uEREaSVkNca7JXWI9ZndlKrARnrvXCxLPlzpVMQBFbYK7cYtM3z9Y89DDCrfThubGcvXUK09lvfCNdMC+R4TXwLQda6ELm1YIyWi/2rq5gGzBs24XACeMqIrFiDxwVRgYhFtlrR/aCNaKdUpoB/IbtIjIXFOOgnSQQkDVYg4qRkbXrHrdYBDVPqfV1szW3tba37VoajtI9unPD1rY0D0zZWDEabjD1WGRYH/8nJvuzCjxmRB4bSoAzNmeGVCn3VFCjfz83QS6NFtiqTFQHeGZ2ERS4uGodR8eSFyDBPc7T+1pj2Kp0CI8fuIq4Hn8rbrWoMX/NinMrQGwVJizfg3qMBP9EfrKeRh+FiSxyapd43w0wZ6c4g+RblGIHr2J4q4yLmgnLFdykuNSpNJTgilZwZWxd6JI4SUpxKG75j18G4SJAJFLB0JSpJhv2XFe5po7rJyTzfIOBdbKxW9CqFgoeDNM5kMYULQAvLt6u9PxEMMZ2IU9XCJ23YhU6Ve4EC6sS1rk52hoBnCuTueoBnCtim0omK/9QDwSw2Axk9vj5Glvx2hmSuByJ7M7/YJazTGBwDqPP6t5AOhfIuaueWZ13OQM+blaEa0EH5aGDH8uoQXoutHk0gRZw3kh/1DTM00lTAkQPeNd5wlJJ2Hztq6upyT9l9KHCkXYQXPEUu65HpqBNe7ZDQiiHHK17hPjqOLT6uLPOD7r0gkyPjXxxszccYBqE91n78dHZe1JPLet4a8hlATj0aAlTK7Z/xpDNkCwWBOAxNZ5HzNUuyaKACMNnepZDLa/npky8c4MwWGflYMlgaqi+bdDIhGljE0wgNiiOSrTTV4POwJUaPBPzV3yjCQ/e8a3b9VIolJa2Qk6y+LTceSmkw/ai+K6vO6YiTpShBZ1Sr7kVwy2z/wdZl0wCQkbhpLS/V1DqZFRKSM0pMuPkbWGiGodxx+rNf7tdSw1MJGrM+mPFg3vQ4yXRrw8tlHcsX/zRf8a+sfcYmod8mZqvkdrIj7Rz+B+zj0iyPTtAdcoarNJvqQmsFTnYmx0m54l4OOw+XnvRO/0kDnlrUdUAUD5icPnbM12OoE8qD/OVyS2/UTBtPi3OKwuPp/7Zd363uvickz5IoP6Ll0HDInuvzTOMf0SmTDBKWN0QuITce7t5rzuQXLkvO2/0X5kwFPA9nwjCXoLC3ivDnsHDmnAgSGCsD+VomfvDD/wAsJBOV8RIQbm8mMvx45Z1XTtBEYK//sm2M0M8of87als8CADiSJbmiabqWgrsC8cy4M72fdYloQiISDAcHK5EA9CAMBQAyGIJMDxKDME0MXgoDQgtjQBQgFk6nPkMK4sOtcXgjSiICl0nopFw0AAFMFwedYAmo3ZiMCaCIMAwsgABgKCwBFbwlnCwNAUQhKngMCAHumdTUzh4emqKuoqjyvpq4gqLZsozIKBHAOhyuGkAkPCwQPeIkCBwtFYz8KSAANowMNr3Ijt7nWPCBsAg9fagcHDguZQQxbRH/W3AMC6I3bISF4voBsDGJqD/Jr2dqK+PwJtNcqyhKAUv4QqDCq8xbGjmIUQVtX4NEKJLRJEjSZAoeDBAgbQRAt7/VbkiLYEkCJ6mIaI4MeYoEvkEhJK2QN8CEViQPErnR1oBAQrCTbTWC9LOSIxE2BuQoIoeEQMziXjAbsTAjItIaZR5FCxEiWKrlfVqIogIPA92AXBgQIABPeC44QKmD9A/AVF9Aqjr0uxZeGTPsGnaUNY8EQ6O+SCRkyiYSPqejVRElEEDgAe2yoFgcwbCwdgKkyZ0mlZqwatvmG69UGFcASPHDrJ3ejRsVK93H/QtGng24WmIqzYe8XbtwbqRo3X+HPpw571bV0d+3Xh22M2lF08+UEVGGNSOe48F78CvVOennxayartw+V/Dp8BNwn6rr+2/U+k6QhWI1bfcCeO9/1DeGfSdpcYBjpWEhnq89RdPCfho9BI88E1IIRkpXFjcGyCOgA9++IgIoWv8dQjTCcHw8cgD5sSjn4F6sZDggailAVCP+jBXAgSPOPBEhOsNsmBZhYAoQIbYbGhCjR6y2OKO6ElZAn5a1YZlbDNR6R4JDTSwBBNjEgAQGC4MVMACDvRwFxAG9HBEY3JhMlSTfCAy2wCY9eUlaxUqGSSgACzg2A90iLQZbQDccicDjv2CGToqppXmoZwxkKeTYC2ZYpOVQtKDHKOOkMcIWkhaGR+RMMPZm/pMVRMBke1UJZjopbCmY8LkxWlAewzkAlw67YFoq2tKUxJAokThKQnd6f9KEgoyapHHi1QV9CgoOCVDAidE8CHNABCIwsOeI2R0EjAFhpmrtEDSBJoASjhCKoy+dDIVuVDd84sU5p0ACg+CCIGupQxqE2oQmkxCrsAlRGNwNHj8xUQBjxgcyALgbomxOC3xSi288ooiyjJypLtsOkcgsJML+EYyLLPdchOOjFMmyR0KS1icEwN2hramXIw4MBQE7xD01Ww2RfZjjnL4w8yUgsq78AndMNOPC9RgFhACfdojoTHIJGfC0HQAIgTUPF9KE4RVEGB2AzXRVjcJWixwRx64lfQ120MkvfRAi9ERb0L+rMD3wFdKw5VTPda8Ry8wI9s15S0f2gDiXr7/vZorKh2ApjkL7JTyo2Pe6DnTe/S01k9zIEKAOe3CnjjJJodFAuLqcf2oOdRghRgXTQzQEVbSLh2cCac/WgDx7nQU+gkKHHELYrjEuXyACpgzJxLm1DU8O+6M0DryIY/Tr8lyiZDUKYur0LiCMHlGAyPUE/i6NA3EfKhymaNla0oGDySxs5Lt6gQXC8MR0CQXbg0EAgVo1CXW5ZahPSFPv0hQN/CmD0Pp7mrVyppWAPKIyIhBXUjgDKQMMAD18OUXjrlR83agDwPIYShFwVMOc2MgOP2ghqSqDBFJ0JOOsOox5RnKnA5gwaURoUm3CpS0jBe/QczvPj+wH8nwB5oC/wTrfQTcRA4BqEI13axYwjKCYECXGjgC0T+DEos1tGRCFhxmN3IkjSl8EDACQFBPBoiLAvKkh0bhRB+yY8MxorLEH4ANAee6BwKtBA+PmcEoCVQg1jy5IqvV8VOMe5cdX9An3/RxXi1Qj9gQIQoY8mEnHuPEEogwoHvcBYYXA4dV+KaWMUUHFn9ingwW00lQfsmTElHFKq2oHTA9k1CxOIDYDqE2aB3qB8wAW5NCIktlOAV4NPBH47jASUxKM5TMVCY7aeCjeMpzntM0jY4wyAJZGVOUFJIFlGyAxxhs548HoyLq5NCLxjGDeDs40ja68YBeSuIuCeDmIeGmq2mVbP+apxxlCRfo0VkYRGzhsiEQTDoCklZymP3x5z71WJKA0nE/1YREkyCoQ20qdCeN2t4+SAQQOUTyUSH8QbtYyiKNUksVCeonSD8Z0mU6JAbUuOdJcRQtaLZUBf+cgUxJ2LusfhQ4cKHpUt+50ROAbaiUQWnPourM3yhEDam6CgR0AbYg0KmkwavCIwmCmUWFBqznMQXUhnAMISxxAMZq0qJucahEFfFG0fAeDf46SLoBRKuw+So/qaTUjKKAGhKFWCWiCVe5PnWqYhpAxVy7QzCIqwy6eJaexJCRPpjWlKttTyE4JoTTmssY6AOXxr4yM0ms8LR27UYdvhAGWMb2s2n/rS5HSXkCavztbrytXmp3V88S7K1vDsitbN2yrlnxpw/m5S5hvVOIxQjBaWLMSQKCgIjyyKxr7hXBEp5RQZvtKZtNVW1DugSL684VrWfN7hRKyz3UQnXCY6WwSKnwvXMwLXquo20w4FMD9sZWKupEg1UTUgjphQN3WhmGccew375GGFUraUmIbXVQPmgid9hA8CsUTJYCf86dUqWKPtgqRAlXeMkMDm8JkrixUAQEvVeFij9ErC7KPIa6aOpiAo60ghMTJrtyCYcGH6APMTRWFzDWlGSKuOXYYWy9gsyhlK1RHTGnwMescAWTxDrTFQi5RQqOSaF5Z+EiK9rJ1DFQ/2iIAGaqvEvPrFUmqB7JgBcKwgpy2cepcNZaqOhjCm31xV4dF7d36AnVKhi07g5tG3cWgp7OpGdipFOLAoQjCR3MS60qhZW92kmxjukuUhscNz2Ek1w0gBzbdoyqT5gjDygT43JdK4RxsVoZqtYsUSZr0283QrIxnsdjM9UHWc14V7C+tazXCZ1cR+MjR5pEVT4ipyF4rVwQIO6PiQyqcYrtpzUYT95GEI1K0Mwz3B3PQD/UMIntVmKQKQYTyr1D2UFvT5p8I8A/Dlpc24gId7VImgayOIdHIagMsC+gS7waVwf6oVIwXiULPiOSLA0cDXjTIzxD4qsqGubctgvdjv9htx75CemQyRzG1UVgAiDNXi/FWrsX/O6Qx9tGwHgAJyAkBvVZpcPuihKu2AMcmZOwJneWZQ0+KOrB+pei5XI2nBGg8m2L4HpE1R4R2qeRpT1lgEig5XSfJ4oEtU6uV0cxyJMq8rToRS08VHPY0tyWr5w5zS8XqHDU/tktOjUFPGgVEbVsNrm7eYXF6kECpovT2EZxyFm3NLwbrXUSLNZYc2FDXBKQWAaMcTIhZIBez1bqAHVqwHBywLCrTmHRbxUbnk0wg0Vb+w41nujwNYG/gcERpTXpv1EAycomipLZ7lYr5+e4cflNXUVE2reZNPa/h357UG4fSZGHPBVc3gv/Xwc/gkAHbkM1C+Bw/eVmUSN1hENf1LVCN0BSMPA8F2Zdj4d2MSB91cJnu9N9x+RWjid511BZ8bFniBJ+/gAfdLA/twNbGhF0YqJximcM9mdhpgF6MrF/Joh/uUcF9XJfgbYCG8g/N6R9WYIrz0ICyGRoXDcLWcGDesN5vOcAKkiACDBGlFJ8Kod6yvdDfRBFGvRZkXERYOAGx1cns5FXprKFc3I2W7JYUYh9O2iBJlAAFyQlfzQDREg5Rjh6jZCEJsWEu9KBMGdV4dEblIZR7bQrCYVt+sYHL0YQLjhb+bF01neB2Rcgq2ZkdxIZBbBmfMEX3LB8kdFIohgVmdWH/9zXGub1VBWYMn8lNj2wE474iWlSRXE3BabIWRmhSDUxG6CYWJuGZiGhXgjXRXLIiBXiiCoXP1VVAAeYd5LWcnzReUJ4hD3ofxaSIiVwWiEGLrclEOe3R8kWBVwiQcuxWbmTJ3FWAsbTEK44SrBYEGAgBmLTDrjgiKMwEOAgMp8QCtEIIL3YB4rlCYg4B/DnKB1XApekjDGgiK6DXRVSUZLygi6DPlOgC5RIZTdDFWfHf5loeyYwN0uYSjUQPzfmNo+iAMtmToxFRJtTYhchfG4SkfAgjxNWgZ3jEvKFXwHEj9JwOJbBNOBkf7nmTQIxEigZVKMwdUqzLhrHIakWZv83UoF8VXTuViF/cpHFMhsCMWXhlood+Q2c95D+R4eYaId4eBE/cHOMUEElBIZS6QtAxQ1SgHjpyFIh0S99YgkFwF5umIY6EYf+VWwLMBv1IhR5sWFOogYhgQkGcAQ3Ng+4VJE90RXq44/sgz9yQpAMRRXJ0BUspgatswDQNpXkcV4scJN1qH9iwYcj0FWEhoG6lyf39ULSEEahODtZWAU/pQyMGXur6HkmYEHlBQhWtieVGJcw830plXPD0FffNwk5uWS3yQiU6SxiqZs2MUW2cixAt52544uxEhC76RgA1EJ8sTRQ2GfZ8Gl5JZhrhFmhEBW9Mmrh5o56l3+xsB7/WRQhDDGbr1abCiQLQjIe4YFllTMZT+ByAeJy9nA5agEpNzVdUaVKECEMrlktFIc+spVtBGSPglQJblFtv5SMITmSB4FF1/gCsTmAxZmW97eijTASGlM7kjY7KpdEZ1c1JcAMEroTXycIuHWhiZahPlgtBzc7ZEcsO3qMLaML5pSi/DmgMDCIagWSZ0kSJHUImeV7fBF8w+dmp4hpQ3VYlTQOuWR1BToROcE37/OeJTBw7Al3CkqiX4FTp2mWV8F5QlqXlZenQjajPAYPOVicddSNHKZyT7qcH7ZpN7ORFFWlXoQCV7oCXJCl3relqVlNXBA/oMAGBEB+3kCOA6kM/8qGPOMjBkaBEb8gTASqiQ3BBW/CCBE4p6/AkCKIezGBqEJYBIx5Qo7FPzeWEVYmpW1XqWhzqdDHAptKp52agTlgTYUkdTVkha6ykkZplwH0N/J1MJHgrKHVn9igI9OYq6dQTLHWqxPxq+8FFh7Kaof1fIu1WI/VB7MoAEtRKm8xG9KqotS6cjgGPdnKgnSpFuIEURKlYoIQEiHIH4XKpXlyE6+HmIz0U7xomPvQJwWZQ8D5kNDKVc4qaHnqh8RREXvliGEKfEZDpucmLOnWfJZ6Fp+YrkDgqgcgXP2Wc/8yBz+Rr+aDC9fWnADLnxCiCHUWQQaLhRz0m44SnKExVP9OZBRHJas1SpJhd0HSCRUMYAzlCJ34tJwdGbIQ26xmsKCs+FYNBYkrO37OUH4Joy/s537TuowpJTj0VY33hR9NRDds401lqBQcKhxlRXtYO6zfNBKASqEtWRt7a7ILCjrxZbaGQLKtZrJqax1OyAtmGEMoeYUrSQ1R95SXy2NYUAkjswqt6YEU1rAs9pE+y0L5Kge4xD09SrjAUX0R66YXEnaLK5RDeiQJmx8IOCOSS7j6yq+hoYr0OrM80S9eoEhje2xJugNucZmfG6MHG1aHkmM0SLN4CwlOIBTrgWbLCgOs21u9RbWIpRNoJhn3Ogb5up2oB0EJYLTh+4Qu6kX/Euup6EMUvztOgxsET1sb8CsGcIe8aplSQvsmlICOwHUAu7oWrrVrj3hLaZuo2MG53Mm0WaguwwmGIWS6I0QCEKAJc/EIQwEGoIG+LaK+dXRi/mu3++tuNBywd5sIgKt0agOupasqdoAHDpCUGoyN1puNDcmmGtMMdDBUhUQUiNQIeYGGYum1U+OVx4KKKwe1TIZsZkBpAMpaOMyfSgoJtbsI3JOXDYs+yVgOGgaa1Huy81GuUGCH4IA8LMiq5zhLnIM16mcF7jIP21C00GWkrWvGQIVpmkYDaDY2jEQCBnAMnqCmDumI9rp8V/uaswo2QilEIlxmUETCSOQ/P9FT/zqbuRusZH9oWXZIAKCBNDCzlOphhtwEkgW3Cwc4yJ07uMaKUmSsv0ClqujDLHYHtrKJEyWHBB/jiN8nt5qswwZarnScyA75oTqjx3OWULYsLYzgcC6oPIpQdv/jEjm6vth3Ai9ZpwKWoI4byZOBUOL6zgEEuSsJzdI8q/S3dYmMwq7cxk9cy48CkmHEhcXHKsdgRnKhnroVFwUCzMzKMHeJFW7JzjlXl7LZwthzUUiEhbjDDPtDm/n8xay8ytNHp5ULFhRsqNMctW0nYHA3nvAzyla7F1iAwKTKQSGNuNW1jRycyGWXGut6xCytS7NguPf30Ga1yT1d0vq80yMdN/+zsLs0ldSLiM9MjbJEnRCFqDeSyTfzh6EvUD/ElL/UlY1VXb1avc/tStIJbYNnwNUIBxUQnDh/xkXXcDkQDW9oPcdQ7dQ+jdUbBw9xzRMS8hcWvVp2jQJjXZXHVNacddZu6teF1X9JnB834gXRRrHhpjCapm6f4D8/VWrKS5Ko6lF/pov6+QPT+1jF1rHCOZ+N9QTF1tejx9eaa9ltTc2BrYSg5gR2jDMOkwKVwJBvYEuecG34yAaAFwgmnJXfFJAoetxIUww5pyPVGaKRqBTPiduRd9uqfNW5ndWJ3NtdNwyURFRhw3QNvA+lCwc9Erg+aQKYCiqCMDcM1wYIUMT/YAC5CZomztigkFvb0/fdQ/3TH8jWJn3ZE/MRIfG5RYoI3WhztUEH69AUMViZpi0gzr132LMI4qkHFRXHTcUMOeq7JlsE/uOjjx3W+lzg8Hrgld3UlI1DXTxnJCaoR9SJvETCA3HKqNfJJqAzHL4JSYY/kFJR6wk4YHDTChzAKJ7Q+HvTAy4eKK0CMLojL27W6Czeu93lqyGyzGVg0Twx6xbDEc2DWg7ZXK7bwKHm2ngW0DqBRD7ZI3BIHyN0K43lMirZbK7gM47gSy3oaXEIv7BYxxoVtC053hkXc6HIfCF8mdw8b07nfv7XgC7j4U3mjXAE92jdJQoJiM0fbrQ//8t9js886X2u1gnu5W1u6adwlR2FAnCCDP2tXgJeQgHoUG0AK+uY6iL96oGO6Ws96DmcR+K1HunykbWDFYVzy4xA6qco0SCNFpQ+5pr+5+Md2H69xWR6WJn1ifzANnTTr5/NwEECLh/BeYgOKbjaBIwuF/3CdqT4Q9Wu6jFO7MPO6tw+ogkjwXS7DAOwBKQTFdem0lxq2/e+7cKu7V9u6SoJ34KTTQHvrZ/rLEBMo3Oo8A6f6a2e7TyNNXOpKuYTDnmZP5JaSMK3bov3v2i58a7e8W6+6l1+YyBceaRjZ+9eCSNhALiCerOX8WiQ19Rk7Yi88DGPxDCP7xDHppuLCv9D31FFf84zr+/edfRLP98gK/NPD5LvinZS3+JXv+9J//F1rtWc1hbCsp2ynVIAMVSlcX1UX/YM7/GXju0gHwvl0n5A4DUv0/VgIFFjBudKL/aAbfiEz/Ex3gY9wgD1wstQr12zDPeDP/dyX/dbX/iID/M1sD8kNS64m5HiM2eTD/ZIavmYf/iVj/Wb718cJENxEeUgCSlvP8Yvr/pjz0enT/dm7+K2b/e/j/qaf/uJT+Ol78XBjvS5v/rDnx6Ti8/GH/fLf/lkD/yW7iA59NZmsEWcqNdaB/2UX/3Jv7bE3+U59Sh0yQp7LrYr3fvArvvKj/v5ju2+1AJoJiOt4rb/mPZp/hrvIHAIycgIwuGQxgEsZ2GcwytAAJ4LOd/7PzAoHBJ3ACMxqVwygcgmNCrVTavW3vOqDWa33mT3K252EQaASFA4DgCNBOChABgIroHIQR8YHr5EgxtE3h7dQUHbAASBQgsAwZoIg9NYpZJRmKUm5WanUKanF2go0yiplenpWJfcJADCmtFC29FB3Z0IziwCSWDOLQGLbBuLDAxsDiTOgIIBLU+qKipOtPRWtfUVdjYYN9S292f4ZheDQcHkQCzOW9xcAgJDAt6OuR+1IwCgYK694XyyRjgIwEl2Bsu4L5gSWgLH8NLDKQ65TYx4xKLCHypOADQi7wSCVxzp/8HQVzKHAxkGHKRRg4PFRgELXMAwJ2DAiZs+KmKk5rOnFp5AoQ1dIlTV0YRJhy7NkasKA4HTipL5SVVK055ZKV6l0lXc129fnkp5cUNb2G4X05Zi29Ytwq9bs82NmAkgAgEHiSwIKcaBVKNwuVgdDNbwYcN1GyIu3HjnD2QAFNhR0reSoqqPvS5m2Fnp489iRIci7S0MhHvbLg9xaMIVxM0/TXOVDbkx7aChbd/uoWBSjQF5S3wUEHK4ccAn9PSoUSClXgcQ2hz4XeNsgnuxZS/kTdS7V8S50eIGHz5HVCom/Mxr10qBn74LfHHa12DRmQYNJPFgvX1zd+aNJ82Alf8UKNFu5q3FQ3o+PUXDLPjIgoADBdiQz3fAnGEAAgIx44wufv2X4IGklFhagl2dKIqCC/Lwm0/r6TOAe78JoAc8ORQQz43QTGLfDcysYRAO2b3FnWO8rdjJkrrJlSJ4qKmGw3AJMFBcSDiNgEADHB3wwJA5QKAGdCsBIKMJM5wpAGxqIemid01qIudUKkIZZ2RhWtGAiEOkBERmRwKYpG10GnhnUYYiqOBdz5ASoQ+AYejmoHAq2aKiWIWVaRScssjopZYWiimiTJX6poChenoNqeU96WqqoI4qKqpRnqrVrbnCWumqTsYq3qa6Aivrm72S96tiwe6KJ7G8torsYMb/xjUstKEW+6ytyyYqbLJT+CcGAjMtem2zzFJ7lbSUmusUCtRU9sO3X4RbRbpv1atpuXDdS2ta+4rVgwiOCPCuD/EGocwS847rbL6znkuVv5xUG7C7A5AggB/IhdSlTjsqYPEMxqhTUjAKCBAIdDIV56i6rkYs6LrRKvuwtewKTIA6AKgTVXwIBHNAVBXewEsyekZFwM8O7FBAIOES3amq2Mas78zdTtyuCTi3AclTfSE3cAF2MPBCAkgPqeXACO9wS7hjj0Bwy8O+LFjDbO0797TZ+hYITgwMsDU6PcLzgAGwhc0DDQSh0S5las/ohrg6Rz6iy1LXLPOrNDvMAyMg/+kMuM4cbZzTIXY8cAJlNo2sQOND7kAARwucLgBlmpFb7eaY26lt7pdXXnelmgOF93e410qi5b27dTe3uuvNsPHBW41u81T3JkUDLOsIN2OzEl9E8nZX7fzU/CpROBCHe/L9bewnVr74mU9fvlAI/6D+EPhD7X340pO/Le+O55My6WEEIwBAyibnhj4p50YFIIFAajCTv13sBAtDHvCqZyr5/U95OwDSEexAGaa9QoEwysF8dNSG6cjhANVxgMVaoL9/3e558OvX+KyHu7XZIRhrCRvbJkeAs6DEQoM43N8ks6O/4WCGtoOeDX23vBxOsWEfDMR9fkiQNjRgcrJLH9Es7PC3Fr6QiQAogHb2V8MbanB4VIzfDhGokgI2EWknMMDk0McDjiWgdJ+jiUz+GDqeuO87hZRYFKu4O+H5DwopxMEDFHiaqGUwgDjkoA4TmYQqTeohh5xN/9qIK0wqUpONlFsoLfnGUTJSlKu0Xk5iKctZ0rKWtrwlLnOpy13yspe+/CUwgynMYRKzmMY8JjKTqcxlMrOZznxmL1skzWlSs5rWvCY2s6nNbXKzm978JjjDKc5xkrOc5jwnOtOpznWys53ufCc84ynPedKznp0IAQA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     &copy; 2007 Chris Johnson, MD, AAP Council on Children with Disabilities. Adapted with permission and contributions from: Frances Page Glascoe, PhD and Nicholas Robertshaw, authors of PEDS:Developmental Milestones; Franklin Trimm, MD, Vice Chair of Pediatrics, USA/APA Education Committee; the Center for Disease Control \"Act Early\" Initiative; the National Institute for Literacy/Reach Out and Read; and the Inventory of Early Development by Albert Brigance published by Curriculum Associates, Inc. Permission is granted to reproduce these pages on the condition that they are only used as guide to average development and not as a substitute for standardized validated screening for developmental-behavioral problems.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 630px\">",
"   <div class=\"ttl\">",
"    Developmental milestones: 4 years, 0 months through 7 to 8 years",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 610px; height: 715px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     &copy; 2007 Chris Johnson, MD, AAP Council on Children with Disabilities. Adapted with permission and contributions from: Frances Page Glascoe, PhD and Nicholas Robertshaw, authors of PEDS:Developmental Milestones; Franklin Trimm, MD, Vice Chair of Pediatrics, USA/APA Education Committee; the Center for Disease Control \"Act Early\" Initiative; the National Institute for Literacy/Reach Out and Read; and the Inventory of Early Development by Albert Brigance published by Curriculum Associates, Inc. Permission is granted to reproduce these pages on the condition that they are only used as guide to average development and not as a substitute for standardized validated screening for developmental-behavioral problems.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 630px\">",
"   <div class=\"ttl\">",
"    Developmental milestones: 4 years, 0 months through 7 to 8 years (continued)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 610px; height: 591px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     &copy; 2007 Chris Johnson, MD, AAP Council on Children with Disabilities. Adapted with permission and contributions from: Frances Page Glascoe, PhD and Nicholas Robertshaw, authors of PEDS:Developmental Milestones; Franklin Trimm, MD, Vice Chair of Pediatrics, USA/APA Education Committee; the Center for Disease Control \"Act Early\" Initiative; the National Institute for Literacy/Reach Out and Read; and the Inventory of Early Development by Albert Brigance published by Curriculum Associates, Inc. Permission is granted to reproduce these pages on the condition that they are only used as guide to average development and not as a substitute for standardized validated screening for developmental-behavioral problems.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44570=[""].join("\n");
var outline_f43_33_44570=null;
var title_f43_33_44571="Hormonally active herbs";
var content_f43_33_44571=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F61831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F61831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hormonally active herbal ingredients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Agnus castus",
"       </td>",
"       <td>",
"        Many uses in hormonal imbalance disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alfalfa",
"       </td>",
"       <td>",
"        Estrogenic, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aniseed",
"       </td>",
"       <td>",
"        Estrogenic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bayberry",
"       </td>",
"       <td>",
"        Mineralocorticoid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cohosh, black",
"       </td>",
"       <td>",
"        Estrogenic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fucus",
"       </td>",
"       <td>",
"        Hyper-/hypothyroidism reported",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ginsengs",
"       </td>",
"       <td>",
"        Estrogenic, human",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Horseradish",
"       </td>",
"       <td>",
"        May depress thyroid activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Liquorice",
"       </td>",
"       <td>",
"        Mineralocorticoid activity, human; estrogenic in vivo, in vitro",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Motherwort",
"       </td>",
"       <td>",
"        Oxytoxic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pleurisy root",
"       </td>",
"       <td>",
"        Estrogenic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Red clover",
"       </td>",
"       <td>",
"        Estrogenic in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Saw palmetto",
"       </td>",
"       <td>",
"        Estrogenic and antiadrogenic in vivo; human use in prostate cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vervain",
"       </td>",
"       <td>",
"        Inhibition of gonadotrophic activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wild carrot",
"       </td>",
"       <td>",
"        Estrogenic",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals, The Pharmaceutical Press, London 1996, p.283.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44571=[""].join("\n");
var outline_f43_33_44571=null;
var title_f43_33_44572="Suicide evaluation";
var content_f43_33_44572=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F63368&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F63368&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    \"MALPRACTICE\" mnemonic for evaluation of suicidal child or adolescent",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"3\">",
"        M -Mental health",
"       </td>",
"       <td>",
"        Does the patient have a psychiatric diagnosis?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Is he or she taking psychotropic medications?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Is there a family history of mental health illness?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"3\">",
"        A -Attempts",
"       </td>",
"       <td>",
"        When did the patient first consider suicide?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has the patient tried to harm him- or herself before?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Did he or she receive medical attention for that attempt?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"3\">",
"        L -Lethality",
"       </td>",
"       <td>",
"        Did the patient want to die?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Does he or she still want to?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Does he or she have access to lethal means?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"3\">",
"        P -Plans",
"       </td>",
"       <td>",
"        Is the patient able to make plans for the future?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Will he or she graduate from school?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        What kind of job will he or she do?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"2\">",
"        R -Risk-taking",
"       </td>",
"       <td>",
"        Is the patient engaging in activities that may be disguised attempts at self-harm?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Is the patient engaging in unprotected sexual activity?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"4\">",
"        A -Alcohol and drugs",
"       </td>",
"       <td>",
"        Were substances involved in the current attempt?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        For how long have substances been used?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        What substances are being used?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        When was the last use?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        C -Conflict",
"       </td>",
"       <td>",
"        Is there an interpersonal conflict that precipitated this event?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"3\">",
"        T -Trauma",
"       </td>",
"       <td>",
"        Does the patient report having been physically or sexually abused?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has the patient been a witness to violence?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has the patient recently lost a loved one?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"4\">",
"        I -Impulsivity",
"       </td>",
"       <td>",
"        Was the act premeditated?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        How much planning went into the suicide attempt?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Was a suicide note written?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Did the patient tell anyone about his or her plans?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        C -Community resources",
"       </td>",
"       <td>",
"        Does the patient have a social support system?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"3\">",
"        E -Exposure",
"       </td>",
"       <td>",
"        Have other family members or friends attempted or completed suicide?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has the patient been exposed to suicide in the media?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Is this attempt part of a suicide epidemic?",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Press, BR, Khan, SA. Curr Opin Pediatr 1997; 9:237.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44572=[""].join("\n");
var outline_f43_33_44572=null;
var title_f43_33_44573="Benefits and harms of aspirin when used for 10 years";
var content_f43_33_44573=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F62463&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F62463&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Estimated number of strokes prevented and estimated harms of using aspirin for 10 years in a hypothetical cohort of 1000 women on the basis of age and 10-year stroke risk",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Variable",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Estimated strokes prevented (per 1000 women),",
"        <em>",
"         n",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        10-year stroke risk, percent",
"       </td>",
"       <td class=\"subtitle2\">",
"        Age 55 to 59 years",
"       </td>",
"       <td class=\"subtitle2\">",
"        Age 60 to 69 years",
"       </td>",
"       <td class=\"subtitle2\">",
"        Age 70 to 79 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1",
"       </td>",
"       <td>",
"        <strong>",
"         1.7",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         1.7",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         1.7",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2",
"       </td>",
"       <td>",
"        <strong>",
"         3.4",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         3.4",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         3.4",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3",
"       </td>",
"       <td>",
"        5.1",
"       </td>",
"       <td>",
"        <strong>",
"         5.1",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         5.1",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4",
"       </td>",
"       <td>",
"        6.8",
"       </td>",
"       <td>",
"        <strong>",
"         6.8",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         6.8",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5",
"       </td>",
"       <td>",
"        8.5",
"       </td>",
"       <td>",
"        <strong>",
"         8.5",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         8.5",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        6",
"       </td>",
"       <td>",
"        10.2",
"       </td>",
"       <td>",
"        <strong>",
"         10.2",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         10.2",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        7",
"       </td>",
"       <td>",
"        11.9",
"       </td>",
"       <td>",
"        <strong>",
"         11.9",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         11.9",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        8",
"       </td>",
"       <td>",
"        13.6",
"       </td>",
"       <td>",
"        13.6",
"       </td>",
"       <td>",
"        <strong>",
"         13.6",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        9",
"       </td>",
"       <td>",
"        15.3",
"       </td>",
"       <td>",
"        15.3",
"       </td>",
"       <td>",
"        <strong>",
"         15.3",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        10",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        <strong>",
"         17",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        11",
"       </td>",
"       <td>",
"        18.7",
"       </td>",
"       <td>",
"        18.7",
"       </td>",
"       <td>",
"        18.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        12",
"       </td>",
"       <td>",
"        20.4",
"       </td>",
"       <td>",
"        20.4",
"       </td>",
"       <td>",
"        20.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        13",
"       </td>",
"       <td>",
"        22.1",
"       </td>",
"       <td>",
"        22.1",
"       </td>",
"       <td>",
"        22.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        14",
"       </td>",
"       <td>",
"        23.8",
"       </td>",
"       <td>",
"        23.8",
"       </td>",
"       <td>",
"        23.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        15",
"       </td>",
"       <td>",
"        25.5",
"       </td>",
"       <td>",
"        25.5",
"       </td>",
"       <td>",
"        25.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        16",
"       </td>",
"       <td>",
"        27.2",
"       </td>",
"       <td>",
"        27.2",
"       </td>",
"       <td>",
"        27.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        17",
"       </td>",
"       <td>",
"        28.9",
"       </td>",
"       <td>",
"        28.9",
"       </td>",
"       <td>",
"        28.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        18",
"       </td>",
"       <td>",
"        30.6",
"       </td>",
"       <td>",
"        30.6",
"       </td>",
"       <td>",
"        30.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        19",
"       </td>",
"       <td>",
"        32.3",
"       </td>",
"       <td>",
"        32.3",
"       </td>",
"       <td>",
"        32.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        20",
"       </td>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        34",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Type of event",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"3\">",
"        Estimated harms,",
"        <em>",
"         n",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        GI bleeding",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        18",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    As indicated, the estimated number of strokes avoided varies with 10-year stroke risk. The estimated harms of using aspirin vary with age. Therefore, both 10-year stroke risk and age must be considered when determining whether the potential harms of aspirin use outweigh the potential benefit in terms of strokes prevented. The boldfaced numbers indicate the combinations of 10-year stroke risk and age for which the number of harms (GI bleeding) are greater than the number of strokes prevented.*",
"    <div class=\"footnotes\">",
"     GI: gastrointestinal.",
"     <br>",
"      * Calculations of estimated benefits and harms rely on assumptions and are by nature somewhat imprecise. Estimates of benefits and harms, especially at the borders of the boldfaced and non-boldfaced areas, should be considered in the full context of clinical decision making and used to stimulate shared decision making. The calculations in the table are based on the following assumptions: that there is a 17 percent risk reduction of strokes with regular aspirin use and that gastrointestinal bleeding includes serious hemorrhage, perforation, or other complications leading to hospitalization or death. Harm of GI bleeding in the table assumes that risk for GI bleeding increases with age and that the women are not taking nonsteroidal anti-inflammatory drugs, do not have upper GI pain, or do not have a history of GI ulcer. \"Strokes prevented\" is the net reduction of strokes, which includes a decrease in ischemic strokes and a small increase in hemorrhagic strokes.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: US Preventive Services Task Force. Aspirin for the Prevention of Cardiovascular Disease: Recommendation Statement. AHRQ Publication No. 09-05129-EF-2, March 2009. Agency for Healthcare Research and Quality, Rockville, MD. file://www.ahrq.gov/clinic/uspstf09/aspirincvd/aspcvdrs.htm.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44573=[""].join("\n");
var outline_f43_33_44573=null;
var title_f43_33_44574="Rotator cuff tear plain xray";
var content_f43_33_44574=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F61275&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F61275&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rotator cuff tendon tear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 335px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This radiograph is from a 74-year-old woman with a 25 year history of \"shoulder bursitis.\" She is unable to raise her arm overhead, cannot comb her hair, and cannot reach up to higher shelves to remove dishes. She uses her left arm to assist with abduction. Her external rotation strength is nonexistent and abduction strength is poor. The plain x-ray provides indirect evidence of a rotator cuff tendon tear. Cephalad migration of the humerus (high-riding humeral head) is evident; the subacromial space, which contains the 7 mm thick rotator cuff tendon and a 1 mm thick subacromial bursa, has worn away.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44574=[""].join("\n");
var outline_f43_33_44574=null;
var title_f43_33_44575="Hemorrhoids PI";
var content_f43_33_44575=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F73076&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F73076&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hemorrhoids",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 316px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hemorrhoids that are hidden inside the rectum are called \"internal\" hemorrhoids. You cannot see them, but they can cause symptoms. Hemorrhoids that you can see or feel are called \"external\" hemorrhoids.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_33_44575=[""].join("\n");
var outline_f43_33_44575=null;
